data_2ksb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.927 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.98 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.897 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.927 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.93 ' HA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.039 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.952 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.039 ' H ' HG21 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.691 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.006 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.022 HD12 HG11 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.022 HG11 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.006 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD22 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.871 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD22 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.828 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.897 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . 0.46 ' NE2' ' HE2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.08 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.428 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.926 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.3 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.97 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.97 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.76 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.2 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52 103.702 172.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.926 HD13 HG11 ' A' ' 4' ' ' VAL . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.85 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.95 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.49 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.95 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.8 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.91 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.861 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.93 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.86 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.46 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.6 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.93 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.87 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.57 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.06 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.94 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.959 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.16 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.978 HG23 HG22 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.39 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.64 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.16 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.3 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.7 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.4 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.57 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.89 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.638 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.01 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.1 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.021 HD12 HG11 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.66 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.105 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.93 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.951 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.99 HG21 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.22 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.6 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.99 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.914 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.3 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.71 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.89 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.89 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.97 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.1 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.876 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.45 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.988 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.6 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.978 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.19 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.894 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.02 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.66 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.901 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.43 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72 112.383 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.58 109.338 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.6 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68 110.851 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.34 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.894 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.582 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.988 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.71 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.7 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.89 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.945 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.83 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.4 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.065 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.3 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.36 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.089 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.73 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.977 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.39 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.34 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.68 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.85 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.119 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.98 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.89 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.797 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.808 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.58 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.71 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.51 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.23 107.829 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.8 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.648 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.29 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.951 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.11 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.33 107.706 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.69 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.86 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.13 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.88 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.86 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.065 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.64 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.57 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.16 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.874 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 1.001 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.67 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.42 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.025 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.4 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.1 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.025 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.8 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.107 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.53 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.81 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.777 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.91 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.825 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.77 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.18 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.3 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.15 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.107 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.89 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.898 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.89 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 1.001 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.42 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.48 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.86 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.16 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.926 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.17 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.6 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.1 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.89 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.977 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.41 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.903 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.41 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.896 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.88 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.29 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.89 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.26 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.71 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.86 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.443 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.443 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.78 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.46 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.35 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.22 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.57 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.871 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.57 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.748 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.41 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.867 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.62 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.29 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.49 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.97 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.878 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.27 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.98 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.059 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.878 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.05 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.01 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.09 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.39 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.42 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.539 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.18 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.33 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.798 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.23 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.845 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.35 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.752 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.23 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.78 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.89 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.834 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.54 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.898 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.03 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.834 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.776 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.26 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.828 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.26 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.07 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.04 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.06 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.855 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.9 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.845 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.92 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.17 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.829 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.57 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.29 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.829 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.749 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.749 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.059 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.43 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.72 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.619 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.48 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.6 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.123 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.46 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.32 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.123 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.11 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.24 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.73 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.68 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.03 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.57 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.986 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.054 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.986 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.22 109.101 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.054 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.73 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.945 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.05 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.995 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.78 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.105 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.34 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.57 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.01 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.78 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.994 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.2 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.994 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.34 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.26 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.784 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.23 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.58 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.95 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.85 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.62 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.88 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.455 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.08 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.3 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.973 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.973 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.76 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.2 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52 103.679 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.85 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.043 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.021 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.73 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.043 ' H ' HG21 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.49 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.98 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.95 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.91 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.93 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.86 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.46 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.843 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.6 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.93 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.843 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.87 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.06 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.94 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.61 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.16 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.914 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.85 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.008 HG23 HG23 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.39 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.64 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.793 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.16 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.3 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.7 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.4 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.57 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.01 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.1 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.673 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.894 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.013 HD12 HG11 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.32 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.66 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.954 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.103 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.93 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.853 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.947 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.994 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.853 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.22 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.939 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.6 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.994 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.013 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.914 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.3 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.71 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.89 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.703 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.89 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.1 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.839 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.45 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.998 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.6 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.19 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.82 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.957 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.902 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.02 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.66 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.902 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.882 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.021 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.58 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.6 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68 110.917 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.34 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.912 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.488 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.998 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.71 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.7 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.89 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.83 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.4 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.3 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.36 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.082 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.73 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.981 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.39 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.867 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.34 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.68 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.867 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.96 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.85 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.98 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.891 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.796 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.791 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.58 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.71 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.51 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.866 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.23 107.837 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.8 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.29 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.947 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.33 107.696 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.69 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.86 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.938 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.13 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.88 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.86 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.785 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.44 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.64 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD22 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.57 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.16 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.876 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 1.0 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.67 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.42 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.028 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.4 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.1 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.028 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.8 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.113 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.53 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.113 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.113 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.789 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.81 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.781 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.818 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.82 ' N ' ' HE2' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.062 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.822 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.77 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.556 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.18 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.842 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.047 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.3 106.735 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.047 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.15 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.113 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.89 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.898 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.062 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 1.0 HG13 HD12 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.42 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.48 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.86 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.16 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.17 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.6 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.1 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.89 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.981 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.41 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.69 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.41 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.88 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.29 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.906 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.891 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.26 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.71 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.86 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.847 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.926 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.78 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.46 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.35 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.803 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.22 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.57 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.869 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.781 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.57 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.577 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.659 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.747 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.41 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.869 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.29 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.49 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.97 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.27 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.98 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.059 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.05 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.01 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.09 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.39 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.42 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.18 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.33 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.564 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.23 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.35 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.752 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.23 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.78 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.54 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.685 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.898 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.03 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.777 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.824 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.26 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.07 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.04 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.052 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.82 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.633 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.9 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.873 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.92 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.664 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.71 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.17 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.57 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.793 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.29 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.748 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.748 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.059 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.43 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.72 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.481 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.6 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.117 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.46 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.32 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.117 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.11 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.24 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.73 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.29 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.815 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.68 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.815 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.03 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.652 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.047 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.22 109.113 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.913 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.047 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.944 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.771 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.996 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.78 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.103 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.34 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.502 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.1 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.507 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.01 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.875 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.78 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.993 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.2 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.993 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.34 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.26 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.785 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.23 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.95 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.85 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.88 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.556 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.863 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' B' ' 365' ' ' ARG . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . 0.73 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.08 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.428 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.929 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.3 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.76 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.922 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.2 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52 103.661 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.85 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.043 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.955 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.043 ' H ' HG21 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.49 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.98 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.8 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.91 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.933 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.845 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.86 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.46 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.6 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.933 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.87 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.693 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.815 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.06 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.94 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.704 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.61 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.16 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.914 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.85 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.998 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.39 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.64 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.792 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.16 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.3 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.7 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.4 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.57 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.01 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.1 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.024 HD12 HG11 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.32 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.66 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.93 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.069 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.006 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.855 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 1.0 HG21 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.855 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.2 m-20 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.22 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.6 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.024 HG11 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.3 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.71 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.89 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.89 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.97 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.1 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.45 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.993 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.6 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.998 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.19 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.898 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.82 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.958 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.02 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.66 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.863 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.43 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.955 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.58 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.6 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.34 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.898 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.485 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.993 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.71 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.941 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.7 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.89 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.83 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.4 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.3 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.36 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.73 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.979 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.39 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.34 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.68 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.127 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.98 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.58 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.892 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.71 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.51 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.23 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.8 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.29 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.11 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.33 107.672 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.786 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.86 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.13 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.88 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.86 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.44 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.64 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.81 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.57 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.16 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.867 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.67 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.42 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.027 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.4 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.027 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.8 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.115 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.53 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.81 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.91 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.828 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.77 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.18 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.842 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.056 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.3 106.755 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.056 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.15 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.115 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.89 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.42 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.48 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.86 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.989 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.16 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.17 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.6 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.1 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.89 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.979 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.41 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.69 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.41 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.88 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.29 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.906 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.71 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.86 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.78 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.46 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.35 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.22 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.57 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.736 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.871 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.57 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.58 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.659 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.41 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.867 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.62 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.29 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.49 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.97 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.27 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.98 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.05 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.09 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.39 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.42 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.18 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.33 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.565 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.23 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.829 ' O ' HG23 ' A' ' 266' ' ' ILE . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.906 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.35 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.23 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.78 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.54 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.03 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.26 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.07 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.04 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.82 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.9 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.906 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.92 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.659 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.17 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.832 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.57 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.792 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.29 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.832 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.746 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.746 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.43 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.849 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.6 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.119 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.46 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.32 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.119 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.11 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.24 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.73 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.29 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.68 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.03 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.57 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.849 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.99 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.063 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.069 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.99 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.22 109.097 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.063 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.73 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.948 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.05 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.2 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.78 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.34 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.51 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.1 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.01 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.878 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.78 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.985 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.2 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.985 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.34 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.26 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.23 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.518 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.58 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.892 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.95 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.622 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.85 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.622 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.88 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.655 ' HB2' HD22 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.08 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.92 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.3 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.968 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.968 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.76 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.979 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.715 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.925 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.2 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52 103.662 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.4 t-20 -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.925 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.85 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.029 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.954 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.73 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.029 ' H ' HG21 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.49 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.98 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.879 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.95 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.8 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.91 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.928 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.845 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.86 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.46 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.839 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.6 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.928 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.82 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.87 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.689 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.57 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.816 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.06 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.94 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.61 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.962 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.16 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.919 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.979 HG23 HG22 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.39 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.64 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.802 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.643 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.16 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.3 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.7 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.4 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.812 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.89 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.636 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.01 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.719 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.1 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.676 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.902 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.034 HD12 HG11 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.66 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.95 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.103 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.93 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.063 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.015 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.861 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.986 HG21 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.861 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.22 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.6 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.986 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.034 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.3 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.71 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.89 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.89 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.97 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.1 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.74 113.847 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.6 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.979 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.19 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.892 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.82 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.962 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.02 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.816 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.879 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.43 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.954 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.58 109.29 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.6 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68 110.902 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.34 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.892 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.7 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.754 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.89 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.83 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.4 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.07 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.3 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.36 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.096 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.73 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.972 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.39 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.34 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.68 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.85 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.117 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.98 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.799 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.58 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.71 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.51 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.23 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.8 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.648 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.29 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.11 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.33 107.666 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.69 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.86 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.13 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.88 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.07 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.779 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.44 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.64 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.816 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.57 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.16 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.87 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.999 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.42 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.021 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.4 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.1 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.021 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.8 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.101 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.53 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.81 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.772 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.772 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.91 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.823 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.059 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.77 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.948 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.067 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.067 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.15 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.101 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.89 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.059 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.999 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.42 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.812 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.48 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.86 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.992 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.16 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.17 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.6 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.1 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.89 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.972 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.41 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.899 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.41 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.88 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.29 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.899 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.26 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.71 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.86 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.78 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.46 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.35 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.22 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.57 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.875 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.932 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.57 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.664 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.41 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.861 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.62 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.29 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.49 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.932 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.97 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.878 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.27 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.98 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.878 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.05 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.01 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.09 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.39 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.42 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.542 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.18 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.33 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.57 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.798 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.23 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.844 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.35 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.23 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.905 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.78 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.887 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.832 HD12 HD22 ' A' ' 279' ' ' LEU . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.54 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.03 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.83 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.851 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.027 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.26 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.832 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.26 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.027 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.04 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.77 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.067 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.82 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.919 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.638 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.856 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.9 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.869 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.844 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.92 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.17 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.828 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.57 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.802 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.29 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.828 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.75 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.75 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.43 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.72 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.704 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.857 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.6 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.134 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.46 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.32 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.134 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.11 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.24 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.73 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.29 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.81 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.68 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.81 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.03 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.857 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.063 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.996 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.22 109.104 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.032 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.05 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.773 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.2 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.994 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.78 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.103 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.34 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.507 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.57 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.1 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.01 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.78 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.994 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.2 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.994 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.34 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.26 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.23 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.95 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.85 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.63 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.88 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.573 ' NH2' HD12 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.834 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.927 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.98 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.897 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.927 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.93 ' HA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.039 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.952 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.039 ' H ' HG21 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.691 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.006 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.022 HD12 HG11 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.022 HG11 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.006 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 1.225 HD11 ' CD1' ' B' ' 372' ' ' PHE . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD22 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.871 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD22 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.828 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.897 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 -75.78 20.97 0.16 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 1.225 ' CD1' HD11 ' A' ' 102' ' ' LEU . 17.0 m-85 -74.96 11.06 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.391 . . . . 1.0 110.274 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.25 -10.49 7.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.527 HD23 ' HE1' ' B' ' 375' ' ' MET . 0.3 OUTLIER -69.74 -42.25 74.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.728 0.299 . . . . 1.0 110.756 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.527 ' HE1' HD23 ' B' ' 374' ' ' LEU . 7.2 mmt . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.08 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.428 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.926 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.3 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.97 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.97 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.76 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.2 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52 103.702 172.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.926 HD13 HG11 ' A' ' 4' ' ' VAL . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.85 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.95 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.49 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.95 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.8 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.662 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.91 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.861 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.93 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.86 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.46 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.6 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.93 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.87 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.57 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.06 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.94 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.959 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.16 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.978 HG23 HG22 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.39 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.64 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.16 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.3 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.7 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.4 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.57 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.89 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.638 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.01 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.1 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.021 HD12 HG11 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.66 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.105 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.93 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.951 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.99 HG21 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.22 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.6 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.99 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.914 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.3 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.71 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.89 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.89 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.97 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.1 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.876 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.45 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.988 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.6 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.978 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.19 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.894 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.02 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.66 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.901 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.43 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 1.057 HD12 ' HB2' ' B' ' 375' ' ' MET . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72 112.383 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' HE1' ' O ' ' B' ' 374' ' ' LEU . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.58 109.338 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.6 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HB2' ' HE2' ' B' ' 375' ' ' MET . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68 110.851 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.34 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.894 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.582 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.988 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.71 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.7 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.89 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.945 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.83 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.4 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.065 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.3 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.36 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.089 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.73 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.977 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.39 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.34 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.68 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.85 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.119 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.98 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.89 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.797 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.808 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.58 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.71 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.51 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.23 107.829 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.8 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.648 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.29 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.951 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.11 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.33 107.706 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.69 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.86 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.13 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.88 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.86 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.065 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.64 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.57 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.16 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.874 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 1.001 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.67 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.42 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.025 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.4 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.1 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.025 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.8 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.107 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.53 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.81 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.777 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.91 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.825 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.77 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.18 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.3 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.15 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.107 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.89 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.898 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.89 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 1.001 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.42 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.48 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.86 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.16 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.926 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.17 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.6 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.1 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.89 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.977 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.41 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.903 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.41 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.896 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.88 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.29 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.89 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.26 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.71 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.86 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.443 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.443 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.78 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.46 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.35 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.22 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.57 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.871 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.57 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.748 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.41 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.867 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.62 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.29 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.49 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.97 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.878 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.27 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.98 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.059 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.878 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.05 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.01 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.09 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.39 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.42 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.539 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.18 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.33 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.798 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.23 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.845 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.35 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.752 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.23 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.78 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.89 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.834 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.54 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.898 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.03 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.834 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.776 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.26 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.828 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.26 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.07 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.04 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.06 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.855 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.9 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.845 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.92 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.17 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.829 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.57 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.29 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.829 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.749 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.749 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.059 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.43 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.72 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.619 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.48 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.6 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.123 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.46 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.32 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.123 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.11 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.24 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.73 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.68 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.03 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.57 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.986 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.054 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.986 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.22 109.101 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.054 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.73 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.945 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.05 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.995 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.78 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.105 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.34 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.57 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.01 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.78 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.994 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.2 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.994 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.34 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.26 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.784 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.23 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.58 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.95 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.85 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.62 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.88 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.455 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 -75.82 21.04 0.16 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' B' ' 370' ' ' GLN . 4.0 m-85 -75.03 11.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.214 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.55 7.31 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.817 HD13 HG22 ' A' ' 19' ' ' THR . 6.5 mt -69.75 -42.28 74.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.758 0.313 . . . . 1.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 1.057 ' HB2' HD12 ' A' ' 102' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.422 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.08 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.3 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.973 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.973 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.76 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.2 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52 103.679 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.85 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.043 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.021 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.73 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.043 ' H ' HG21 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.49 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.98 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.95 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.91 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.93 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.86 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.46 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.843 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.6 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.93 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.843 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.87 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.06 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.94 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.61 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.957 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.16 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.914 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.85 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.008 HG23 HG23 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.39 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.64 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.793 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.16 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.3 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.7 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.4 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.57 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.01 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.1 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.673 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.894 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.013 HD12 HG11 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.32 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.66 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.954 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.103 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.93 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.853 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.947 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.994 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.853 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.22 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.939 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.6 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.994 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.013 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.914 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.3 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.71 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.89 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.703 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.89 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.1 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.839 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.45 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.998 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.6 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.19 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.82 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.957 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.902 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.02 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.66 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.902 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.882 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.021 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.58 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.6 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68 110.917 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.34 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.912 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.488 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.998 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.71 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.7 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.89 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.83 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.4 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.062 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.3 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.36 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.082 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.73 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.981 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.39 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.867 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.34 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.68 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.867 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.96 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.85 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.98 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.891 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.796 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.791 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.58 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.71 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.51 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.866 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.23 107.837 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.8 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.29 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.947 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.33 107.696 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.69 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.86 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.938 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.13 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.498 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.88 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.86 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.062 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.785 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.44 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.64 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD22 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.57 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.16 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.876 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 1.0 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.67 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.42 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.028 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.4 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.1 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.028 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.8 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.113 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.53 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.113 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.113 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.789 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.81 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.781 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.818 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.82 ' N ' ' HE2' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.062 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.822 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.77 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.556 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.18 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.842 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.047 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.3 106.735 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.047 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.15 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.113 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.89 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.898 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.062 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 1.0 HG13 HD12 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.42 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.48 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.86 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.16 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.17 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.6 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.1 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.68 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.89 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.981 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.41 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.69 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.41 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.88 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.29 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.906 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.891 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.26 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.71 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.86 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.847 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.926 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.78 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.46 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.35 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.803 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.22 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.57 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.869 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.781 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.57 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.577 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.659 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.747 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.41 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.869 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.29 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.49 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.97 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.27 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.98 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.059 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.05 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.01 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.09 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.39 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.42 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.18 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.33 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.564 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.23 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.35 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.752 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.23 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.78 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.54 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.685 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.898 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.03 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.777 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.824 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.26 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.07 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.04 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.052 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.82 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.633 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.9 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.873 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.92 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.664 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.71 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.17 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.57 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.793 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.29 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.748 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.748 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.059 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.43 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.72 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.481 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.6 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.117 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.46 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.32 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.117 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.11 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.24 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.73 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.29 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.815 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.68 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.815 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.03 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.652 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.047 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.22 109.113 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.913 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.047 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.944 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.771 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.996 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.78 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.103 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.34 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.502 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.1 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.507 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.01 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.875 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.78 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.993 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.2 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.993 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.34 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.26 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.785 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.23 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.95 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.85 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.88 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.556 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.863 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' B' ' 365' ' ' ARG . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.73 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 -75.69 20.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' B' ' 370' ' ' GLN . 3.5 m-85 -74.9 10.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 1.0 110.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.55 7.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' B' ' 374' ' ' LEU . 0.7 OUTLIER -69.76 -42.21 74.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.748 0.308 . . . . 1.0 110.72 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.08 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.428 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.929 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.3 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.76 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.922 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.2 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52 103.661 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.85 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.043 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.955 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.043 ' H ' HG21 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.49 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.98 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.8 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.91 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.933 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.845 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.86 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.46 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.6 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.933 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.87 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.693 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.815 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.06 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.94 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.704 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.61 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.16 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.914 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.85 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.998 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.39 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.64 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.792 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.16 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.3 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.7 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.4 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.57 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.01 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.1 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.024 HD12 HG11 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.32 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.66 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.93 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.069 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.006 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.855 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 1.0 HG21 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.855 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.2 m-20 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.22 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.6 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.024 HG11 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.3 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.71 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.89 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.89 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.97 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.1 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.45 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.993 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.6 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.998 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.19 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.898 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.82 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.958 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.02 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.66 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.815 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.863 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.43 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.955 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.58 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.6 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.34 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.898 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.485 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.993 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.71 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.941 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.7 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.89 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.83 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.4 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.3 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.36 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.73 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.979 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.39 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.34 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.68 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.127 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.98 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.58 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.892 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.71 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.51 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.23 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.8 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.29 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.11 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.33 107.672 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.786 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.86 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.13 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.88 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.86 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.782 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.44 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.64 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.81 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.57 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.16 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.867 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.67 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.42 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.027 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.4 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.027 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.8 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.115 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.53 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.81 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.91 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.828 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.77 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.18 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.842 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.056 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.3 106.755 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.056 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.15 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.115 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.89 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.42 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.48 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.86 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.989 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.16 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.17 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.6 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.1 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.89 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.979 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.41 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.69 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.41 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.88 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.29 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.906 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.71 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.86 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.78 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.46 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.35 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.22 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.57 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.736 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.871 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.57 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.58 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.659 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.41 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.867 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.62 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.29 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.49 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.97 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.27 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.98 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.05 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.09 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.39 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.42 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.18 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.33 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.565 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.23 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.829 ' O ' HG23 ' A' ' 266' ' ' ILE . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.906 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.35 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.23 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.78 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.54 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.03 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.26 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.07 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.04 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.82 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.9 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.906 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.92 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.659 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.17 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.832 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.57 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.792 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.29 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.832 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.746 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.746 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.43 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.849 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.6 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.119 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.46 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.32 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.119 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.11 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.24 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.73 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.29 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.68 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.03 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.57 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.849 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.99 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.063 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.069 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.99 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.22 109.097 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.063 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.73 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.948 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.05 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.772 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.2 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.78 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.34 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.51 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.1 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.01 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.878 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.78 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.985 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.2 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.985 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.34 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.26 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.23 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.518 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.58 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.892 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.95 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.622 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.85 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.622 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.88 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.655 ' HB2' HD22 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' B' ' 372' ' ' PHE . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 -75.67 20.85 0.16 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' B' ' 370' ' ' GLN . 31.7 m-85 -74.91 10.99 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 1.0 110.288 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.52 7.28 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' B' ' 374' ' ' LEU . 0.1 OUTLIER -69.84 -42.19 73.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.718 0.294 . . . . 1.0 110.731 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' B' ' 375' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.08 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.92 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.3 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.968 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.968 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.76 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.979 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.715 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.925 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.2 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52 103.662 172.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.4 t-20 -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.925 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.85 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.029 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.954 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.73 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.029 ' H ' HG21 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.49 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.98 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.879 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.95 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.8 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.91 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.928 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.845 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.86 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.46 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.839 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.6 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.928 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.82 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.87 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.689 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.57 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.816 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.06 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.94 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.61 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.962 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.16 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.919 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.979 HG23 HG22 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.39 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.64 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.802 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.643 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.16 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.3 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.7 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.4 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.812 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.89 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.636 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.01 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.719 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.1 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.676 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.902 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.034 HD12 HG11 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.66 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.95 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.103 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.93 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.063 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.015 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.861 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.986 HG21 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.861 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.22 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.6 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.986 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.034 HG11 HD12 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.913 HD22 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.3 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.71 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.89 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.89 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.97 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.1 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.74 113.847 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.6 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.979 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.19 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.892 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.82 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.962 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.02 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.694 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.816 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.879 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.43 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.954 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' B' ' 375' ' ' MET . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.58 109.29 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.6 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68 110.902 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.34 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.892 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.7 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.754 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.89 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.83 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.4 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.07 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.3 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.36 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.096 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.73 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.972 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.39 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.34 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.68 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.765 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.85 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.117 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.98 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.799 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.58 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.851 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.71 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.51 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.23 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.8 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.648 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.29 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.11 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.33 107.666 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.69 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.86 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.13 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.88 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.07 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.779 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.44 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.64 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.816 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.57 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.16 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.87 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.999 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.42 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.021 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.4 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.1 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.021 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.8 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.101 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.53 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.81 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.772 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.772 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.91 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.823 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.059 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.77 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.014 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.948 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.067 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.067 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.15 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.101 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.89 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.059 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.999 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.42 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.812 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.48 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.86 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.992 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.16 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.922 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.17 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.6 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.1 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.89 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.972 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.41 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.899 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.41 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.88 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.29 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.899 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.26 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.71 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.86 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.78 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.46 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.35 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.22 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.57 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.875 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.932 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.57 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.664 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.41 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.861 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.62 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.29 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.49 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.932 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.97 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.878 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.27 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.98 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.878 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.05 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.01 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.005 HG23 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.09 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.39 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.42 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.542 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.18 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.33 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.57 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.798 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.23 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.844 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.35 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.23 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.905 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.78 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.887 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.832 HD12 HD22 ' A' ' 279' ' ' LEU . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.54 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.03 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.83 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.851 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.027 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.26 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.832 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.26 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.027 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.04 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.77 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.067 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.82 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.919 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.638 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.856 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.9 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.869 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.844 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.92 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.17 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.828 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.57 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.802 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.29 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.828 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.75 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.75 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.005 ' CD1' HG23 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.43 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.72 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.704 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.857 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.6 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.134 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.46 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.32 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.134 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.11 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.24 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.73 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.29 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.81 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.68 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.81 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.03 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.838 HD12 ' HB3' ' A' ' 314' ' ' LEU . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.857 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.063 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.996 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.22 109.104 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.032 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.05 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.773 ' CD ' HD21 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.2 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.994 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.78 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.103 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.34 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.507 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.57 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.1 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.01 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.78 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.994 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.2 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.994 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.34 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.26 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.23 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.522 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.95 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.85 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.63 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.88 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.573 ' NH2' HD12 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.834 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.486 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 -75.72 20.9 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.7 m-85 -74.92 11.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.0 110.274 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.21 -10.52 7.43 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -42.26 74.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 1.0 110.829 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.552 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.877 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.808 ' CA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.877 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.808 ' HD3' ' CA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLN . . . . . 0.428 ' NE2' ' HE2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.079999999999998 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.30000000000001 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.75999999999999 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76000000000001 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.19999999999999 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52000000000001 103.702 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61000000000001 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.917 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.84999999999999 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36000000000001 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.943 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.72999999999999 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.489999999999995 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.94999999999999 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.799999999999997 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.909999999999997 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.859999999999999 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.460000000000001 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.59999999999999 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26000000000001 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.869999999999997 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.56999999999999 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.060000000000002 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.939999999999998 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.609999999999999 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04000000000001 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.159999999999997 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.850000000000001 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.953 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.390000000000001 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.640000000000001 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65000000000001 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.159999999999997 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.299999999999997 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.40000000000001 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.56999999999999 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.890000000000001 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.010000000000005 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.09999999999999 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96000000000001 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.31999999999999 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11000000000001 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.659999999999997 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.926 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18000000000001 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.930000000000007 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.016 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35000000000002 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54000000000001 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.902 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.219999999999999 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.59999999999999 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46000000000001 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93000000000001 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.984 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.30000000000001 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.710000000000001 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.890000000000001 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.890000000000001 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.969999999999999 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.09999999999999 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.739999999999995 113.876 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.44999999999999 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.934 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.59999999999999 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.953 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61000000000001 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.189999999999998 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.81999999999999 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98000000000002 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.01999999999998 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.65999999999997 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05000000000001 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.792 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99000000000001 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.42999999999995 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22000000000003 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.943 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72000000000003 112.383 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.57999999999998 109.338 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.60000000000002 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48000000000002 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68000000000001 110.851 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.33999999999997 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17000000000002 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.934 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.70999999999998 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.69999999999999 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27000000000001 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08000000000001 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.88999999999999 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61000000000001 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.829999999999998 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.400000000000006 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.101 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.299999999999997 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.359999999999999 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.984 ' HE1' HD21 ' A' ' 74' ' ' LEU . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.730000000000004 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74000000000001 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.390000000000001 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.340000000000003 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.680000000000007 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.84999999999999 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.980000000000004 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74000000000001 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55000000000001 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.57999999999998 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.883 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.70999999999998 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.50999999999999 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41000000000003 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.229999999999997 107.829 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.800000000000001 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.289999999999999 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.109999999999999 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.329999999999998 107.706 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.690000000000001 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.859999999999999 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.917 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.129999999999995 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.879999999999995 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.859999999999999 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52000000000001 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.439999999999998 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.640000000000001 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.79 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.56999999999999 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.159999999999997 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15000000000001 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.06 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.66999999999999 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.41999999999999 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46000000000001 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.39999999999998 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.10000000000002 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.80000000000001 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.52999999999997 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99000000000001 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98000000000002 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.80999999999995 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99000000000001 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32000000000005 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.90999999999997 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99000000000001 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86000000000001 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18000000000001 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.76999999999998 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99000000000001 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99000000000001 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.180000000000007 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99000000000001 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99000000000001 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72000000000003 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.29999999999995 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.14999999999998 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61000000000001 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.88999999999999 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21000000000001 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46000000000001 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61000000000001 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01000000000001 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.06 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.41999999999999 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.47999999999999 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.859999999999999 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68000000000001 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.041 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.159999999999997 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02000000000001 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.170000000000002 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.59999999999999 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.100000000000001 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.890000000000001 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.409999999999997 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.690000000000001 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.409999999999997 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.880000000000003 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.290000000000006 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.260000000000005 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.710000000000001 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.859999999999999 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72000000000003 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.780000000000001 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.459999999999994 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.34999999999999 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.219999999999999 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.56999999999999 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96000000000001 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68000000000001 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.56999999999999 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29000000000002 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92000000000002 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.409999999999997 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.620000000000005 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.289999999999999 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.969999999999999 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.269999999999996 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.980000000000004 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.82 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.049999999999997 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.010000000000005 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.090000000000003 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.390000000000001 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.420000000000002 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51000000000001 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.180000000000007 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.329999999999998 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.230000000000004 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.34999999999999 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.22999999999999 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.77999999999997 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11000000000001 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.53999999999999 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.02999999999997 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21000000000001 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.866 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35000000000002 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91000000000003 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54000000000002 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.25999999999999 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.25999999999999 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.069999999999993 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21000000000001 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.03999999999999 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36000000000001 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.928 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.89999999999998 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.91999999999999 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18000000000001 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.16999999999999 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27000000000001 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.759 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15000000000001 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.56999999999999 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.28999999999999 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.759 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15000000000001 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68000000000001 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.430000000000007 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.719999999999999 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.858 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.519 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.59999999999999 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.45999999999999 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49000000000001 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.31999999999999 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.109999999999999 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.23999999999999 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.72999999999999 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.28999999999999 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.680000000000007 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05000000000001 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.02999999999997 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29000000000002 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.56999999999999 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24000000000001 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.858 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79000000000001 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.045 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58000000000001 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.045 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.219999999999999 109.101 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36000000000001 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.72999999999999 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.016 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.049999999999997 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.768 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49000000000001 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.780000000000001 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.340000000000003 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.56999999999999 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.522 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.09999999999999 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.00999999999999 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.892 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.77999999999997 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.19999999999999 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47000000000003 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.340000000000003 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.25999999999999 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.229999999999997 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.579999999999998 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.883 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.94999999999999 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79000000000001 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.850000000000001 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55000000000001 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.880000000000003 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.079999999999998 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.30000000000001 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.75999999999999 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76000000000001 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.915 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.19999999999999 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52000000000001 103.679 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61000000000001 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.84999999999999 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.079 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36000000000001 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.72999999999999 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.079 ' H ' HG23 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.489999999999995 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.980000000000004 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.94999999999999 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.799999999999997 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.909999999999997 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.895 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.859999999999999 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.460000000000001 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.59999999999999 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26000000000001 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.869999999999997 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.56999999999999 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.060000000000002 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.939999999999998 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.733 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.609999999999999 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04000000000001 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.159999999999997 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.850000000000001 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.955 HG22 HG21 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.390000000000001 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.640000000000001 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65000000000001 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.159999999999997 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.299999999999997 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.700000000000003 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.40000000000001 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.56999999999999 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.010000000000005 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.09999999999999 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96000000000001 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.943 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.31999999999999 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11000000000001 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.659999999999997 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.927 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18000000000001 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.930000000000007 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.039 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35000000000002 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.838 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54000000000001 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.219999999999999 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.59999999999999 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.929 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46000000000001 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93000000000001 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.994 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.30000000000001 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.710000000000001 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.890000000000001 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.890000000000001 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.09999999999999 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.739999999999995 113.839 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.44999999999999 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.926 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.59999999999999 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.955 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61000000000001 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.189999999999998 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.81999999999999 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98000000000002 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.01999999999998 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.053 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.65999999999997 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05000000000001 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91000000000003 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99000000000001 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.42999999999995 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22000000000003 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72000000000003 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.57999999999998 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.60000000000002 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48000000000002 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68000000000001 110.917 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.33999999999997 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17000000000002 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.926 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.70999999999998 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.69999999999999 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27000000000001 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08000000000001 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.654 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.88999999999999 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61000000000001 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.829999999999998 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.400000000000006 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.096 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.299999999999997 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.359999999999999 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.994 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.730000000000004 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74000000000001 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.390000000000001 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.340000000000003 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.680000000000007 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.84999999999999 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.980000000000004 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74000000000001 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55000000000001 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.57999999999998 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.88 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.70999999999998 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.50999999999999 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41000000000003 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.229999999999997 107.837 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.800000000000001 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.289999999999999 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.109999999999999 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.329999999999998 107.696 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.690000000000001 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.859999999999999 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.129999999999995 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.879999999999995 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.859999999999999 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.096 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.702 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.439999999999998 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.640000000000001 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.56999999999999 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.159999999999997 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15000000000001 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.66999999999999 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.41999999999999 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.913 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46000000000001 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.39999999999998 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.10000000000002 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.80000000000001 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.52999999999997 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99000000000001 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.05 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98000000000002 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.80999999999995 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99000000000001 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.053 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32000000000005 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.90999999999997 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99000000000001 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.965 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86000000000001 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18000000000001 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.76999999999998 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99000000000001 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99000000000001 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.180000000000007 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99000000000001 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99000000000001 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72000000000003 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.29999999999995 106.735 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.14999999999998 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61000000000001 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.88999999999999 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21000000000001 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46000000000001 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61000000000001 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01000000000001 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.41999999999999 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.796 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.47999999999999 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.859999999999999 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68000000000001 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.796 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.159999999999997 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02000000000001 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.170000000000002 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.59999999999999 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.100000000000001 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.890000000000001 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.409999999999997 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.690000000000001 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.409999999999997 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.880000000000003 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.290000000000006 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.260000000000005 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.710000000000001 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.859999999999999 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72000000000003 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.780000000000001 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.459999999999994 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.34999999999999 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.219999999999999 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.56999999999999 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.728 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96000000000001 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68000000000001 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.56999999999999 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.477 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29000000000002 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92000000000002 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.739 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.409999999999997 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.813 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.620000000000005 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.289999999999999 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.48999999999999 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.969999999999999 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.443 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.269999999999996 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.980000000000004 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.762 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.049999999999997 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.010000000000005 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.090000000000003 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.390000000000001 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.420000000000002 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51000000000001 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.484 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.180000000000007 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.329999999999998 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.230000000000004 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.34999999999999 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.737 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.22999999999999 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.894 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.77999999999997 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11000000000001 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.53999999999999 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.02999999999997 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21000000000001 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35000000000002 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.872 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91000000000003 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54000000000002 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.017 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.25999999999999 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.25999999999999 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.069999999999993 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21000000000001 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.017 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.03999999999999 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36000000000001 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.81999999999999 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.929 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.547 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.89999999999998 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.91999999999999 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18000000000001 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.16999999999999 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27000000000001 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15000000000001 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.56999999999999 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.28999999999999 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15000000000001 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.929 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68000000000001 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.430000000000007 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.719999999999999 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.52 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.59999999999999 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.45999999999999 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49000000000001 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.31999999999999 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.109999999999999 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.23999999999999 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.72999999999999 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.28999999999999 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.757 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.680000000000007 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05000000000001 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.02999999999997 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29000000000002 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.56999999999999 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24000000000001 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79000000000001 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.051 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58000000000001 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.039 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24000000000001 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.051 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.219999999999999 109.113 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.881 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36000000000001 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.72999999999999 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.049999999999997 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49000000000001 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.19999999999999 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.780000000000001 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.340000000000003 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.56999999999999 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.521 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.09999999999999 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.00999999999999 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.889 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.77999999999997 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.19999999999999 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47000000000003 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.340000000000003 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.25999999999999 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.229999999999997 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.579999999999998 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.88 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.94999999999999 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79000000000001 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.850000000000001 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55000000000001 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.880000000000003 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLN . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.079999999999998 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.30000000000001 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.75999999999999 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76000000000001 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.19999999999999 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52000000000001 103.661 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61000000000001 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.84999999999999 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36000000000001 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.72999999999999 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.489999999999995 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.980000000000004 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.94999999999999 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.799999999999997 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.909999999999997 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.859999999999999 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.460000000000001 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.59999999999999 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26000000000001 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.869999999999997 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.674 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.56999999999999 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.060000000000002 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.939999999999998 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.609999999999999 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04000000000001 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.159999999999997 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.850000000000001 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.390000000000001 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.640000000000001 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65000000000001 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.159999999999997 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.299999999999997 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.700000000000003 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.40000000000001 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.56999999999999 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.010000000000005 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.807 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.09999999999999 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.642 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.021 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96000000000001 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.31999999999999 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11000000000001 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.659999999999997 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18000000000001 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.930000000000007 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.044 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.025 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35000000000002 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.877 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54000000000001 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.219999999999999 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.59999999999999 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46000000000001 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93000000000001 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.30000000000001 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.710000000000001 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.890000000000001 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.890000000000001 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.969999999999999 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.09999999999999 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.872 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.44999999999999 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.929 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.59999999999999 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61000000000001 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.189999999999998 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.81999999999999 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98000000000002 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.01999999999998 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.65999999999997 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05000000000001 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91000000000003 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99000000000001 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.42999999999995 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22000000000003 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72000000000003 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.57999999999998 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.60000000000002 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48000000000002 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68000000000001 110.885 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.33999999999997 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17000000000002 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.929 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.70999999999998 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.873 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.69999999999999 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27000000000001 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08000000000001 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.88999999999999 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61000000000001 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.829999999999998 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.400000000000006 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.299999999999997 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.359999999999999 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.730000000000004 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74000000000001 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.390000000000001 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.340000000000003 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.680000000000007 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.980000000000004 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74000000000001 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55000000000001 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.57999999999998 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.70999999999998 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.50999999999999 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41000000000003 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.229999999999997 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.800000000000001 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.289999999999999 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.109999999999999 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.329999999999998 107.672 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.859999999999999 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.129999999999995 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.879999999999995 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.859999999999999 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52000000000001 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.439999999999998 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.640000000000001 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.56999999999999 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.159999999999997 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.796 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15000000000001 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.058 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.66999999999999 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.41999999999999 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46000000000001 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.39999999999998 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.10000000000002 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.80000000000001 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.135 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.52999999999997 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99000000000001 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98000000000002 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.80999999999995 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99000000000001 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32000000000005 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.90999999999997 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99000000000001 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.974 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86000000000001 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.76999999999998 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99000000000001 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99000000000001 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.180000000000007 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.833 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99000000000001 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99000000000001 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72000000000003 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.29999999999995 106.755 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.14999999999998 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61000000000001 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.135 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.88999999999999 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21000000000001 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46000000000001 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61000000000001 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01000000000001 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.058 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.41999999999999 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.47999999999999 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.859999999999999 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68000000000001 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.159999999999997 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02000000000001 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.170000000000002 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.59999999999999 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.100000000000001 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.890000000000001 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.409999999999997 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.690000000000001 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.409999999999997 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.880000000000003 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.290000000000006 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.260000000000005 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.710000000000001 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.859999999999999 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72000000000003 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.780000000000001 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.459999999999994 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.34999999999999 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.219999999999999 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.56999999999999 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96000000000001 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68000000000001 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.713 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.56999999999999 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29000000000002 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92000000000002 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.409999999999997 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.809 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.620000000000005 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.289999999999999 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.48999999999999 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.969999999999999 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.445 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.269999999999996 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.980000000000004 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.049999999999997 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.010000000000005 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.090000000000003 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.390000000000001 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.420000000000002 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51000000000001 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.180000000000007 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.329999999999998 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.230000000000004 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.34999999999999 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.22999999999999 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.77999999999997 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11000000000001 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.53999999999999 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.02999999999997 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21000000000001 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35000000000002 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91000000000003 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.25999999999999 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.25999999999999 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.069999999999993 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21000000000001 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.03999999999999 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36000000000001 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.81999999999999 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.89999999999998 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.91999999999999 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18000000000001 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.16999999999999 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27000000000001 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15000000000001 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.56999999999999 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.28999999999999 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15000000000001 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68000000000001 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.430000000000007 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.719999999999999 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.59999999999999 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.874 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.45999999999999 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.021 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49000000000001 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.31999999999999 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.109999999999999 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.23999999999999 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.576 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.72999999999999 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.28999999999999 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.680000000000007 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05000000000001 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.02999999999997 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29000000000002 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.56999999999999 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24000000000001 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58000000000001 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.044 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24000000000001 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.219999999999999 109.097 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36000000000001 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.72999999999999 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.049999999999997 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49000000000001 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.19999999999999 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.780000000000001 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.340000000000003 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.56999999999999 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.09999999999999 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.00999999999999 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.77999999999997 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.19999999999999 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47000000000003 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.340000000000003 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.25999999999999 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.229999999999997 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.579999999999998 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.94999999999999 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79000000000001 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.850000000000001 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55000000000001 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.880000000000003 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.565 ' HB2' HD21 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.079999999999998 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.884 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.30000000000001 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.75999999999999 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76000000000001 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.19999999999999 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52000000000001 103.662 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61000000000001 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.84999999999999 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.085 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36000000000001 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.72999999999999 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.085 ' H ' HG23 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.489999999999995 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.980000000000004 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.94999999999999 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.799999999999997 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.909999999999997 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.859999999999999 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.460000000000001 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.59999999999999 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.906 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26000000000001 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.869999999999997 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.56999999999999 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.060000000000002 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.939999999999998 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.609999999999999 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04000000000001 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.159999999999997 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.850000000000001 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.952 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.390000000000001 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.640000000000001 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65000000000001 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.159999999999997 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.299999999999997 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.700000000000003 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.40000000000001 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.56999999999999 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.890000000000001 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.010000000000005 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.09999999999999 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96000000000001 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.955 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.31999999999999 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11000000000001 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.659999999999997 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18000000000001 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.930000000000007 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.032 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35000000000002 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54000000000001 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.219999999999999 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.59999999999999 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.924 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46000000000001 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93000000000001 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.0 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.30000000000001 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.710000000000001 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.890000000000001 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.890000000000001 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.969999999999999 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.09999999999999 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.739999999999995 113.847 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.44999999999999 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.942 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.59999999999999 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.952 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61000000000001 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.189999999999998 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.81999999999999 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98000000000002 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.01999999999998 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05000000000001 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91000000000003 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99000000000001 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.42999999999995 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22000000000003 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72000000000003 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.57999999999998 109.29 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.60000000000002 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48000000000002 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68000000000001 110.902 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.33999999999997 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17000000000002 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.70999999999998 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.69999999999999 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27000000000001 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08000000000001 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.88999999999999 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.921 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61000000000001 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.829999999999998 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.400000000000006 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.104 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.299999999999997 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.359999999999999 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 1.0 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.730000000000004 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74000000000001 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.390000000000001 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.340000000000003 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.680000000000007 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.84999999999999 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.980000000000004 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74000000000001 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.755 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55000000000001 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.57999999999998 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.70999999999998 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.755 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.50999999999999 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41000000000003 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.229999999999997 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.800000000000001 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.289999999999999 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.848 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.109999999999999 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.329999999999998 107.666 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.690000000000001 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.859999999999999 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.129999999999995 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.879999999999995 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.859999999999999 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.104 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52000000000001 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.698 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.439999999999998 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.640000000000001 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.56999999999999 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.159999999999997 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15000000000001 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.66999999999999 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.41999999999999 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46000000000001 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.39999999999998 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.10000000000002 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.80000000000001 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.143 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.52999999999997 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99000000000001 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.048 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98000000000002 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.779 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.80999999999995 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99000000000001 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32000000000005 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.90999999999997 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99000000000001 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86000000000001 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.036 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18000000000001 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.76999999999998 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99000000000001 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99000000000001 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.3 p80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99000000000001 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99000000000001 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72000000000003 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.14999999999998 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61000000000001 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.143 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.88999999999999 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21000000000001 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46000000000001 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.036 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61000000000001 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01000000000001 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.41999999999999 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.47999999999999 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.859999999999999 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68000000000001 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.053 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.159999999999997 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.904 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02000000000001 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.170000000000002 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.59999999999999 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.100000000000001 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.890000000000001 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.409999999999997 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.690000000000001 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.409999999999997 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.880000000000003 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.290000000000006 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.260000000000005 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.710000000000001 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.859999999999999 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.82 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72000000000003 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.780000000000001 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.459999999999994 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.34999999999999 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.219999999999999 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.56999999999999 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96000000000001 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68000000000001 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.56999999999999 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29000000000002 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.7 m80 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92000000000002 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.409999999999997 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.620000000000005 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.289999999999999 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.48999999999999 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.969999999999999 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.439 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.269999999999996 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.980000000000004 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.049999999999997 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.010000000000005 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.090000000000003 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.390000000000001 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.420000000000002 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51000000000001 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.49 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.180000000000007 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.329999999999998 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.507 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.230000000000004 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.34999999999999 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.22999999999999 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.77999999999997 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11000000000001 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.53999999999999 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.02999999999997 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21000000000001 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.866 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35000000000002 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.865 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91000000000003 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.866 HD12 HD22 ' A' ' 274' ' ' ASN . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54000000000002 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.25999999999999 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.25999999999999 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.791 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.791 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21000000000001 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.03999999999999 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36000000000001 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.81999999999999 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.948 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.89999999999998 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.91999999999999 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18000000000001 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.16999999999999 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27000000000001 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15000000000001 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.56999999999999 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.28999999999999 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15000000000001 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.924 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.430000000000007 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.719999999999999 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.803 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.59999999999999 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.45999999999999 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.009 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49000000000001 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.31999999999999 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.109999999999999 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.23999999999999 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.72999999999999 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.28999999999999 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.680000000000007 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05000000000001 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.02999999999997 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29000000000002 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.56999999999999 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24000000000001 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.632 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79000000000001 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.038 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.019 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58000000000001 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.032 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24000000000001 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.038 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.219999999999999 109.104 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36000000000001 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.019 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.72999999999999 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.013 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.049999999999997 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49000000000001 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.19999999999999 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.899 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.780000000000001 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.340000000000003 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.44 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.56999999999999 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.09999999999999 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.00999999999999 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.896 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.77999999999997 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.19999999999999 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47000000000003 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.340000000000003 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.25999999999999 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.229999999999997 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.579999999999998 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.94999999999999 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79000000000001 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.850000000000001 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55000000000001 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.880000000000003 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.553 ' NH2' HD11 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.877 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.877 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.808 ' CA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.194 HD11 ' CD1' ' B' ' 372' ' ' PHE . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.877 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.808 ' HD3' ' CA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 -75.78 20.97 0.16 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 1.194 ' CD1' HD11 ' A' ' 102' ' ' LEU . 17.0 m-85 -74.96 11.06 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.391 . . . . 1.0 110.274 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.25 -10.49 7.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -42.25 74.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.728 0.299 . . . . 1.0 110.756 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 171' ' ' THR . 7.2 mmt . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.079999999999998 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.30000000000001 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.75999999999999 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76000000000001 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.19999999999999 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52000000000001 103.702 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61000000000001 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.917 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.84999999999999 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36000000000001 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.943 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.72999999999999 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.489999999999995 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.94999999999999 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.799999999999997 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.909999999999997 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.859999999999999 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.460000000000001 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.59999999999999 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26000000000001 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.869999999999997 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.56999999999999 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.060000000000002 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.939999999999998 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.609999999999999 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04000000000001 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.159999999999997 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.850000000000001 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.953 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.390000000000001 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.640000000000001 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65000000000001 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.159999999999997 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.299999999999997 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.40000000000001 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.56999999999999 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.890000000000001 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.010000000000005 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.09999999999999 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96000000000001 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.31999999999999 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11000000000001 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.659999999999997 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.926 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18000000000001 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.930000000000007 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.016 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35000000000002 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54000000000001 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.902 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.219999999999999 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.59999999999999 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46000000000001 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93000000000001 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.984 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.30000000000001 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.710000000000001 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.890000000000001 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.890000000000001 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.969999999999999 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.09999999999999 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.739999999999995 113.876 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.44999999999999 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.934 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.59999999999999 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.953 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61000000000001 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.189999999999998 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.81999999999999 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98000000000002 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.01999999999998 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.65999999999997 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05000000000001 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.792 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99000000000001 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.42999999999995 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22000000000003 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.943 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' B' ' 375' ' ' MET . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72000000000003 112.383 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' B' ' 374' ' ' LEU . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.57999999999998 109.338 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.60000000000002 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48000000000002 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68000000000001 110.851 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.33999999999997 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17000000000002 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.934 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.70999999999998 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.69999999999999 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27000000000001 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08000000000001 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.88999999999999 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61000000000001 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.829999999999998 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.400000000000006 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.101 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.299999999999997 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.359999999999999 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.984 ' HE1' HD21 ' A' ' 74' ' ' LEU . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.730000000000004 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74000000000001 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.390000000000001 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.340000000000003 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.680000000000007 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.84999999999999 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.980000000000004 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74000000000001 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55000000000001 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.57999999999998 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.883 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.70999999999998 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.50999999999999 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41000000000003 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.229999999999997 107.829 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.800000000000001 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.289999999999999 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.109999999999999 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.329999999999998 107.706 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.690000000000001 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.859999999999999 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.917 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.129999999999995 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.879999999999995 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.859999999999999 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52000000000001 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.439999999999998 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.640000000000001 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.79 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.56999999999999 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.159999999999997 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15000000000001 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.06 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.66999999999999 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.41999999999999 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46000000000001 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.39999999999998 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.10000000000002 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.80000000000001 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.52999999999997 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99000000000001 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98000000000002 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.80999999999995 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99000000000001 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32000000000005 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.90999999999997 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99000000000001 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86000000000001 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18000000000001 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.76999999999998 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99000000000001 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99000000000001 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.180000000000007 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99000000000001 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99000000000001 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72000000000003 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.29999999999995 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.14999999999998 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61000000000001 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.88999999999999 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21000000000001 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46000000000001 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61000000000001 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01000000000001 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.06 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.41999999999999 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.47999999999999 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.859999999999999 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68000000000001 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.041 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.159999999999997 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02000000000001 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.170000000000002 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.59999999999999 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.100000000000001 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.890000000000001 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.409999999999997 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.690000000000001 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.409999999999997 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.880000000000003 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.290000000000006 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.260000000000005 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.710000000000001 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.859999999999999 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72000000000003 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.780000000000001 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.459999999999994 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.34999999999999 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.219999999999999 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.56999999999999 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96000000000001 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68000000000001 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.56999999999999 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29000000000002 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92000000000002 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.409999999999997 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.620000000000005 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.289999999999999 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.969999999999999 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.269999999999996 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.980000000000004 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.82 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.049999999999997 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.010000000000005 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.090000000000003 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.390000000000001 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.420000000000002 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51000000000001 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.180000000000007 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.329999999999998 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.230000000000004 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.34999999999999 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.22999999999999 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.77999999999997 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11000000000001 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.53999999999999 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.02999999999997 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21000000000001 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.866 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35000000000002 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91000000000003 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54000000000002 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.25999999999999 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.25999999999999 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.069999999999993 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21000000000001 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.03999999999999 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36000000000001 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.928 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.89999999999998 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.91999999999999 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18000000000001 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.16999999999999 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27000000000001 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.759 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15000000000001 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.56999999999999 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.28999999999999 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.759 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15000000000001 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68000000000001 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.430000000000007 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.719999999999999 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.858 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.519 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.59999999999999 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.45999999999999 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49000000000001 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.31999999999999 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.109999999999999 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.23999999999999 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.72999999999999 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.28999999999999 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.680000000000007 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05000000000001 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.02999999999997 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29000000000002 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.56999999999999 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24000000000001 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.858 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79000000000001 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.045 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58000000000001 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.045 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.219999999999999 109.101 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36000000000001 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.72999999999999 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.016 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.049999999999997 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.768 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49000000000001 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.780000000000001 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.340000000000003 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.56999999999999 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.522 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.09999999999999 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.00999999999999 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.892 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.77999999999997 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.19999999999999 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47000000000003 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.340000000000003 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.25999999999999 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.229999999999997 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.579999999999998 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.883 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.94999999999999 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79000000000001 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.850000000000001 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55000000000001 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.880000000000003 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 -75.82 21.04 0.16 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' B' ' 370' ' ' GLN . 4.0 m-85 -75.03 11.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.214 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.14 -10.55 7.31 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 19' ' ' THR . 6.5 mt -69.75 -42.28 74.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.758 0.313 . . . . 1.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.965 ' HB2' HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.422 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.079999999999998 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.30000000000001 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.75999999999999 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76000000000001 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.915 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.19999999999999 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52000000000001 103.679 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61000000000001 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.84999999999999 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.079 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36000000000001 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.72999999999999 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.079 ' H ' HG23 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.489999999999995 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.980000000000004 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.94999999999999 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.799999999999997 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.909999999999997 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.895 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.859999999999999 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.460000000000001 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.59999999999999 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26000000000001 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.869999999999997 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.56999999999999 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.060000000000002 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.939999999999998 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.733 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.609999999999999 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04000000000001 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.159999999999997 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.850000000000001 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.955 HG22 HG21 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.390000000000001 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.640000000000001 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65000000000001 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.159999999999997 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.299999999999997 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.700000000000003 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.40000000000001 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.56999999999999 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.010000000000005 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.09999999999999 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96000000000001 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.943 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.31999999999999 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11000000000001 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.659999999999997 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.927 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18000000000001 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.930000000000007 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.039 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35000000000002 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.838 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54000000000001 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.219999999999999 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.59999999999999 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.929 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46000000000001 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93000000000001 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.994 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.30000000000001 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.710000000000001 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.890000000000001 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.890000000000001 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.09999999999999 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.739999999999995 113.839 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.44999999999999 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.926 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.59999999999999 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.955 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61000000000001 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.189999999999998 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.81999999999999 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98000000000002 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.01999999999998 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.053 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.65999999999997 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05000000000001 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91000000000003 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99000000000001 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.42999999999995 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22000000000003 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72000000000003 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.57999999999998 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.60000000000002 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48000000000002 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68000000000001 110.917 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.33999999999997 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17000000000002 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.926 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.70999999999998 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.69999999999999 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27000000000001 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08000000000001 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.654 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.88999999999999 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61000000000001 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.829999999999998 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.400000000000006 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.096 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.299999999999997 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.359999999999999 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.994 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.730000000000004 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74000000000001 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.390000000000001 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.340000000000003 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.680000000000007 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.84999999999999 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.980000000000004 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74000000000001 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55000000000001 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.57999999999998 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.88 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.70999999999998 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.50999999999999 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41000000000003 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.229999999999997 107.837 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.800000000000001 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.289999999999999 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.109999999999999 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.329999999999998 107.696 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.690000000000001 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.859999999999999 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.129999999999995 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.879999999999995 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.859999999999999 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.096 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.702 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.439999999999998 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.640000000000001 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.56999999999999 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.159999999999997 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15000000000001 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.66999999999999 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.41999999999999 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.913 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46000000000001 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.39999999999998 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.10000000000002 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.80000000000001 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.52999999999997 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99000000000001 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.05 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98000000000002 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.80999999999995 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99000000000001 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.053 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32000000000005 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.90999999999997 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99000000000001 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.965 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86000000000001 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18000000000001 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.76999999999998 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99000000000001 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99000000000001 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.180000000000007 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99000000000001 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99000000000001 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72000000000003 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.29999999999995 106.735 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.14999999999998 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61000000000001 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.88999999999999 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21000000000001 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46000000000001 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61000000000001 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01000000000001 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.41999999999999 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.796 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.47999999999999 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.859999999999999 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68000000000001 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.796 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.159999999999997 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02000000000001 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.170000000000002 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.59999999999999 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.100000000000001 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.890000000000001 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.409999999999997 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.690000000000001 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.409999999999997 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.880000000000003 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.290000000000006 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.260000000000005 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.710000000000001 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.859999999999999 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72000000000003 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.780000000000001 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.459999999999994 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.34999999999999 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.219999999999999 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.56999999999999 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.728 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96000000000001 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68000000000001 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.56999999999999 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.477 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29000000000002 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92000000000002 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.739 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.409999999999997 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.813 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.620000000000005 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.289999999999999 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.48999999999999 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.969999999999999 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.443 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.269999999999996 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.980000000000004 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.762 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.049999999999997 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.010000000000005 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.090000000000003 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.390000000000001 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.420000000000002 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51000000000001 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.484 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.180000000000007 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.329999999999998 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.230000000000004 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.34999999999999 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.737 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.22999999999999 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.894 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.77999999999997 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11000000000001 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.53999999999999 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.02999999999997 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21000000000001 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35000000000002 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.872 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91000000000003 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54000000000002 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.017 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.25999999999999 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.25999999999999 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.069999999999993 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21000000000001 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.017 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.03999999999999 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36000000000001 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.81999999999999 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.929 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.547 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.89999999999998 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.91999999999999 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18000000000001 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.16999999999999 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27000000000001 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15000000000001 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.56999999999999 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.28999999999999 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15000000000001 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.929 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68000000000001 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.430000000000007 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.719999999999999 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.52 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.59999999999999 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.45999999999999 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49000000000001 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.31999999999999 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.109999999999999 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.23999999999999 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.72999999999999 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.28999999999999 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.757 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.680000000000007 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05000000000001 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.02999999999997 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29000000000002 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.56999999999999 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24000000000001 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79000000000001 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.051 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58000000000001 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.039 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24000000000001 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.051 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.219999999999999 109.113 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.881 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36000000000001 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.72999999999999 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.049999999999997 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49000000000001 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.19999999999999 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.780000000000001 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.340000000000003 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.56999999999999 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.521 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.09999999999999 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.00999999999999 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.889 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.77999999999997 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.19999999999999 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47000000000003 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.340000000000003 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.25999999999999 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.229999999999997 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.579999999999998 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.88 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.94999999999999 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79000000000001 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.850000000000001 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55000000000001 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.880000000000003 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 -75.69 20.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' B' ' 370' ' ' GLN . 3.5 m-85 -74.9 10.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 1.0 110.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.55 7.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -42.21 74.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.748 0.308 . . . . 1.0 110.72 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.079999999999998 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.30000000000001 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.75999999999999 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76000000000001 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.19999999999999 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52000000000001 103.661 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61000000000001 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.84999999999999 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36000000000001 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.72999999999999 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.489999999999995 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.980000000000004 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.94999999999999 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.799999999999997 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.909999999999997 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.859999999999999 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.460000000000001 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.59999999999999 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26000000000001 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.869999999999997 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.674 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.56999999999999 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.060000000000002 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.939999999999998 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.609999999999999 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04000000000001 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.159999999999997 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.850000000000001 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.390000000000001 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.640000000000001 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65000000000001 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.159999999999997 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.299999999999997 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.700000000000003 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.40000000000001 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.56999999999999 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.010000000000005 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.807 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.09999999999999 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.642 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.021 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96000000000001 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.31999999999999 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11000000000001 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.659999999999997 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18000000000001 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.930000000000007 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.044 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.025 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35000000000002 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.877 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54000000000001 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.219999999999999 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.59999999999999 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46000000000001 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93000000000001 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.30000000000001 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.710000000000001 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.890000000000001 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.890000000000001 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.969999999999999 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.09999999999999 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.872 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.44999999999999 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.929 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.59999999999999 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61000000000001 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.189999999999998 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.81999999999999 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98000000000002 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.01999999999998 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.65999999999997 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05000000000001 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91000000000003 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99000000000001 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.42999999999995 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22000000000003 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72000000000003 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.57999999999998 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.60000000000002 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48000000000002 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68000000000001 110.885 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.33999999999997 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17000000000002 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.929 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.70999999999998 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.873 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.69999999999999 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27000000000001 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08000000000001 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.88999999999999 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61000000000001 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.829999999999998 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.400000000000006 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.299999999999997 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.359999999999999 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.730000000000004 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74000000000001 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.390000000000001 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.340000000000003 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.680000000000007 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.980000000000004 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74000000000001 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55000000000001 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.57999999999998 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.70999999999998 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.50999999999999 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41000000000003 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.229999999999997 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.800000000000001 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.289999999999999 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.109999999999999 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.329999999999998 107.672 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.859999999999999 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.129999999999995 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.879999999999995 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.859999999999999 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52000000000001 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.439999999999998 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.640000000000001 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.56999999999999 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.159999999999997 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.796 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15000000000001 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.058 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.66999999999999 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.41999999999999 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46000000000001 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.39999999999998 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.10000000000002 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.80000000000001 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.135 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.52999999999997 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99000000000001 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98000000000002 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.80999999999995 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99000000000001 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32000000000005 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.90999999999997 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99000000000001 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.974 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86000000000001 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.76999999999998 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99000000000001 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99000000000001 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.180000000000007 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.833 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99000000000001 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99000000000001 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72000000000003 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.29999999999995 106.755 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.14999999999998 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61000000000001 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.135 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.88999999999999 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21000000000001 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46000000000001 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61000000000001 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01000000000001 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.058 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.41999999999999 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.47999999999999 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.859999999999999 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68000000000001 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.159999999999997 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02000000000001 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.170000000000002 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.59999999999999 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.100000000000001 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.890000000000001 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.409999999999997 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.690000000000001 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.409999999999997 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.880000000000003 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.290000000000006 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.260000000000005 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.710000000000001 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.859999999999999 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72000000000003 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.780000000000001 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.459999999999994 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.34999999999999 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.219999999999999 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.56999999999999 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96000000000001 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68000000000001 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.713 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.56999999999999 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29000000000002 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92000000000002 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.409999999999997 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.809 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.620000000000005 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.289999999999999 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.48999999999999 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.969999999999999 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.445 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.269999999999996 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.980000000000004 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.049999999999997 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.010000000000005 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.090000000000003 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.390000000000001 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.420000000000002 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51000000000001 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.180000000000007 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.329999999999998 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.230000000000004 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.34999999999999 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.22999999999999 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.77999999999997 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11000000000001 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.53999999999999 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.02999999999997 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21000000000001 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35000000000002 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91000000000003 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.25999999999999 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.25999999999999 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.069999999999993 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21000000000001 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.03999999999999 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36000000000001 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.81999999999999 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.89999999999998 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.91999999999999 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18000000000001 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.16999999999999 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27000000000001 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15000000000001 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.56999999999999 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.28999999999999 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15000000000001 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68000000000001 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.430000000000007 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.719999999999999 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.59999999999999 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.874 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.45999999999999 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.021 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49000000000001 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.31999999999999 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.109999999999999 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.23999999999999 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.576 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.72999999999999 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.28999999999999 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.680000000000007 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05000000000001 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.02999999999997 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29000000000002 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.56999999999999 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24000000000001 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58000000000001 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.044 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24000000000001 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.219999999999999 109.097 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36000000000001 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.72999999999999 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.049999999999997 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49000000000001 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.19999999999999 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.780000000000001 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.340000000000003 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.56999999999999 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.09999999999999 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.00999999999999 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.77999999999997 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.19999999999999 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47000000000003 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.340000000000003 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.25999999999999 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.229999999999997 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.579999999999998 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.94999999999999 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79000000000001 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.850000000000001 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55000000000001 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.880000000000003 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.565 ' HB2' HD21 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 372' ' ' PHE . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 -75.67 20.85 0.16 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 370' ' ' GLN . 31.7 m-85 -74.91 10.99 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 1.0 110.288 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.52 7.28 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -42.19 73.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.718 0.294 . . . . 1.0 110.731 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.417 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.079999999999998 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.884 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.30000000000001 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.75999999999999 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76000000000001 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.19999999999999 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52000000000001 103.662 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61000000000001 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.84999999999999 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.085 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36000000000001 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.72999999999999 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.085 ' H ' HG23 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.489999999999995 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.980000000000004 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.94999999999999 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.799999999999997 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.909999999999997 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.859999999999999 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.460000000000001 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.59999999999999 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.906 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26000000000001 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.869999999999997 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.56999999999999 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.060000000000002 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.939999999999998 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.609999999999999 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04000000000001 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.159999999999997 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.850000000000001 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.952 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.390000000000001 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.640000000000001 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65000000000001 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.159999999999997 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.299999999999997 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.700000000000003 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.40000000000001 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.56999999999999 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.890000000000001 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.010000000000005 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.09999999999999 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96000000000001 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.955 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.31999999999999 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11000000000001 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.659999999999997 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18000000000001 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.930000000000007 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.032 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35000000000002 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54000000000001 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.219999999999999 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.59999999999999 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.924 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46000000000001 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93000000000001 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.0 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.30000000000001 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.710000000000001 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.890000000000001 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.890000000000001 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.969999999999999 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.09999999999999 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.739999999999995 113.847 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.44999999999999 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.942 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.59999999999999 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.952 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61000000000001 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.189999999999998 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.81999999999999 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98000000000002 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.01999999999998 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05000000000001 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91000000000003 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99000000000001 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.42999999999995 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22000000000003 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72000000000003 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' B' ' 375' ' ' MET . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.57999999999998 109.29 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.60000000000002 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48000000000002 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68000000000001 110.902 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.33999999999997 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17000000000002 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.70999999999998 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.69999999999999 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27000000000001 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08000000000001 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.88999999999999 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.921 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61000000000001 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.829999999999998 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.400000000000006 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.104 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.299999999999997 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.359999999999999 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 1.0 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.730000000000004 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74000000000001 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.390000000000001 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.340000000000003 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.680000000000007 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.84999999999999 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.980000000000004 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74000000000001 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.755 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55000000000001 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.57999999999998 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.70999999999998 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.755 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.50999999999999 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41000000000003 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.229999999999997 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.800000000000001 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.289999999999999 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.848 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.109999999999999 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.329999999999998 107.666 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.690000000000001 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.859999999999999 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.129999999999995 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.879999999999995 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.859999999999999 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.104 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52000000000001 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.698 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.439999999999998 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.640000000000001 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.56999999999999 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.159999999999997 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15000000000001 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.66999999999999 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.41999999999999 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46000000000001 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.39999999999998 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.10000000000002 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.80000000000001 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.143 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.52999999999997 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99000000000001 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.048 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98000000000002 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.779 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.80999999999995 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99000000000001 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32000000000005 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.90999999999997 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99000000000001 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86000000000001 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.036 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18000000000001 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.76999999999998 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99000000000001 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99000000000001 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.3 p80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99000000000001 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99000000000001 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72000000000003 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.14999999999998 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61000000000001 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.143 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.88999999999999 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21000000000001 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46000000000001 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.036 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61000000000001 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01000000000001 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.41999999999999 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.47999999999999 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.859999999999999 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68000000000001 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.053 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.159999999999997 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.904 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02000000000001 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.170000000000002 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.59999999999999 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.100000000000001 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.890000000000001 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.409999999999997 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.690000000000001 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.409999999999997 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.880000000000003 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.290000000000006 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.260000000000005 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.710000000000001 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.859999999999999 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.82 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72000000000003 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.780000000000001 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.459999999999994 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.34999999999999 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.219999999999999 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.56999999999999 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96000000000001 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68000000000001 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.56999999999999 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29000000000002 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.7 m80 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92000000000002 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.409999999999997 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.620000000000005 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.289999999999999 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.48999999999999 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.969999999999999 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.439 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.269999999999996 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.980000000000004 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.049999999999997 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.010000000000005 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.090000000000003 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.390000000000001 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.420000000000002 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51000000000001 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.49 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.180000000000007 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.329999999999998 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.507 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.230000000000004 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.34999999999999 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.22999999999999 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.77999999999997 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11000000000001 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.53999999999999 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.02999999999997 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21000000000001 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.866 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35000000000002 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.865 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91000000000003 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.866 HD12 HD22 ' A' ' 274' ' ' ASN . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54000000000002 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.25999999999999 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.25999999999999 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.791 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.791 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21000000000001 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.03999999999999 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36000000000001 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.81999999999999 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.948 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.89999999999998 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.91999999999999 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18000000000001 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.16999999999999 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27000000000001 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15000000000001 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.56999999999999 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.28999999999999 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15000000000001 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.924 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.430000000000007 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.719999999999999 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.803 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.59999999999999 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.45999999999999 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.009 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49000000000001 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.31999999999999 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.109999999999999 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.23999999999999 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.72999999999999 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.28999999999999 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.680000000000007 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05000000000001 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.02999999999997 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29000000000002 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.56999999999999 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24000000000001 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.632 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79000000000001 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.038 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.019 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58000000000001 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.032 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24000000000001 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.038 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.219999999999999 109.104 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36000000000001 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.019 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.72999999999999 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.013 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.049999999999997 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49000000000001 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.19999999999999 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.899 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.780000000000001 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.340000000000003 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.44 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.56999999999999 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.09999999999999 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.00999999999999 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.896 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.77999999999997 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.19999999999999 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47000000000003 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.340000000000003 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.25999999999999 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.229999999999997 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.579999999999998 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.94999999999999 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79000000000001 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.850000000000001 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55000000000001 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.880000000000003 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.553 ' NH2' HD11 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.877 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 -75.72 20.9 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.501 ' CZ ' HG21 ' A' ' 19' ' ' THR . 11.7 m-85 -74.92 11.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.0 110.274 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.21 -10.52 7.43 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 374' ' ' LEU . 0.0 OUTLIER -69.65 -42.26 74.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 1.0 110.829 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.534 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.877 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.808 ' CA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.877 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.808 ' HD3' ' CA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . 0.428 ' NE2' ' HE2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.08 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.3 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.76 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.2 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52 103.702 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.917 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.85 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.943 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.49 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.95 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.8 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.91 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.86 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.46 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.6 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.87 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.57 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.06 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.94 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.16 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.953 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.39 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.64 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.16 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.3 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.7 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.4 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.57 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.89 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.01 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.1 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.66 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.926 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.93 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.016 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.902 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.22 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.6 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.984 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.3 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.71 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.89 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.89 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.97 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.1 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.876 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.45 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.934 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.6 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.953 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.19 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.808 HG22 ' HD2' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.02 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.66 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.808 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.792 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.43 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.943 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72 112.383 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.58 109.338 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.6 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68 110.851 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.34 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.934 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.71 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.7 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.89 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.83 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.4 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.101 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.3 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.36 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.984 ' HE1' HD21 ' A' ' 74' ' ' LEU . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.73 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.39 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.34 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.68 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.85 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.98 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.58 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.883 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.71 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.51 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.23 107.829 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.8 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.29 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.11 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.33 107.706 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.69 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.86 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.917 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.13 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.88 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.86 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.64 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.79 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.57 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.16 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.06 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.67 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.42 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.014 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.4 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.1 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.8 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.53 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.81 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.91 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.77 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.18 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.3 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.15 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.89 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.06 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.42 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.48 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.86 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.041 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.16 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.17 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.6 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.1 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.89 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.41 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.41 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.88 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.29 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.26 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.71 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.86 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.78 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.46 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.35 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.22 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.57 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.57 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.41 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.62 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.29 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.49 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.97 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.27 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.98 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.82 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.05 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.01 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.09 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.39 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.42 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.18 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.33 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.23 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.35 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.23 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.78 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.54 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.03 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.26 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.26 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.07 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.04 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.928 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.9 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.92 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.17 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.759 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.57 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.29 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.759 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.43 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.72 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.858 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.519 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.6 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.46 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.32 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.11 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.24 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.73 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.68 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.03 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.57 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.858 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.045 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.045 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.22 109.101 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.73 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.016 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.05 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.768 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.78 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.34 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.57 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.522 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.01 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.892 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.78 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.2 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.34 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.26 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.23 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.58 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.883 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.95 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.85 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.88 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 . . . . . 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.08 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.3 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.76 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.915 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.2 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52 103.679 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.85 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.079 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.73 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.079 ' H ' HG23 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.49 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.98 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.95 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.91 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.895 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.86 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.46 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.6 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.87 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.06 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.94 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.733 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.61 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.16 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.85 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.955 HG22 HG21 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.39 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.64 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.16 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.3 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.7 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.4 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.57 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.01 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.1 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.943 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.32 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.66 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.927 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.93 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.039 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.838 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.22 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.6 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.929 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.994 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.3 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.71 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.89 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.89 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.1 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.839 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.45 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.926 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.6 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.955 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.19 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.82 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.807 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.02 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.053 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.66 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.807 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.58 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.6 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68 110.917 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.34 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.926 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.71 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.7 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.654 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.89 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.83 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.4 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.096 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.3 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.36 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.994 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.73 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.39 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.34 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.68 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.85 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.98 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.58 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.88 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.71 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.51 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.23 107.837 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.8 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.29 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.33 107.696 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.69 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.86 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.13 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.88 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.86 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.096 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.702 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.44 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.64 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.57 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.16 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.67 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.42 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.017 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.4 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.1 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.8 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.53 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.05 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.81 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.053 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.965 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.77 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.18 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.3 106.735 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.15 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.89 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.42 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.796 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.48 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.86 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.796 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.16 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.17 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.6 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.1 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.89 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.41 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.69 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.41 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.88 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.29 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.26 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.71 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.86 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.78 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.46 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.35 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.22 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.57 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.728 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.57 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.739 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.41 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.813 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.29 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.49 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.97 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.443 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.27 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.98 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.762 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.05 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.01 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.09 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.39 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.42 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.484 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.18 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.33 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.23 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.35 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.737 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.23 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.894 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.78 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.54 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.03 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.872 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.017 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.26 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.07 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.017 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.04 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.82 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.929 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.547 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.9 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.92 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.17 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.57 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.29 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.929 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.43 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.72 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.52 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.6 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.46 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.32 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.11 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.24 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.73 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.29 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.757 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.68 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.03 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.051 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.039 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.051 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.22 109.113 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.881 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.78 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.34 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.521 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.1 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.01 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.889 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.78 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.2 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.34 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.26 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.23 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.88 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.95 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.85 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.88 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.08 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.3 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.76 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.2 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52 103.661 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.85 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.49 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.98 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.625 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.8 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.91 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.86 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.46 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.6 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.87 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.674 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.06 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.94 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.61 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.16 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.85 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.39 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.64 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.16 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.3 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.7 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.4 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.57 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.01 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.807 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.1 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.642 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.021 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.32 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.66 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.93 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.044 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.025 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.877 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.22 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.6 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.3 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.71 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.89 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.89 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.97 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.1 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.45 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.929 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.6 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.19 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.82 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.02 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.66 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.43 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.58 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.6 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68 110.885 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.34 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.929 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.71 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.873 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.7 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.89 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.83 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.4 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.3 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.36 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.73 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.39 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.34 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.68 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.98 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.58 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.71 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.51 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.23 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.8 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.29 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.11 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.33 107.672 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.86 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.13 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.88 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.86 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.44 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.64 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.57 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.16 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.796 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.058 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.67 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.42 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.4 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.8 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.135 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.53 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.81 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.91 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.974 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.77 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.18 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.833 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.3 106.755 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.15 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.135 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.89 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.058 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.42 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.48 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.86 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.16 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.17 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.6 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.1 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.89 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.41 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.69 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.41 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.88 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.29 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.71 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.86 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.78 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.46 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.35 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.22 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.57 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.713 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.57 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.41 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.809 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.62 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.29 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.49 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.97 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.445 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.27 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.98 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.05 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.09 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.39 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.42 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.18 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.33 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.23 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.35 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.23 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.78 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.54 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.03 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.782 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.26 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.07 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.04 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.82 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.9 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.92 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.17 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.57 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.29 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.43 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.6 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.874 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.46 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.021 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.32 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.11 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.24 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.576 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.73 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.29 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.68 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.03 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.57 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.044 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.22 109.097 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.73 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.05 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.2 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.78 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.34 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.1 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.01 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.78 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.2 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.34 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.26 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.23 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.58 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.95 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.85 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.88 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.565 ' HB2' HD21 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.08 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.884 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.3 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.76 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.2 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52 103.662 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.85 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.085 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.73 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.085 ' H ' HG23 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.49 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.98 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.95 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.8 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.91 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.86 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.46 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.6 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.906 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.87 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.57 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.06 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.94 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.61 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.16 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.952 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.39 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.64 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.16 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.3 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.7 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.4 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.89 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.01 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.1 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.955 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.66 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.93 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.032 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.22 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.6 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.924 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.0 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.3 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.71 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.89 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.89 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.97 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.1 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.74 113.847 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.942 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.6 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.952 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.19 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.82 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.02 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.43 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.58 109.29 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.6 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68 110.902 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.34 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.7 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.89 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.921 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.83 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.4 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.104 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.3 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.36 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 1.0 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.73 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.39 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.34 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.68 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.85 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.98 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.755 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.58 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.71 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.755 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.51 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.23 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.8 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.29 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.848 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.11 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.33 107.666 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.69 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.86 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.13 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.88 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.104 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.698 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.44 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.64 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.57 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.16 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.42 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.4 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.1 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.8 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.143 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.53 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.048 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.779 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.81 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.91 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.036 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.77 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.15 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.143 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.89 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.036 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.42 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.48 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.86 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.053 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.16 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.904 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.17 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.6 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.1 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.89 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.41 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.41 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.88 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.29 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.26 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.71 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.86 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.82 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.78 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.46 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.35 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.22 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.57 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.57 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.41 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.62 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.29 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.49 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.97 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.439 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.27 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.98 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.05 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.01 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.09 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.39 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.42 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.49 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.18 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.33 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.507 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.23 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.35 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.23 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.78 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.54 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.03 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.785 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.865 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.26 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.26 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.791 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.791 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.04 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.82 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.948 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.9 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.92 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.17 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.57 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.29 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.924 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.43 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.72 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.803 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.6 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.46 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.009 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.32 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.11 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.24 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.73 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.29 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.68 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.03 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.632 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.038 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.019 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.032 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.038 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.22 109.104 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.019 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.013 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.05 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.2 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.899 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.78 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.34 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.44 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.57 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.1 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.01 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.896 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.78 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.2 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.34 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.26 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.23 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.95 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.85 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.88 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.553 ' NH2' HD11 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.877 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.877 ' HB3' HH21 ' B' ' 365' ' ' ARG . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.808 ' CA ' ' HD3' ' B' ' 366' ' ' PRO . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.194 HD11 ' CD1' ' B' ' 372' ' ' PHE . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.877 HH21 ' HB3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.808 ' HD3' ' CA ' ' A' ' 16' ' ' SER . 48.4 Cg_endo -66.57 -20.25 53.79 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 123.144 2.563 . . . . 1.0 113.775 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.85 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.695 0.257 . . . . 1.0 111.695 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.8 Cg_endo -60.3 -27.6 85.19 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.893 1.729 . . . . 1.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' B' ' 371' ' ' PHE . 54.1 mt-30 -94.78 51.15 1.36 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.343 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.7 OUTLIER -83.24 16.87 2.26 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' B' ' 369' ' ' GLN . 66.8 m-85 -75.78 20.97 0.16 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.689 -1.141 . . . . 1.0 110.738 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 1.194 ' CD1' HD11 ' A' ' 102' ' ' LEU . 17.0 m-85 -74.96 11.06 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.391 . . . . 1.0 110.274 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.25 -10.49 7.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -42.25 74.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.728 0.299 . . . . 1.0 110.756 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 171' ' ' THR . 7.2 mmt . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.366 -0.975 . . . . 97.08 108.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.086 0.946 . . . . 123.41 110.769 -172.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.57 -162.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.497 1 N-CA-C 100.053 -4.055 . . . . 151.3 100.053 173.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.59 58.22 Favored Pre-proline 0 N--CA 1.44 -0.957 0 C-N-CA 115.931 -2.307 . . . . 169.25 106.148 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.6 Cg_exo -81.31 168.59 16.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 122.242 0.601 . . . . 185.76 110.563 171.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 127.022 2.129 . . . . 145.47 110.353 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.42 21.51 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 121.076 -1.015 . . . . 102.76 109.468 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.63 154.18 25.05 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 107.977 -1.12 . . . . 106.25 107.977 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.84 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 117.797 -1.561 . . . . 157.81 107.674 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.11 -45.9 91.43 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 103.617 -2.735 . . . . 150.2 103.617 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.05 164.68 35.31 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 103.702 -2.703 . . . . 183.52 103.702 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -76.74 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.986 0 N-CA-C 110.008 -0.805 . . . . 235.61 110.008 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.92 -41.26 82.33 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 124.798 1.239 . . . . 113.77 113.345 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.917 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.6 pt -52.17 136.24 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 119.547 1.067 . . . . 150.85 110.964 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.661 -1.237 . . . . 100.42 107.661 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.963 0.887 . . . . 129.36 110.436 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.05 -25.45 68.38 Favored 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.291 1.836 . . . . 112.34 106.695 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.943 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.21 -40.07 62.69 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.748 177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.7 m -84.5 -42.85 15.13 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 116.99 2.218 . . . . 80.49 116.99 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.57 3.32 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.6 Cg_exo -61.78 -10.77 18.12 Favored 'Trans proline' 0 C--N 1.321 -0.892 1 N-CA-C 128.918 6.469 . . . . 246.95 128.918 -170.058 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-N 126.181 4.082 . . . . 269.62 114.216 175.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.27 67.17 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.791 -1.188 . . . . 86.8 107.791 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.81 -29.3 69.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.162 -0.962 . . . . 85.91 110.485 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.5 t -68.63 -40.17 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.697 0.799 . . . . 82.0 111.309 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.42 167.7 12.54 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.511 -0.922 . . . . 120.73 108.511 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.01 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.115 0 C-N-CA 120.566 0.844 . . . . 87.86 109.912 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.97 -38.03 89.5 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.827 -0.805 . . . . 36.46 108.827 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.85 76.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.82 -1.178 . . . . 150.6 107.82 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.73 73.43 Favored 'General case' 0 CA--C 1.49 -1.339 0 O-C-N 121.284 -0.885 . . . . 123.26 108.654 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.51 -47.09 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.187 -0.672 . . . . 120.14 109.187 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 107.86 -1.163 . . . . 112.19 107.86 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.92 -47.16 84.47 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.925 -0.71 . . . . 60.87 109.639 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.05 -35.71 81.26 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 119.958 -0.697 . . . . 157.57 110.324 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.56 -40.89 98.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.668 -0.864 . . . . 47.06 108.668 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.27 97.91 Favored 'General case' 0 CA--C 1.495 -1.135 0 O-C-N 121.722 -0.611 . . . . 43.94 109.556 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.23 99.27 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.39 -41.29 93.84 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.638 -0.256 . . . . 140.66 111.04 -178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.93 97.89 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.584 -1.246 . . . . 116.04 110.257 -175.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.73 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.717 -0.845 . . . . 97.16 108.717 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.31 -39.96 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.953 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.76 -42.35 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.892 -0.781 . . . . 45.39 108.892 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.45 -51.02 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.846 -1.142 . . . . 48.64 110.165 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -47.0 78.12 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.131 -0.628 . . . . 116.65 111.701 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.9 97.86 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.704 -0.48 . . . . 51.16 109.704 -174.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.5 t -65.55 -48.91 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 119.841 -0.744 . . . . 44.3 110.879 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.6 t -64.75 -46.96 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 120.284 -0.567 . . . . 48.82 111.029 -174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.75 -44.18 95.19 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.513 -0.851 . . . . 58.7 111.99 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.63 -34.22 67.17 Favored 'General case' 0 CA--C 1.488 -1.414 0 O-C-N 122.075 -0.662 . . . . 101.4 110.992 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.75 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.761 -1.2 . . . . 103.57 107.761 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.4 t -61.45 -43.02 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.959 -0.756 . . . . 61.89 108.959 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.0 t -63.41 -50.96 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.481 -0.562 . . . . 70.01 109.481 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.4 98.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.12 -0.696 . . . . 132.1 109.12 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.63 83.06 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.633 -0.258 . . . . 104.5 110.486 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.84 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.282 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.947 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.1 pt -64.76 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.949 -176.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.38 98.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 117.754 -1.579 . . . . 137.11 109.468 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.53 91.07 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.19 -0.319 . . . . 54.66 111.021 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.926 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-O 121.64 0.733 . . . . 127.18 109.603 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.85 -36.82 80.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 124.103 0.961 . . . . 87.93 110.845 -176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.42 -34.63 78.64 Favored 'General case' 0 CA--C 1.491 -1.323 0 O-C-N 121.634 -0.666 . . . . 131.12 111.521 -175.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.016 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.41 7.15 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 115.298 -2.561 . . . . 246.56 109.652 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.45 -2.056 . . . . 339.35 105.45 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.12 165.26 17.84 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 103.037 -2.949 . . . . 114.66 103.037 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.18 -39.45 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 106.718 -1.586 . . . . 143.28 106.718 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.3 m -59.69 -38.0 80.36 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.726 -0.842 . . . . 160.22 108.726 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 108.877 -0.786 . . . . 120.54 108.877 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.902 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.56 -43.8 95.99 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.468 -0.567 . . . . 67.22 109.468 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.56 -39.73 88.65 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.463 -0.773 . . . . 138.6 109.67 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.66 -35.88 81.99 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 122.494 0.317 . . . . 151.46 110.588 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.947 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.55 -37.96 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 C-N-CA 117.422 -1.711 . . . . 117.93 106.733 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.08 -46.03 90.95 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.836 -1.172 . . . . 56.82 107.836 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.984 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.35 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.905 -0.776 . . . . 145.3 108.905 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.536 -0.913 . . . . 45.71 108.536 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.37 -42.06 99.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 109.358 -0.608 . . . . 105.61 109.358 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.47 92.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 47.89 108.662 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.53 -37.42 84.98 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.979 -0.378 . . . . 124.53 109.979 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.2 99.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 121.96 -0.462 . . . . 35.89 109.883 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.31 84.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.024 -1.473 . . . . 88.97 107.024 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.14 77.01 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.821 -0.752 . . . . 239.91 109.103 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.39 90.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.533 -0.73 . . . . 146.1 110.637 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.21 -58.16 3.44 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.876 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.57 -61.34 1.99 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 115.781 1.771 . . . . 197.45 115.781 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.934 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.28 -42.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 117.875 -1.53 . . . . 242.6 114.038 -170.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.953 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 118.91 -1.116 . . . . 215.61 109.824 -172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.3 -46.93 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 O-C-N 121.79 -0.569 . . . . 87.19 110.459 -175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.98 -41.81 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.35 -34.13 76.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.339 -0.985 . . . . 364.98 108.339 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.22 -44.67 75.23 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 121.537 -0.727 . . . . 181.63 111.306 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.808 HG22 ' HD2' ' A' ' 95' ' ' HIS . 56.9 m -60.83 -45.81 93.0 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.454 -1.314 . . . . 269.02 107.454 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.76 -44.98 93.61 Favored 'General case' 0 CA--C 1.47 -2.125 0 C-N-CA 118.671 -1.212 . . . . 562.66 109.989 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.13 -45.29 95.29 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.715 -1.194 . . . . 446.75 108.071 -167.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.34 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 C-N-CA 115.872 -2.331 . . . . 370.05 112.195 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.808 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.46 60.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 121.593 -0.692 . . . . 354.91 112.526 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.79 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.053 1.341 . . . . 462.44 111.918 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.37 178.05 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.044 0.926 . . . . 652.37 111.126 171.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.792 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.24 2.17 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.516 2.726 . . . . 905.99 107.907 -174.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.84 -36.37 80.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.292 -1.003 . . . . 570.43 108.292 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.6 -36.37 82.52 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 125.323 1.449 . . . . 453.22 111.149 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.943 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.58 178.67 33.85 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.869 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' B' ' 375' ' ' MET . 89.0 mt -56.37 -41.25 75.88 Favored 'General case' 0 CA--C 1.497 -1.058 0 C-N-CA 125.266 1.426 . . . . 457.72 112.383 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' B' ' 374' ' ' LEU . 22.6 m-85 -58.66 -46.86 86.25 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 118.618 -1.233 . . . . 340.58 109.338 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.12 71.69 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 118.797 -1.161 . . . . 453.6 111.625 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.37 73.35 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.989 -1.856 . . . . 541.48 105.989 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.85 -47.12 76.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 O-C-N 123.943 0.777 . . . . 466.68 110.851 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.77 -47.05 86.91 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 117.485 -1.686 . . . . 427.34 107.332 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.1 -36.8 82.72 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 112.417 0.525 . . . . 537.87 112.417 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.35 -42.74 74.87 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 116.891 -1.924 . . . . 422.12 111.566 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.08 -50.08 75.44 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 121.327 -0.858 . . . . 340.17 111.802 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.31 -46.54 71.21 Favored Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 119.112 -1.035 . . . . 258.06 111.695 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.934 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.47 -31.58 87.98 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 N-CA-C 115.379 1.261 . . . . 305.71 115.379 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.39 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.71 -0.848 . . . . 252.7 108.71 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.62 93.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.757 -1.201 . . . . 149.27 107.757 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.637 -0.425 . . . . 138.08 111.479 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.3 t -66.91 -42.42 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 O-C-N 121.646 -0.658 . . . . 132.89 110.965 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.72 -44.73 92.75 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.87 -0.789 . . . . 193.61 108.87 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.67 84.34 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 122.835 0.454 . . . . 63.83 110.13 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.2 m -64.02 -52.42 59.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.755 -0.378 . . . . 76.4 111.217 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.159 -1.052 . . . . 171.13 108.159 -174.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.101 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.5 91.31 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 121.856 -0.528 . . . . 78.3 110.624 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.18 -35.73 80.27 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.934 -1.106 . . . . 92.36 109.177 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.984 ' HE1' HD21 ' A' ' 74' ' ' LEU . 6.0 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.2 -1.037 . . . . 93.73 108.2 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 33.0 p -67.38 -41.68 84.64 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 119.207 -0.997 . . . . 132.74 109.357 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.69 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.151 -1.426 . . . . 43.39 107.151 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.1 t -58.42 -41.98 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.636 -0.876 . . . . 59.34 108.636 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.12 95.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 121.784 -0.573 . . . . 69.68 110.529 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.43 -42.79 92.08 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.715 -0.794 . . . . 147.63 108.928 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.2 -41.52 99.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.501 -0.925 . . . . 190.06 108.501 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.03 97.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.301 -1.0 . . . . 118.85 108.301 -177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.38 -42.66 98.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.974 -0.38 . . . . 102.5 109.974 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.61 95.11 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.825 -0.547 . . . . 89.98 109.834 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.51 -50.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 C-N-CA 118.121 -1.432 . . . . 106.09 110.997 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.06 -48.32 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.096 0 C-N-CA 117.111 -1.835 . . . . 227.74 111.814 -174.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.07 50.95 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.224 -2.19 . . . . 262.55 110.078 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.6 -10.38 28.55 Favored 'Trans proline' 0 C--N 1.29 -2.541 0 C-N-CA 121.613 1.542 . . . . 210.25 111.361 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.29 112.01 1.0 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 106.522 -1.659 . . . . 270.58 106.522 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.883 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.46 23.3 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.359 -0.837 . . . . 129.84 112.368 -175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.4 Cg_exo -61.37 -26.57 81.66 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 N-CA-C 116.274 1.606 . . . . 330.71 116.274 -174.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.21 7.99 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.455 -2.898 . . . . 204.51 107.295 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.451 -1.314 . . . . 387.41 107.451 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.7 147.01 33.62 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 118.818 -1.153 . . . . 166.22 109.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.11 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.829 -1.174 . . . . 44.23 107.829 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.26 -39.13 85.71 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.22 -1.03 . . . . 28.8 108.22 -175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.83 -38.78 92.12 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 109.104 -0.702 . . . . 30.29 109.104 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.6 -43.0 93.86 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.006 -0.739 . . . . 46.11 109.006 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -42.17 99.28 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.706 -1.22 . . . . 87.33 107.706 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.61 -42.07 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 107.976 -1.12 . . . . 23.69 107.976 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.23 -44.28 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.669 -0.493 . . . . 43.86 109.669 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.917 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.56 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.326 -0.99 . . . . 91.13 108.326 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.62 -37.97 88.41 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.708 -0.849 . . . . 65.88 108.708 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.08 -41.85 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.59 -0.522 . . . . 33.86 109.59 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.101 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.32 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.91 -38.28 90.35 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.934 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.4 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.003 -1.061 . . . . 43.64 109.749 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.79 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.72 -38.01 89.51 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.999 -0.741 . . . . 102.57 108.999 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.96 -41.11 86.69 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.423 -1.325 . . . . 58.16 107.423 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.1 -32.46 73.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.002 -0.74 . . . . 121.11 109.002 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.37 85.09 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 118.581 -1.248 . . . . 153.15 109.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.06 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -80.98 -43.79 19.13 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 113.113 -3.435 . . . . 133.67 113.571 173.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.03 -39.86 96.0 Favored 'General case' 0 CA--C 1.49 -1.353 0 O-C-N 120.899 -1.125 . . . . 157.42 112.189 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.41 -36.13 2.48 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 115.048 1.499 . . . . 250.91 115.048 -173.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.294 53.1 Cg_exo -59.46 -25.57 79.06 Favored 'Trans proline' 0 CA--C 1.488 -1.815 0 N-CA-C 118.039 2.284 . . . . 207.34 118.039 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.014 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.14 -34.2 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.948 -1.501 . . . . 192.46 106.948 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.03 98.12 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.996 -2.041 . . . . 261.0 107.996 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.83 159.13 26.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 101.535 -3.505 . . . . 491.4 101.535 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.0 106.83 0.55 Allowed 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 116.234 -2.186 . . . . 386.1 109.834 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.01 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 103.557 -2.757 . . . . 289.8 103.557 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.9 175.38 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.739 -1.124 . . . . 402.06 109.56 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.0 p -165.25 177.49 7.58 Favored 'General case' 0 CA--C 1.586 2.359 0 C-N-CA 127.372 2.269 . . . . 690.53 114.943 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.37 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.051 1 N-CA-C 123.158 4.503 . . . . 633.62 123.158 162.7 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.66 153.84 22.08 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.386 2.274 . . . . 617.99 110.855 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.63 174.39 6.02 Favored Pre-proline 0 C--N 1.364 1.211 0 C-N-CA 130.293 3.437 . . . . 434.98 113.434 -175.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.8 Cg_endo -44.26 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.378 3.953 . . . . 365.88 122.378 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.839 -2.282 . . . . 635.81 104.839 178.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.34 152.21 18.82 Favored 'General case' 1 CA--C 1.419 -4.082 3 N-CA-C 131.983 7.772 . . . . 999.99 131.983 -135.753 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.814 1 CA-C-N 103.322 -6.308 . . . . 594.32 113.618 149.203 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.09 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.651 1 N-CA-C 98.333 -4.691 . . . . 811.91 98.333 162.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.413 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.15 -175.62 4.9 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.981 0.896 . . . . 431.86 110.068 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.69 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 C-N-CA 124.357 1.063 . . . . 457.18 108.761 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.5 3.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.121 0.968 . . . . 458.77 113.459 -174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.39 -31.55 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 124.974 1.31 . . . . 999.99 112.418 168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -66.03 -45.74 5.55 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 N-CA-C 120.834 3.359 . . . . 999.99 120.834 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.72 8.16 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.16 -1.816 . . . . 81.18 107.282 -172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 CA-C-O 114.89 -2.481 . . . . 999.99 108.733 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.55 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.13 1 C-N-CA 125.994 4.462 . . . . 999.99 105.682 -170.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.25 -44.07 97.39 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.793 2.037 . . . . 967.72 112.019 -165.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.58 78.07 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.757 -1.572 . . . . 934.3 106.757 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.48 -30.27 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 129.227 3.011 . . . . 565.15 113.943 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 61.49 55.36 2.84 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 118.437 0.562 . . . . 755.61 109.913 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.42 -49.29 67.25 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 124.562 1.145 . . . . 325.89 113.272 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.97 78.29 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 123.585 0.754 . . . . 250.21 111.615 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.71 -43.39 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.621 0.724 . . . . 142.46 110.368 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.16 -41.49 96.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 123.957 0.903 . . . . 247.69 108.805 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.8 t60 -60.47 -51.39 69.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 125.452 1.501 . . . . 199.61 113.092 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.31 -44.48 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 107.753 -1.203 . . . . 106.73 107.753 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.15 -48.51 81.33 Favored 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 115.81 -0.632 . . . . 115.01 110.261 -173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.06 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.26 -49.1 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 C-N-CA 119.417 -0.913 . . . . 129.42 111.865 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.2 m -61.9 -53.17 59.42 Favored 'General case' 0 CA--C 1.482 -1.66 0 C-N-CA 118.231 -1.388 . . . . 172.48 109.964 -172.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.4 t -63.86 -54.21 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 C-N-CA 120.543 -0.463 . . . . 55.86 110.996 -174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.503 -1.279 . . . . 184.68 111.476 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.041 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.38 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 116.623 -2.031 . . . . 291.81 114.756 -174.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.08 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.84 -48.52 68.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 114.517 1.303 . . . . 80.16 114.517 -170.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.61 -45.44 82.79 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.943 -0.703 . . . . 136.02 109.509 -174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.5 Cg_exo -64.85 -27.03 59.3 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.643 -0.56 . . . . 92.17 110.643 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.38 76.52 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.453 -1.314 . . . . 135.6 107.453 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.1 -44.76 91.31 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.566 -0.531 . . . . 52.1 109.566 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.65 -43.5 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 109.106 -0.702 . . . . 95.89 109.106 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.35 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.676 -1.602 . . . . 43.41 106.676 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.26 99.1 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 117.415 0.607 . . . . 54.41 110.468 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.45 -34.07 74.8 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.95 -1.5 . . . . 53.88 106.95 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.95 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.504 -0.924 . . . . 68.29 108.504 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.82 -39.05 92.94 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.597 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.0 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 C-N-CA 119.634 -0.827 . . . . 111.61 109.476 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.34 -22.46 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.391 -0.966 . . . . 85.26 108.391 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.43 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.067 -0.813 . . . . 40.71 111.067 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.05 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.441 -0.948 . . . . 95.86 108.441 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.91 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.405 -0.961 . . . . 144.37 108.405 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.13 47.42 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 107.615 -1.254 . . . . 326.72 107.615 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.009 -1.848 . . . . 158.38 106.009 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.94 98.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 109.639 -0.504 . . . . 36.78 109.639 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.13 125.8 25.03 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.134 -1.027 . . . . 85.46 109.828 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.541 -2.022 . . . . 127.78 105.541 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.76 Favored Pre-proline 0 CA--C 1.493 -1.23 0 N-CA-C 105.995 -1.854 . . . . 164.84 105.995 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.5 Cg_exo -56.78 -39.92 87.98 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 N-CA-C 113.955 0.714 . . . . 222.35 113.955 -175.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.15 166.96 44.88 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 106.395 -2.682 . . . . 45.22 106.395 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.95 -45.78 93.34 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 106.017 -1.845 . . . . 107.57 106.017 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.86 58.15 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 118.88 -1.128 . . . . 167.96 109.146 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.46 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 126.738 2.015 . . . . 280.68 109.759 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.01 11.28 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.454 1.102 . . . . 218.25 110.681 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.37 137.62 54.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.218 -2.141 . . . . 343.57 105.218 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.877 -1.527 . . . . 263.29 106.877 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 126.555 1.942 . . . . 261.92 108.496 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.17 -38.12 89.93 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 107.941 -1.133 . . . . 106.81 107.941 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.96 94.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.354 -1.338 . . . . 112.2 107.549 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.6 t -64.25 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.253 -0.647 . . . . 45.41 109.253 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.7 p -70.9 -32.12 68.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 110.281 -0.266 . . . . 97.62 110.281 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.67 81.87 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.729 0.811 . . . . 59.29 110.963 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.51 83.9 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.658 1.183 . . . . 106.49 110.677 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.99 -30.62 69.24 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.304 -0.998 . . . . 106.62 108.304 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.0 91.3 Favored 'General case' 0 N--CA 1.436 -1.163 0 O-C-N 121.851 -0.531 . . . . 75.97 110.025 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.5 t -65.54 -40.84 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 122.967 0.507 . . . . 65.27 109.761 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.04 -41.58 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 120.437 -0.505 . . . . 107.94 110.139 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.51 -40.81 98.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 121.711 -0.618 . . . . 87.98 110.312 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.82 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.37 96.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 118.822 -1.151 . . . . 65.5 108.372 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.74 -36.39 80.85 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.137 -1.06 . . . . 85.05 108.137 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.79 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 109.087 -0.709 . . . . 42.25 109.087 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.28 -38.22 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 C-N-CA 119.522 -0.871 . . . . 91.01 109.442 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.89 -41.5 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.997 -1.112 . . . . 66.09 107.997 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.15 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.748 -0.381 . . . . 52.39 110.301 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.81 88.03 Favored 'General case' 0 CA--C 1.488 -1.404 0 O-C-N 121.876 -0.515 . . . . 46.42 109.853 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.35 -38.09 88.19 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.316 -0.994 . . . . 116.51 108.316 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.24 -48.25 82.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.429 -0.582 . . . . 65.18 109.429 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.6 97.17 Favored 'General case' 0 CA--C 1.489 -1.374 0 O-C-N 122.156 -0.34 . . . . 51.33 110.466 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.67 -43.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 C-N-CA 118.891 -1.123 . . . . 126.3 109.035 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.62 -49.31 69.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.502 -0.879 . . . . 133.94 112.512 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.63 -33.41 35.78 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 48.0 tp -58.47 -41.55 89.8 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.64 -0.663 . . . . 72.23 111.631 -167.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.7 -35.97 86.89 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 CA-C-N 119.848 0.982 . . . . 106.13 111.354 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.37 -44.75 82.29 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 119.765 -0.774 . . . . 128.35 110.007 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.41 -37.87 89.02 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 110.19 -0.3 . . . . 100.73 110.19 -177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 119.303 -0.959 . . . . 172.72 109.157 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.09 68.21 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.169 -1.048 . . . . 249.23 108.169 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.5 -55.09 35.85 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.71 -1.589 . . . . 259.78 106.71 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.2 -44.23 72.53 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 113.566 0.95 . . . . 233.11 113.566 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.36 -48.28 91.54 Favored Pre-proline 0 N--CA 1.44 -0.962 0 C-N-CA 119.201 -0.999 . . . . 169.54 110.575 -170.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.18 -24.48 79.18 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 116.708 -1.728 . . . . 255.47 114.691 174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.55 -44.3 94.54 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 119.21 0.914 . . . . 279.03 108.859 177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.83 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.37 84.82 59.32 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.104 -178.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.2 164.02 11.33 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 N-CA-C 107.479 -1.777 . . . . 278.35 107.479 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.08 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 123.784 0.678 . . . . 312.91 109.345 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.68 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.67 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.403 -1.332 . . . . 251.26 107.403 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.116 -3.291 . . . . 175.26 102.116 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.52 -44.93 96.16 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 100.849 -3.76 . . . . 99.07 100.849 172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.19 9.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 103.442 -2.799 . . . . 243.21 103.442 171.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.98 25.12 Favored 'General case' 0 CA--C 1.473 -2.001 0 C-N-CA 116.062 -2.255 . . . . 201.04 105.277 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.824 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.52 -41.46 90.03 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.843 174.479 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.928 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.32 -45.7 86.75 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.179 -1.408 . . . . 215.06 112.562 -171.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 77.8 t -65.62 -46.46 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.47 0 C-N-CA 118.553 -1.259 . . . . 125.28 112.91 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.71 -37.06 86.32 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.22 -1.4 . . . . 268.9 107.22 -171.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -45.01 74.53 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 125.645 1.578 . . . . 280.88 108.817 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.55 -47.49 85.95 Favored 'General case' 0 CA--C 1.485 -1.557 0 C-N-CA 118.957 -1.097 . . . . 184.47 109.054 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.283 -0.967 . . . . 167.92 112.7 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.83 90.23 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.759 -1.577 . . . . 367.18 110.756 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.7 73.99 Favored 'General case' 0 N--CA 1.434 -1.244 0 O-C-N 121.823 -0.548 . . . . 173.97 110.466 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.75 85.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.522 0.729 . . . . 119.66 109.819 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.97 74.36 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.687 -1.227 . . . . 112.3 107.687 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.19 -32.01 73.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 116.248 -0.433 . . . . 174.17 110.197 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.72 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 124.703 1.201 . . . . 145.27 110.614 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.759 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.4 m -57.58 -35.4 70.34 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.109 -1.071 . . . . 170.15 108.109 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.31 -34.16 63.93 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.24 -0.436 . . . . 214.57 110.63 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.17 56.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.043 1.737 . . . . 168.29 115.556 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.759 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.45 -34.81 79.05 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 114.075 1.139 . . . . 167.15 114.075 -168.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.7 p-10 -64.24 -38.29 32.99 Favored Pre-proline 0 N--CA 1.434 -1.258 0 C-N-CA 115.514 -2.474 . . . . 165.13 113.908 -171.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.5 -31.88 80.3 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 122.823 2.044 . . . . 123.92 111.24 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.3 pt -68.76 -42.57 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.913 -1.115 . . . . 110.55 109.73 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.01 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 108.819 -0.808 . . . . 145.31 108.819 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.11 -48.84 78.96 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.41 -0.916 . . . . 246.68 109.835 -177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.19 -47.48 84.28 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.585 -0.846 . . . . 64.43 109.568 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.0 79.58 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.932 -1.107 . . . . 80.72 110.233 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.5 -35.74 75.82 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 115.992 1.849 . . . . 140.44 115.992 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.81 132.23 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 112.667 -3.613 . . . . 178.87 113.086 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.12 86.6 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.427 -1.26 . . . . 110.22 110.083 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.858 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.72 -50.56 72.8 Favored 'General case' 0 CA--C 1.493 -1.241 0 O-C-N 121.821 -0.55 . . . . 174.78 109.753 -174.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.88 -41.73 95.4 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 108.252 -1.018 . . . . 161.84 108.252 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.519 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.19 73.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.19 -0.67 . . . . 117.2 109.19 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.07 75.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.368 -0.533 . . . . 112.6 111.085 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.4 94.54 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.679 -0.968 . . . . 101.46 110.679 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.23 -45.97 90.95 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 118.465 1.132 . . . . 151.49 109.505 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.14 -36.27 77.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.96 -1.496 . . . . 142.32 106.96 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.75 -41.84 91.87 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.923 -1.51 . . . . 109.09 106.923 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.48 85.84 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.334 -0.229 . . . . 76.11 111.057 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.4 -55.48 30.92 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.865 -0.734 . . . . 120.24 109.326 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.49 41.21 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 102.931 -2.988 . . . . 192.73 102.931 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.13 -44.2 92.03 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.189 -172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.39 -177.08 0.81 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 106.298 -1.742 . . . . 69.68 106.298 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.1 Cg_exo -59.0 -75.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.363 0 C-N-CA 118.316 -0.656 . . . . 191.05 112.614 176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.49 43.9 16.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 123.513 0.508 . . . . 287.03 109.745 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 C-N-CA 112.99 -3.484 . . . . 292.29 109.876 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.89 0.05 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.174 -2.528 . . . . 184.57 104.174 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.73 8.67 4.93 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.073 0.768 . . . . 274.56 113.073 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.91 57.24 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 117.742 -2.171 . . . . 268.24 113.435 172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.4 m-20 51.6 -172.0 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 118.651 1.226 . . . . 200.06 110.702 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.858 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.5 t80 -63.94 -32.99 74.71 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.85 -1.167 . . . . 114.44 107.85 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.11 21.88 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 107.603 -1.258 . . . . 263.81 107.603 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.34 3.6 Favored Glycine 0 CA--C 1.479 -2.213 1 N-CA-C 102.504 -4.239 . . . . 103.79 102.504 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.045 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.28 95.59 10.24 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.941 -2.704 . . . . 117.3 106.028 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.72 90.64 Favored 'General case' 0 CA--C 1.468 -2.198 1 N-CA-C 98.012 -4.81 . . . . 231.58 98.012 167.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.04 163.4 29.33 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 169.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.045 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.61 -48.59 78.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 116.037 -2.265 . . . . 112.72 108.42 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.101 -0.703 . . . . 83.22 109.101 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.7 m -156.3 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.817 -2.66 . . . . 174.36 103.817 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.4 mtt180 -60.85 160.93 8.8 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.765 -1.939 . . . . 202.73 105.765 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.016 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.07 52.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.07 -1.455 . . . . 180.62 107.07 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.57 -171.87 0.26 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.408 -2.071 . . . . 145.25 105.408 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.13 88.18 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.123 -1.806 . . . . 66.05 106.123 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.768 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 103.507 -2.775 . . . . 266.49 103.507 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.37 -124.98 0.27 Allowed 'General case' 0 N--CA 1.427 -1.594 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.727 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.4 94.17 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.518 -1.219 . . . . 94.78 112.84 -175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.39 9.06 Favored 'General case' 0 CA--C 1.483 -1.606 0 C-N-CA 112.3 -3.76 . . . . 121.41 109.473 -171.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.55 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 85.34 108.943 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.77 143.46 41.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.845 -1.168 . . . . 267.57 107.845 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.522 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.03 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.004 -1.48 . . . . 154.84 107.004 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.38 161.96 8.55 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.531 0.681 . . . . 180.01 110.727 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.892 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.5 156.9 23.72 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.933 -1.506 . . . . 333.78 106.933 -178.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.49 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.365 -1.346 . . . . 335.2 107.365 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.8 158.89 0.13 Allowed 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.726 -0.842 . . . . 266.47 108.726 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.2 m -60.52 -46.99 88.1 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.674 -1.973 . . . . 59.34 105.674 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.52 173.85 11.99 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.456 -2.424 . . . . 201.26 104.456 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.95 106.75 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 C-N-CA 116.339 -2.144 . . . . 56.23 105.493 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.22 -59.51 5.2 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.226 -0.657 . . . . 87.58 109.226 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.883 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.7 22.31 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 107.866 -1.161 . . . . 219.95 107.866 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.95 83.76 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 116.381 -2.128 . . . . 121.79 105.481 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.09 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 N-CA-C 105.853 -1.906 . . . . 53.85 105.853 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.23 16.6 77.07 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.879 -1.156 . . . . 35.88 107.879 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' B' ' 366' ' ' PRO . 4.4 mmt85 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.0 Cg_endo -66.63 -20.26 53.35 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.16 2.573 . . . . 1.0 113.75 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 2.6 tttt -82.92 -55.2 0.53 Allowed Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 121.018 -0.273 . . . . 1.0 111.677 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.35 -27.55 85.08 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.894 1.729 . . . . 1.0 111.885 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' B' ' 371' ' ' PHE . 1.5 mp0 -94.84 51.25 1.36 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.311 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.29 16.92 2.26 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 178.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' B' ' 369' ' ' GLN . 63.0 m-85 -75.82 21.04 0.16 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.672 -1.149 . . . . 1.0 110.79 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' B' ' 370' ' ' GLN . 4.0 m-85 -75.03 11.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.214 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.14 -10.55 7.31 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 19' ' ' THR . 6.5 mt -69.75 -42.28 74.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.758 0.313 . . . . 1.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.965 ' HB2' HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.422 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.384 -0.969 . . . . 97.08 108.384 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.57 155.46 22.29 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 122.052 0.93 . . . . 123.41 110.755 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.61 -162.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.088 -4.041 . . . . 151.3 100.088 173.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.68 -38.57 57.96 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.892 -2.323 . . . . 169.25 106.135 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.3 Cg_exo -81.27 168.56 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 122.248 0.604 . . . . 185.76 110.554 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.52 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 127.04 2.136 . . . . 145.47 110.339 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.081 -1.012 . . . . 102.76 109.512 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.6 154.15 25.1 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.957 -1.127 . . . . 106.25 107.957 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.915 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.86 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 117.781 -1.567 . . . . 157.81 107.647 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.13 -45.92 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.6 -2.741 . . . . 150.2 103.6 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.02 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 103.679 -2.711 . . . . 183.52 103.679 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.78 6.83 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.997 0 N-CA-C 109.94 -0.831 . . . . 235.61 109.94 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.94 -41.23 82.36 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.76 1.224 . . . . 113.77 113.364 -170.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.915 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 119.601 1.092 . . . . 150.85 111.03 -176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.45 156.28 46.42 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.646 -1.242 . . . . 100.42 107.646 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.079 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.62 58.35 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.972 0.891 . . . . 129.36 110.463 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.52 68.4 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 126.35 1.86 . . . . 112.34 106.651 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.17 -40.13 62.76 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.539 -0.755 . . . . 131.73 111.712 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.079 ' H ' HG23 ' A' ' 17' ' ' THR . 71.5 m -84.47 -42.88 15.15 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 117.017 2.228 . . . . 80.49 117.017 -174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.98 174.5 3.38 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 118.185 -1.406 . . . . 98.98 111.211 -169.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.2 Cg_exo -61.7 -10.79 17.95 Favored 'Trans proline' 0 C--N 1.321 -0.92 1 N-CA-C 128.96 6.485 . . . . 246.95 128.96 -170.108 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.55 8.73 Favored 'General case' 0 C--N 1.324 -0.506 1 CA-C-N 126.126 4.057 . . . . 269.62 114.237 175.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.24 67.13 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.86 -29.36 69.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.122 -0.986 . . . . 85.91 110.471 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.27 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 123.708 0.803 . . . . 82.0 111.312 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.895 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.37 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.394 0 N-CA-C 108.528 -0.915 . . . . 120.73 108.528 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.79 89.73 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 120.629 0.886 . . . . 87.86 109.869 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -38.01 89.5 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.774 -0.824 . . . . 36.46 108.774 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.79 -33.81 76.5 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.817 -1.179 . . . . 150.6 107.817 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.25 -32.73 73.46 Favored 'General case' 0 CA--C 1.491 -1.317 0 O-C-N 121.257 -0.902 . . . . 123.26 108.641 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.745 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.44 -47.18 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 N-CA-C 109.142 -0.688 . . . . 120.14 109.142 176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.1 m -67.42 -31.02 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 107.867 -1.16 . . . . 112.19 107.867 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.16 84.32 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 119.94 -0.704 . . . . 60.87 109.57 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.02 -35.62 81.05 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.392 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.87 98.39 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.597 -0.89 . . . . 47.06 108.597 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.91 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.78 -0.575 . . . . 43.94 109.502 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.733 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.26 99.2 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.751 -0.833 . . . . 42.61 108.751 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.28 93.83 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.043 -178.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.93 97.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 118.576 -1.25 . . . . 116.04 110.272 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.46 -38.8 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 108.719 -0.845 . . . . 97.16 108.719 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -39.99 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 108.995 -0.742 . . . . 54.85 108.995 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.955 HG22 HG21 ' A' ' 86' ' ' THR . 93.3 t -57.67 -42.37 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.895 -0.78 . . . . 45.39 108.895 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.55 -50.97 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.815 -1.154 . . . . 48.64 110.186 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.21 -47.09 78.09 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.199 -0.6 . . . . 116.65 111.691 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.6 m -62.0 -43.9 97.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.688 -0.486 . . . . 51.16 109.688 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.93 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.809 -0.756 . . . . 44.3 110.866 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.71 -47.02 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 120.334 -0.547 . . . . 48.82 111.0 -174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.16 95.26 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.544 -0.836 . . . . 58.7 111.994 -174.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.17 67.01 Favored 'General case' 0 CA--C 1.488 -1.427 0 O-C-N 122.131 -0.629 . . . . 101.4 111.015 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.7 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.763 -1.199 . . . . 103.57 107.763 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.41 -43.05 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.49 -50.89 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 120.273 -0.571 . . . . 70.01 109.49 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.42 98.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 132.1 109.104 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.61 83.09 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.684 -0.235 . . . . 104.5 110.436 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.65 -49.91 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 120.239 -0.584 . . . . 142.96 111.282 -173.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.943 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.81 -41.62 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 C-N-CA 116.974 -1.89 . . . . 158.32 110.869 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.42 98.07 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 117.751 -1.579 . . . . 137.11 109.476 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.52 91.15 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.147 -0.346 . . . . 54.66 111.047 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.927 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.42 117.11 29.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.677 0.751 . . . . 127.18 109.586 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.81 -36.85 80.1 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 124.07 0.948 . . . . 87.93 110.847 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.039 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.4 -34.63 78.63 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 121.661 -0.65 . . . . 131.12 111.544 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.48 7.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 115.293 -2.563 . . . . 246.56 109.595 -175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.46 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.456 -2.053 . . . . 339.35 105.456 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.16 165.31 17.79 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.963 -2.977 . . . . 114.66 102.963 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.47 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.762 -1.57 . . . . 143.28 106.762 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.838 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.09 80.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.668 -0.864 . . . . 160.22 108.668 -176.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.35 -31.77 72.46 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.89 -0.782 . . . . 120.54 108.89 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.84 95.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.47 -0.567 . . . . 67.22 109.47 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.51 -39.8 88.86 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.453 -0.779 . . . . 138.6 109.686 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.929 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.51 -35.98 82.27 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 122.483 0.313 . . . . 151.46 110.666 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.51 -37.93 80.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 C-N-CA 117.374 -1.73 . . . . 117.93 106.739 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.06 -46.02 90.94 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.874 -1.158 . . . . 56.82 107.874 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.994 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.91 98.05 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.909 -0.775 . . . . 145.3 108.909 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.44 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.562 -0.903 . . . . 45.71 108.562 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.42 -42.02 99.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.375 -0.602 . . . . 105.61 109.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.45 92.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.657 -0.868 . . . . 47.89 108.657 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.73 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.936 -0.394 . . . . 124.53 109.936 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.2 99.39 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 121.98 -0.45 . . . . 35.89 109.789 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.18 -37.37 84.99 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.15 -49.17 76.93 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 119.823 -0.751 . . . . 239.91 109.029 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.43 -43.35 90.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.495 -0.753 . . . . 146.1 110.605 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.19 -58.23 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.378 -1.729 . . . . 91.74 113.839 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 115.776 1.769 . . . . 197.45 115.776 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.926 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.22 -42.31 55.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 117.925 -1.51 . . . . 242.6 114.028 -170.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.955 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.38 -36.53 84.28 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 118.886 -1.126 . . . . 215.61 109.893 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.31 -46.98 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 120.347 -0.541 . . . . 87.19 110.429 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.4 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 109.714 -0.476 . . . . 231.82 109.714 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.29 -34.15 76.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.22 -44.7 75.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.54 -0.725 . . . . 181.63 111.263 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.807 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.8 m -60.87 -45.76 93.26 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 107.429 -1.323 . . . . 269.02 107.429 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.053 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.81 -44.98 93.72 Favored 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 118.674 -1.211 . . . . 562.66 109.996 -179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.23 95.54 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.661 -1.216 . . . . 446.75 108.118 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.52 -26.28 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 115.832 -2.347 . . . . 370.05 112.176 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.807 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.51 60.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.596 -0.69 . . . . 354.91 112.517 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.84 4.5 0.98 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.064 1.345 . . . . 462.44 111.91 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.8 mm-40 -172.36 178.07 2.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 121.973 0.892 . . . . 652.37 111.113 171.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.33 2.17 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 128.444 2.698 . . . . 905.99 107.933 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.35 80.07 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.33 82.38 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 125.324 1.45 . . . . 453.22 111.188 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.51 178.7 33.93 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 118.801 -1.666 . . . . 445.63 109.938 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.45 -41.17 76.03 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 125.251 1.42 . . . . 457.72 112.372 -170.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.68 -46.9 86.22 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.653 -1.219 . . . . 340.58 109.274 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.71 -32.16 71.77 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.774 -1.17 . . . . 453.6 111.584 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.0 -40.37 73.25 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.987 -1.857 . . . . 541.48 105.987 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.77 -47.16 76.13 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 123.989 0.806 . . . . 466.68 110.917 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.07 86.82 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 117.475 -1.69 . . . . 427.34 107.326 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.01 -36.84 83.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.451 0.537 . . . . 537.87 112.451 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.37 -42.75 74.79 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.856 -1.938 . . . . 422.12 111.568 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.13 75.27 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 121.343 -0.848 . . . . 340.17 111.848 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.21 -46.57 72.24 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 119.064 -1.054 . . . . 258.06 111.768 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.926 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.48 -31.57 87.95 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 N-CA-C 115.322 1.239 . . . . 305.71 115.322 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.93 -40.4 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.67 -0.863 . . . . 252.7 108.67 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.91 -40.63 93.88 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.782 -1.192 . . . . 149.27 107.782 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.85 95.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.623 -0.431 . . . . 138.08 111.499 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.654 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.4 t -66.93 -42.39 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 O-C-N 121.566 -0.709 . . . . 132.89 110.952 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.69 92.72 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.878 -0.786 . . . . 193.61 108.878 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.66 84.39 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 122.843 0.457 . . . . 63.83 110.093 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.04 -52.34 59.87 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 122.083 -0.385 . . . . 76.4 111.259 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.746 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.63 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 108.161 -1.052 . . . . 171.13 108.161 -174.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.096 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.79 -38.58 91.62 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.813 -0.554 . . . . 78.3 110.605 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.11 -35.72 80.36 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 118.915 -1.114 . . . . 92.36 109.244 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.994 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.59 -34.2 76.52 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.167 -1.049 . . . . 93.73 108.167 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.65 84.45 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.238 -0.985 . . . . 132.74 109.321 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.09 94.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.125 -1.435 . . . . 43.39 107.125 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.99 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 108.561 -0.903 . . . . 59.34 108.561 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.05 95.28 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 121.776 -0.578 . . . . 69.68 110.495 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.41 -42.8 92.17 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.351 -0.981 . . . . 106.98 108.351 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.62 81.47 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.686 -0.806 . . . . 147.63 108.943 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.15 -41.52 99.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.582 -0.896 . . . . 190.06 108.582 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.37 -44.05 97.82 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.32 -0.993 . . . . 118.85 108.32 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.34 -42.69 98.95 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.975 -0.379 . . . . 102.5 109.975 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.63 95.22 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 121.801 -0.562 . . . . 89.98 109.837 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.69 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 118.094 -1.442 . . . . 106.09 110.992 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.38 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 C-N-CA 117.124 -1.831 . . . . 227.74 111.792 -174.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.83 100.09 51.0 Favored Pre-proline 0 CA--C 1.486 -1.513 0 C-N-CA 116.284 -2.166 . . . . 262.55 110.025 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.41 28.59 Favored 'Trans proline' 0 C--N 1.289 -2.555 0 C-N-CA 121.641 1.561 . . . . 210.25 111.304 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.93 0.98 Allowed 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.568 -1.641 . . . . 270.58 106.568 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.88 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.388 -0.824 . . . . 129.84 112.345 -175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.37 -26.58 81.71 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 116.279 1.607 . . . . 330.71 116.279 -174.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.0 77.15 7.93 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 114.476 -2.89 . . . . 204.51 107.29 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.74 147.46 0.09 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.4 -1.333 . . . . 387.41 107.4 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 147.02 33.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.787 -1.165 . . . . 166.22 109.514 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.83 -40.79 88.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.837 -1.171 . . . . 44.23 107.837 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.27 -39.15 85.81 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.182 -1.044 . . . . 28.8 108.182 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.77 -38.86 92.25 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.086 -0.709 . . . . 30.29 109.086 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.0 m -59.56 -43.07 93.67 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -42.16 99.24 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.696 -1.224 . . . . 87.33 107.696 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.3 t -61.69 -42.08 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.893 -1.151 . . . . 23.69 107.893 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.5 t -63.22 -44.32 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 109.658 -0.497 . . . . 43.86 109.658 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.25 -42.55 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.312 -0.996 . . . . 91.13 108.312 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.57 -37.97 88.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.78 -0.822 . . . . 65.88 108.78 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.1 -41.86 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.561 -0.533 . . . . 33.86 109.561 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.096 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.32 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.702 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.86 -38.43 90.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.478 -0.889 . . . . 75.44 108.869 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.5 -48.43 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 O-C-N 121.049 -1.032 . . . . 43.64 109.727 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.787 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.04 89.61 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 109.008 -0.738 . . . . 102.57 109.008 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.14 86.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.382 -1.34 . . . . 58.16 107.382 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.46 73.84 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.38 85.12 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 118.6 -1.24 . . . . 153.15 109.914 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.03 -43.76 19.07 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 113.109 -3.436 . . . . 133.67 113.517 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.91 -39.94 96.06 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 120.949 -1.095 . . . . 157.42 112.214 -171.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.42 -36.13 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.045 1.498 . . . . 250.91 115.045 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 52.8 Cg_exo -59.49 -25.51 78.93 Favored 'Trans proline' 0 CA--C 1.488 -1.78 0 N-CA-C 117.972 2.259 . . . . 207.34 117.972 -174.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.017 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.14 -34.27 74.72 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.919 -1.511 . . . . 192.46 106.919 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.51 -41.08 98.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 107.94 -2.064 . . . . 261.0 107.94 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.7 159.11 25.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.496 -3.52 . . . . 491.4 101.496 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -59.99 106.83 0.54 Allowed 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 116.272 -2.171 . . . . 386.1 109.786 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 103.512 -2.773 . . . . 289.8 103.512 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.43 0.86 Allowed 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 117.716 -1.135 . . . . 402.06 109.587 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.29 177.5 7.54 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.335 2.254 . . . . 690.53 114.973 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.04 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.718 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.5 p -85.68 153.89 22.03 Favored 'General case' 0 C--N 1.39 2.332 0 C-N-CA 127.312 2.245 . . . . 617.99 110.86 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.05 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.68 174.37 6.05 Favored Pre-proline 0 C--N 1.364 1.2 0 C-N-CA 130.289 3.436 . . . . 434.98 113.403 -175.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.541 0 N-CA-C 122.423 3.97 . . . . 365.88 122.423 -168.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.5 m -84.85 20.94 1.68 Allowed 'General case' 0 CA--C 1.466 -2.265 0 N-CA-C 104.795 -2.298 . . . . 635.81 104.795 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.37 152.25 18.78 Favored 'General case' 1 CA--C 1.42 -4.041 3 N-CA-C 131.989 7.774 . . . . 999.99 131.989 -135.735 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.053 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.87 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.777 1 CA-C-N 103.289 -6.323 . . . . 594.32 113.6 149.217 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.19 144.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.45 144.53 45.91 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.03 -1.868 . . . . 999.99 109.423 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.965 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.2 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 122.034 0.921 . . . . 431.86 110.03 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.12 148.66 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 124.358 1.063 . . . . 457.18 108.8 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.3 85.41 3.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.151 0.98 . . . . 458.77 113.561 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.59 0.99 Allowed Pre-proline 0 N--CA 1.439 -1.015 0 C-N-CA 124.967 1.307 . . . . 999.99 112.425 168.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.75 5.67 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 N-CA-C 120.89 3.381 . . . . 999.99 120.89 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.034 0 C-N-CA 117.128 -1.829 . . . . 81.18 107.217 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.06 45.07 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.885 0 CA-C-O 114.906 -2.473 . . . . 999.99 108.809 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.7 Cg_endo -41.57 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.133 1 C-N-CA 125.993 4.462 . . . . 999.99 105.716 -170.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.25 -44.04 97.45 Favored 'General case' 0 CA--C 1.483 -1.631 0 C-N-CA 126.729 2.011 . . . . 967.72 112.036 -165.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.48 77.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.735 -1.58 . . . . 934.3 106.735 -175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.187 2.995 . . . . 565.15 113.922 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.39 2.79 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 118.395 0.543 . . . . 755.61 109.889 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.24 67.13 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.579 1.152 . . . . 325.89 113.218 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.85 -44.97 78.54 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.538 0.735 . . . . 250.21 111.644 -169.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.65 -43.35 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-O 121.599 0.714 . . . . 142.46 110.442 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.18 -41.44 96.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.96 0.904 . . . . 247.69 108.807 -173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 125.467 1.507 . . . . 199.61 113.15 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.39 -44.49 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 107.709 -1.219 . . . . 106.73 107.709 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.05 -48.57 81.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.851 -0.613 . . . . 115.01 110.242 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.4 t -65.21 -49.17 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 119.422 -0.911 . . . . 129.42 111.86 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.796 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.87 -53.16 59.69 Favored 'General case' 0 CA--C 1.483 -1.609 0 C-N-CA 118.211 -1.395 . . . . 172.48 109.943 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.3 t -63.84 -54.28 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 120.451 -0.499 . . . . 55.86 110.982 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.56 -51.5 59.33 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 118.529 -1.269 . . . . 184.68 111.518 -174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.63 -52.37 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 C-N-CA 116.648 -2.021 . . . . 291.81 114.731 -174.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -82.09 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.143 1.535 . . . . 130.66 115.143 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.796 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.88 -48.49 68.6 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 114.509 1.3 . . . . 80.16 114.509 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.45 83.08 Favored Pre-proline 0 N--CA 1.434 -1.23 0 C-N-CA 119.971 -0.692 . . . . 136.02 109.521 -174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.6 Cg_exo -64.82 -27.11 59.51 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.697 0.57 . . . . 92.17 110.63 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.25 -41.4 76.98 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.54 -1.281 . . . . 135.6 107.54 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.13 -44.73 91.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.572 -0.529 . . . . 52.1 109.572 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.66 -43.55 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.066 -0.716 . . . . 95.89 109.066 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.21 -42.35 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 106.75 -1.574 . . . . 43.41 106.75 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.32 99.08 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.346 -1.502 . . . . 27.69 109.346 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.67 -47.4 75.63 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.163 -0.61 . . . . 54.41 110.459 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.81 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.022 -1.473 . . . . 53.88 107.022 -177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.84 93.91 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.455 -0.943 . . . . 68.29 108.455 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.07 93.0 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 119.698 -0.801 . . . . 107.59 110.569 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.97 -38.42 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.635 -0.826 . . . . 111.61 109.52 -177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.7 t -63.23 -22.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.404 -0.961 . . . . 85.26 108.404 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.91 -41.94 99.48 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.996 -0.842 . . . . 40.71 110.996 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.04 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 108.417 -0.957 . . . . 95.86 108.417 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.491 -0.929 . . . . 144.37 108.491 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.37 132.1 47.35 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.584 -1.265 . . . . 326.72 107.584 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.3 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.046 -1.835 . . . . 158.38 106.046 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.3 -41.98 99.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.643 -0.503 . . . . 36.78 109.643 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.3 m -61.11 125.87 25.29 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.175 -1.01 . . . . 85.46 109.842 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.53 8.81 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.548 -2.019 . . . . 127.78 105.548 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.93 34.9 Favored Pre-proline 0 CA--C 1.493 -1.215 0 N-CA-C 105.959 -1.867 . . . . 164.84 105.959 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.9 Cg_exo -56.84 -39.97 87.55 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.88 0.685 . . . . 222.35 113.88 -175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.09 166.98 45.0 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 106.407 -2.677 . . . . 45.22 106.407 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.91 -45.83 93.09 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.007 -1.849 . . . . 107.57 106.007 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.728 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.74 141.83 58.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 118.885 -1.126 . . . . 167.96 109.136 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.0 m 99.52 106.72 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 126.69 1.996 . . . . 280.68 109.71 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.27 0.7 Allowed 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 124.464 1.106 . . . . 218.25 110.744 174.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.59 54.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.183 -2.154 . . . . 343.57 105.183 177.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.89 81.86 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.903 -1.517 . . . . 263.29 106.903 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.28 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.576 1.95 . . . . 261.92 108.502 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.17 90.12 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.912 -1.144 . . . . 106.81 107.912 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.4 -39.93 94.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.389 -1.324 . . . . 112.2 107.54 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.739 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.89 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.248 -0.649 . . . . 45.41 109.248 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.813 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.6 p -70.89 -32.02 68.86 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.48 -39.58 81.3 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.716 0.806 . . . . 59.29 110.963 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.53 83.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 124.637 1.175 . . . . 106.49 110.692 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.65 69.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.295 -1.002 . . . . 106.62 108.295 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.07 -41.02 91.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 121.826 -0.546 . . . . 75.97 110.037 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.443 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 77.1 t -65.53 -40.87 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 C-N-CA 122.903 0.481 . . . . 65.27 109.799 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.97 -41.65 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 C-N-CA 120.449 -0.501 . . . . 107.94 110.114 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.52 -40.74 97.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 121.669 -0.645 . . . . 87.98 110.32 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.67 -40.39 96.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.855 -1.138 . . . . 65.5 108.372 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.762 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.69 -36.42 80.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.158 -1.053 . . . . 85.05 108.158 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.43 -45.76 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.071 -0.714 . . . . 42.25 109.071 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.35 -38.24 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 119.517 -0.873 . . . . 91.01 109.441 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.59 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.995 -1.113 . . . . 66.09 107.995 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.11 -43.13 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 O-C-N 122.096 -0.378 . . . . 52.39 110.32 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.73 -46.8 88.06 Favored 'General case' 0 CA--C 1.488 -1.409 0 O-C-N 121.909 -0.495 . . . . 46.42 109.869 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.29 -38.13 88.16 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.342 -0.984 . . . . 116.51 108.342 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.484 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.21 82.73 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.359 -0.608 . . . . 65.18 109.359 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.65 97.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 122.165 -0.335 . . . . 51.33 110.462 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.904 -1.119 . . . . 126.3 108.973 -176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.59 -49.3 69.28 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.504 -0.878 . . . . 133.94 112.486 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.39 35.34 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.36 -41.65 90.48 Favored Pre-proline 0 CA--C 1.492 -1.266 0 O-C-N 121.656 -0.653 . . . . 72.23 111.655 -167.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.7 -36.0 86.81 Favored 'Trans proline' 0 C--N 1.295 -2.283 0 CA-C-N 119.868 0.989 . . . . 106.13 111.312 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.4 -44.66 82.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.754 -0.778 . . . . 128.35 110.054 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.93 89.26 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 110.209 -0.293 . . . . 100.73 110.209 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.57 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.28 -0.968 . . . . 172.72 109.154 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.737 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.52 -28.14 68.32 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.219 -1.03 . . . . 249.23 108.219 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.894 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.06 36.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.717 -1.586 . . . . 259.78 106.717 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.23 -44.22 72.45 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.532 0.938 . . . . 233.11 113.532 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.0 mt -61.31 -48.3 91.67 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 119.197 -1.001 . . . . 169.54 110.62 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.3 Cg_exo -61.17 -24.56 79.38 Favored 'Trans proline' 0 N--CA 1.43 -2.261 0 C-N-CA 116.77 -1.687 . . . . 255.47 114.593 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.58 -44.21 94.74 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.284 0.947 . . . . 279.03 108.894 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.38 -44.71 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 110.072 -0.344 . . . . 162.21 110.072 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.46 84.84 59.48 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.07 -178.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.05 11.27 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 N-CA-C 107.473 -1.78 . . . . 278.35 107.473 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.872 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.76 0.662 . . . . 312.91 109.314 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.77 -170.68 2.49 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.542 -1.651 . . . . 353.54 106.542 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.017 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.25 47.0 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 102.107 -3.294 . . . . 175.26 102.107 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.45 -44.99 96.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.885 -3.746 . . . . 99.07 100.885 172.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.47 124.13 9.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.456 -2.794 . . . . 243.21 103.456 171.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.017 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.93 112.91 25.03 Favored 'General case' 0 CA--C 1.474 -1.961 0 C-N-CA 116.059 -2.256 . . . . 201.04 105.313 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.78 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 115.952 -2.299 . . . . 201.36 108.763 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.56 -41.44 90.16 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 113.238 -1.801 . . . . 203.82 107.851 174.479 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.929 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.3 -45.72 86.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.205 -1.398 . . . . 215.06 112.543 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.547 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.41 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.465 0 C-N-CA 118.554 -1.259 . . . . 125.28 112.931 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.97 86.04 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.195 -1.409 . . . . 268.9 107.195 -171.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.04 74.4 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.667 1.587 . . . . 280.88 108.82 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.4 86.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 118.918 -1.113 . . . . 184.47 109.041 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.97 -42.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 119.301 -0.96 . . . . 167.92 112.71 -175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.82 -38.78 89.84 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 117.808 -1.557 . . . . 367.18 110.719 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.15 -32.72 74.02 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.855 -0.528 . . . . 173.97 110.497 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.42 -36.78 85.26 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.516 0.727 . . . . 119.66 109.824 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.97 74.37 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.743 -1.206 . . . . 112.3 107.743 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.03 73.31 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.195 -0.457 . . . . 174.17 110.255 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 124.686 1.195 . . . . 145.27 110.627 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.59 -35.4 70.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.074 -1.084 . . . . 170.15 108.074 -175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.12 63.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 119.262 -0.399 . . . . 214.57 110.618 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.26 -33.15 56.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.01 1.724 . . . . 168.29 115.545 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.79 79.02 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 114.079 1.14 . . . . 167.15 114.079 -168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.7 p-10 -64.28 -38.26 32.43 Favored Pre-proline 0 N--CA 1.433 -1.281 0 C-N-CA 115.474 -2.49 . . . . 165.13 113.943 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.6 Cg_exo -62.5 -31.86 80.27 Favored 'Trans proline' 0 N--CA 1.432 -2.097 0 CA-C-N 122.786 2.031 . . . . 123.92 111.265 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.73 -42.57 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 118.903 -1.119 . . . . 110.55 109.799 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -40.01 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.815 -0.809 . . . . 145.31 108.815 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.929 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 119.38 -0.928 . . . . 246.68 109.848 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.11 -47.55 84.1 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 119.552 -0.859 . . . . 64.43 109.604 -173.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.72 -45.1 79.77 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.98 -1.088 . . . . 80.72 110.253 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.51 -35.62 75.69 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 116.026 1.861 . . . . 140.44 116.026 -173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.18 34.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 112.689 -3.604 . . . . 178.87 113.064 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.0 -37.11 86.57 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.443 -1.253 . . . . 110.22 110.106 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.67 -50.65 72.48 Favored 'General case' 0 CA--C 1.492 -1.264 0 O-C-N 121.717 -0.614 . . . . 174.78 109.776 -174.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.7 95.48 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.253 -1.017 . . . . 161.84 108.253 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.52 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.36 -50.23 73.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.168 -0.679 . . . . 117.2 109.168 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.49 -44.11 75.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.354 -0.538 . . . . 112.6 111.082 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.4 94.53 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.619 -0.993 . . . . 101.46 110.619 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.14 -46.06 90.65 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 118.564 1.182 . . . . 151.49 109.491 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.32 77.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.916 -1.513 . . . . 142.32 106.916 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.86 92.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.853 -1.536 . . . . 109.09 106.853 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.88 -42.42 85.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 122.306 -0.246 . . . . 76.11 110.99 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.51 30.56 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 119.91 -0.716 . . . . 120.24 109.304 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.32 131.58 41.28 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 102.928 -2.99 . . . . 192.73 102.928 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.18 -44.25 92.17 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.035 -1.066 . . . . 176.29 109.169 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.757 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.467 0 N-CA-C 106.29 -1.745 . . . . 69.68 106.29 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.01 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.402 0 C-N-CA 118.333 -0.645 . . . . 191.05 112.568 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.757 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.59 43.81 16.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 123.573 0.546 . . . . 287.03 109.749 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.45 78.53 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.985 -3.486 . . . . 292.29 109.854 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.49 -152.83 0.05 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.69 4.95 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 113.05 0.759 . . . . 274.56 113.05 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.9 57.27 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 117.724 -2.179 . . . . 268.24 113.463 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.62 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 118.637 1.218 . . . . 200.06 110.739 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.87 -33.05 74.83 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.886 -1.153 . . . . 114.44 107.886 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.04 21.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.594 -1.261 . . . . 263.81 107.594 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.33 3.59 Favored Glycine 0 CA--C 1.479 -2.177 1 N-CA-C 102.509 -4.237 . . . . 103.79 102.509 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.051 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.1 mt -88.32 95.62 10.26 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 114.925 -2.71 . . . . 117.3 106.02 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.194 1 N-CA-C 98.017 -4.809 . . . . 231.58 98.017 167.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.039 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.51 29.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.067 -3.309 . . . . 303.24 102.067 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.051 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.65 78.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 116.076 -2.249 . . . . 112.72 108.413 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.0 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 109.113 -0.699 . . . . 83.22 109.113 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.881 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.27 -126.17 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.873 -2.64 . . . . 174.36 103.873 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.89 161.02 8.73 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.07 52.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.086 -1.45 . . . . 180.62 107.086 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.56 -171.89 0.26 Allowed 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 105.372 -2.084 . . . . 145.25 105.372 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.17 88.06 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.64 -152.11 0.48 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 103.522 -2.77 . . . . 266.49 103.522 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.33 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.779 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.06 -37.45 94.21 Favored Glycine 0 N--CA 1.426 -2.014 0 CA-C-N 114.53 -1.214 . . . . 94.78 112.831 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.13 100.42 9.04 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 112.309 -3.757 . . . . 121.41 109.501 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.07 145.49 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.931 -0.766 . . . . 85.34 108.931 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.7 143.43 41.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.521 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.62 0.59 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.538 -0.542 . . . . 226.1 109.538 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.001 -1.481 . . . . 154.84 107.001 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.38 161.99 8.49 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.606 0.717 . . . . 180.01 110.696 -173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.889 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.51 156.9 23.73 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.938 -1.504 . . . . 333.78 106.938 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.53 48.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.361 -1.348 . . . . 335.2 107.361 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.767 -0.827 . . . . 266.47 108.767 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.7 m -60.63 -46.91 88.52 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.67 -1.974 . . . . 59.34 105.67 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.55 173.85 11.98 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 104.455 -2.424 . . . . 201.26 104.455 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 116.337 -2.145 . . . . 56.23 105.536 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.16 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.88 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.51 153.75 22.24 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.831 -1.174 . . . . 219.95 107.831 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.0 83.75 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 C-N-CA 116.367 -2.133 . . . . 121.79 105.477 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.8 t -154.09 159.76 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.81 -1.922 . . . . 53.85 105.81 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.56 77.08 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 106.049 -2.82 . . . . 196.55 106.049 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.682 0 N-CA-C 107.893 -1.151 . . . . 35.88 107.893 -178.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' B' ' 368' ' ' PRO . 7.1 mmt180 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.666 -0.865 . . . . 1.0 108.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 47.6 Cg_endo -66.62 -20.29 53.44 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.173 2.582 . . . . 1.0 113.743 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.797 ' HG3' ' HB3' ' A' ' 188' ' ' PRO . 6.6 tmtt? -82.78 -55.28 0.54 Allowed Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 111.686 0.254 . . . . 1.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.5 Cg_endo -60.37 -27.56 85.1 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.889 1.726 . . . . 1.0 111.865 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.8 OUTLIER -94.8 51.15 1.36 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.082 0.468 . . . . 1.0 110.348 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.5 tp-100 -83.22 16.8 2.28 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.099 -1.074 . . . . 1.0 108.099 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 369' ' ' GLN . 11.1 t80 -75.69 20.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.752 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' B' ' 370' ' ' GLN . 3.5 m-85 -74.9 10.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 1.0 110.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.55 7.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -42.21 74.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.748 0.308 . . . . 1.0 110.72 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.425 -0.954 . . . . 97.08 108.425 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.65 155.39 22.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 122.108 0.956 . . . . 123.41 110.711 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.58 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.474 1 N-CA-C 100.066 -4.05 . . . . 151.3 100.066 173.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.905 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.63 58.88 Favored Pre-proline 0 N--CA 1.44 -0.966 0 C-N-CA 115.956 -2.297 . . . . 169.25 106.092 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.23 168.56 16.71 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 122.231 0.595 . . . . 185.76 110.555 171.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.5 t -64.51 -25.96 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 127.017 2.127 . . . . 145.47 110.313 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.32 157.36 21.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 121.049 -1.032 . . . . 102.76 109.434 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.55 154.17 25.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.987 -1.116 . . . . 106.25 107.987 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.9 51.87 0.74 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 117.766 -1.573 . . . . 157.81 107.644 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.574 -2.75 . . . . 150.2 103.574 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.06 164.66 35.35 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 103.661 -2.718 . . . . 183.52 103.661 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.92 3.81 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 N-CA-C 109.982 -0.814 . . . . 235.61 109.982 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.21 82.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.781 1.232 . . . . 113.77 113.387 -170.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.2 136.26 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 119.532 1.06 . . . . 150.85 111.003 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.5 156.27 46.39 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.605 -1.257 . . . . 100.42 107.605 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.06 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.913 0.863 . . . . 129.36 110.45 -174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 126.331 1.852 . . . . 112.34 106.652 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.2 -40.12 62.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.717 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.41 -42.91 15.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 116.98 2.215 . . . . 80.49 116.98 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.22 -1.392 . . . . 98.98 111.235 -169.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.335 86.1 Cg_exo -61.79 -10.82 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.911 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.1 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.625 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.54 8.72 Favored 'General case' 0 C--N 1.325 -0.496 1 CA-C-N 126.147 4.067 . . . . 269.62 114.221 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.3 67.22 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.808 -1.182 . . . . 86.8 107.808 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.78 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.073 -1.017 . . . . 85.91 110.518 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.47 -40.29 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 C-N-CA 123.734 0.813 . . . . 82.0 111.344 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.36 167.73 12.48 Favored Pre-proline 0 CA--C 1.488 -1.438 0 N-CA-C 108.593 -0.891 . . . . 120.73 108.593 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.94 149.78 89.84 Favored 'Trans proline' 0 N--CA 1.432 -2.11 0 C-N-CA 120.615 0.877 . . . . 87.86 109.946 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.92 89.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.85 -0.796 . . . . 36.46 108.85 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.83 -33.86 76.64 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.808 -1.182 . . . . 150.6 107.808 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.7 73.4 Favored 'General case' 0 CA--C 1.491 -1.321 0 O-C-N 121.266 -0.897 . . . . 123.26 108.646 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.54 -47.12 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 109.155 -0.683 . . . . 120.14 109.155 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.45 -31.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 107.881 -1.155 . . . . 112.19 107.881 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.7 tp -63.01 -47.08 84.62 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.923 -0.711 . . . . 60.87 109.605 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.674 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.6 m-90 -66.06 -35.61 81.0 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.941 -0.703 . . . . 157.57 110.413 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.748 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.4 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.662 -0.866 . . . . 47.06 108.662 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.78 -41.26 97.99 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.812 -0.555 . . . . 43.94 109.536 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.27 99.19 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.702 -0.851 . . . . 42.61 108.702 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.901 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.46 -41.18 93.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.627 -0.26 . . . . 140.66 111.02 -178.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.85 -43.93 97.85 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.549 -1.26 . . . . 116.04 110.217 -175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.41 -38.78 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 108.734 -0.839 . . . . 97.16 108.734 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.24 -40.06 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 108.977 -0.749 . . . . 54.85 108.977 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.883 -0.784 . . . . 45.39 108.883 -175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.57 -50.91 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 C-N-CA 118.87 -1.132 . . . . 48.64 110.155 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.31 -47.08 77.83 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.133 -0.627 . . . . 116.65 111.664 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.91 -43.94 97.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.717 -0.475 . . . . 51.16 109.717 -174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.94 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.892 -0.723 . . . . 44.3 110.815 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.75 -46.96 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 C-N-CA 120.324 -0.55 . . . . 48.82 111.036 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.22 95.18 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.508 -0.853 . . . . 58.7 112.005 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 O-C-N 122.059 -0.671 . . . . 101.4 110.993 -175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.82 -38.73 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.803 -1.184 . . . . 103.57 107.803 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.3 t -61.4 -43.08 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.44 -50.9 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 120.281 -0.568 . . . . 70.01 109.488 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.807 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.99 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 109.079 -0.712 . . . . 132.1 109.079 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.642 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.3 -46.53 83.21 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 116.737 -0.21 . . . . 104.5 110.435 -176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.021 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.85 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.179 -0.608 . . . . 142.96 111.268 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 25.0 pt -64.8 -41.67 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 C-N-CA 116.92 -1.912 . . . . 158.32 110.892 -175.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.807 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.7 -41.42 98.12 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 117.746 -1.582 . . . . 137.11 109.483 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.12 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 122.166 -0.334 . . . . 54.66 111.036 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.38 117.08 29.37 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.603 0.716 . . . . 127.18 109.589 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.86 -36.8 80.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.05 0.94 . . . . 87.93 110.816 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.044 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.65 78.65 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 121.668 -0.645 . . . . 131.12 111.535 -175.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.025 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.66 69.45 7.18 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 115.343 -2.543 . . . . 246.56 109.591 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 105.493 -2.04 . . . . 339.35 105.493 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.23 17.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 103.0 -2.963 . . . . 114.66 103.0 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.877 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.09 -39.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 106.819 -1.548 . . . . 143.28 106.819 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 96.6 m -59.65 -38.06 80.41 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.721 -0.844 . . . . 160.22 108.721 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.36 -31.78 72.48 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 108.879 -0.786 . . . . 120.54 108.879 -177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.54 -43.82 95.99 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.48 -0.563 . . . . 67.22 109.48 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.3 m-85 -66.55 -39.74 88.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.545 -0.722 . . . . 138.6 109.69 -177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.93 82.12 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 122.518 0.327 . . . . 151.46 110.659 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 C-N-CA 117.381 -1.728 . . . . 117.93 106.719 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.01 -46.05 90.76 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.861 -1.163 . . . . 56.82 107.861 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.934 -0.765 . . . . 145.3 108.934 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.37 95.55 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.517 -0.92 . . . . 45.71 108.517 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.44 -41.98 99.13 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.352 -0.61 . . . . 105.61 109.352 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.48 92.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.633 -0.877 . . . . 47.89 108.633 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.52 -37.4 84.95 Favored 'General case' 0 N--CA 1.438 -1.052 0 O-C-N 122.069 -0.394 . . . . 124.53 110.007 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.16 99.3 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.955 -0.466 . . . . 35.89 109.827 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.21 -37.33 84.92 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.055 -1.461 . . . . 88.97 107.055 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.072 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.39 90.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.509 -0.744 . . . . 146.1 110.583 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.2 3.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.61 -61.37 1.99 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 115.713 1.745 . . . . 197.45 115.713 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.929 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.24 -42.29 55.63 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.906 -1.518 . . . . 242.6 114.055 -170.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.52 84.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 118.947 -1.101 . . . . 215.61 109.839 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.8 t -60.3 -46.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.792 -0.567 . . . . 87.19 110.444 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.9 t -65.91 -41.88 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.136 0 N-CA-C 109.722 -0.473 . . . . 231.82 109.722 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.901 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.08 75.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.344 -0.984 . . . . 364.98 108.344 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.567 -0.708 . . . . 181.63 111.269 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.88 -45.75 93.34 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.444 -1.317 . . . . 269.02 107.444 -175.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.04 93.39 Favored 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 118.648 -1.221 . . . . 562.66 110.036 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.31 95.23 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 118.698 -1.201 . . . . 446.75 108.062 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.748 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.2 m -70.42 -26.36 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.852 -2.339 . . . . 370.05 112.219 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.56 60.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.533 -0.729 . . . . 354.91 112.508 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.5 m-20 82.82 4.6 0.98 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.069 1.348 . . . . 462.44 111.852 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.38 178.06 2.9 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.076 0.941 . . . . 652.37 111.076 171.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.71 86.28 2.16 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 128.468 2.707 . . . . 905.99 107.978 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.89 -36.38 80.12 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.213 -1.032 . . . . 570.43 108.213 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.33 82.33 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 125.288 1.435 . . . . 453.22 111.182 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.65 33.93 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 118.755 -1.688 . . . . 445.63 109.899 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.19 76.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.247 1.419 . . . . 457.72 112.346 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.89 86.13 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 118.646 -1.221 . . . . 340.58 109.322 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.77 -32.08 71.57 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 118.729 -1.188 . . . . 453.6 111.592 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.06 -40.38 73.48 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 105.947 -1.871 . . . . 541.48 105.947 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -65.82 -47.09 76.21 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.008 0.818 . . . . 466.68 110.885 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.79 -47.07 86.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.478 -1.689 . . . . 427.34 107.318 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.8 82.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 112.449 0.537 . . . . 537.87 112.449 -174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.64 74.77 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.798 -1.961 . . . . 422.12 111.615 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.1 t80 -59.07 -50.09 75.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.296 -0.878 . . . . 340.17 111.822 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.26 -46.58 71.7 Favored Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 119.104 -1.039 . . . . 258.06 111.728 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.929 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.4 Cg_exo -61.48 -31.58 87.89 Favored 'Trans proline' 0 N--CA 1.435 -1.969 0 N-CA-C 115.364 1.255 . . . . 305.71 115.364 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.873 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.38 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.727 -0.842 . . . . 252.7 108.727 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.55 93.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.796 -1.187 . . . . 149.27 107.796 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.82 95.9 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.631 -0.428 . . . . 138.08 111.486 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.5 t -66.99 -42.35 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.586 -0.696 . . . . 132.89 110.973 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.84 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.901 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.53 -37.62 84.42 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.794 0.438 . . . . 63.83 110.096 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.03 -52.39 59.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.737 -0.385 . . . . 76.4 111.207 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.61 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.199 -1.038 . . . . 171.13 108.199 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.83 -38.52 91.41 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.837 -0.539 . . . . 78.3 110.62 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.17 -35.69 80.21 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 118.895 -1.122 . . . . 92.36 109.203 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.52 -34.26 76.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.198 -1.038 . . . . 93.73 108.198 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.43 -41.61 84.5 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 119.235 -0.986 . . . . 132.74 109.382 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.07 94.69 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.202 -1.407 . . . . 43.39 107.202 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.49 -42.02 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.569 -0.9 . . . . 59.34 108.569 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.08 95.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 121.796 -0.565 . . . . 69.68 110.572 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.78 92.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.342 -0.984 . . . . 106.98 108.342 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.58 81.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.664 -0.814 . . . . 147.63 108.944 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.706 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.0 mmp_? -63.18 -41.53 99.23 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.507 -0.923 . . . . 190.06 108.507 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.601 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.37 -44.02 97.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.67 98.81 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.991 -0.374 . . . . 102.5 109.991 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.68 95.33 Favored 'General case' 0 CA--C 1.488 -1.411 0 O-C-N 121.824 -0.547 . . . . 89.98 109.859 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.1 mt -66.47 -50.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 C-N-CA 118.142 -1.423 . . . . 106.09 110.998 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.27 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 C-N-CA 117.079 -1.848 . . . . 227.74 111.834 -174.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.91 100.1 50.9 Favored Pre-proline 0 CA--C 1.486 -1.509 0 C-N-CA 116.223 -2.191 . . . . 262.55 110.033 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.62 -10.31 28.35 Favored 'Trans proline' 0 C--N 1.29 -2.508 0 C-N-CA 121.601 1.534 . . . . 210.25 111.393 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 106.485 -1.672 . . . . 270.58 106.485 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.84 -39.44 23.27 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.349 -0.842 . . . . 129.84 112.362 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 80.9 Cg_exo -61.41 -26.59 81.51 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 116.264 1.602 . . . . 330.71 116.264 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 114.481 -2.887 . . . . 204.51 107.275 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.67 147.43 0.09 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.403 -1.332 . . . . 387.41 107.403 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.72 147.0 33.6 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.809 -1.156 . . . . 166.22 109.513 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.78 88.07 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.849 -1.167 . . . . 44.23 107.849 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.1 m -60.27 -39.18 85.92 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.185 -1.043 . . . . 28.8 108.185 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.79 -38.8 92.06 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.098 -0.704 . . . . 30.29 109.098 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.62 -43.0 93.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.02 -0.733 . . . . 46.11 109.02 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -42.22 99.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.672 -1.233 . . . . 87.33 107.672 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.9 t -61.61 -42.13 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.9 t -63.16 -44.28 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.727 -0.471 . . . . 43.86 109.727 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.54 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.295 -1.002 . . . . 91.13 108.295 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.66 -37.94 88.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.738 -0.838 . . . . 65.88 108.738 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.11 -41.84 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.537 -0.542 . . . . 33.86 109.537 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.35 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.594 -1.262 . . . . 146.52 107.594 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.525 -0.87 . . . . 75.44 108.91 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.53 -48.45 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 O-C-N 121.055 -1.028 . . . . 43.64 109.672 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.67 -38.02 89.53 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 109.059 -0.719 . . . . 102.57 109.059 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.13 86.68 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.451 -1.314 . . . . 58.16 107.451 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.796 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.05 -32.44 73.81 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.063 -0.717 . . . . 121.11 109.063 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.06 -42.32 85.2 Favored 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 118.601 -1.239 . . . . 153.15 109.875 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.058 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.12 -43.66 19.08 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 113.091 -3.444 . . . . 133.67 113.533 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.06 -39.85 95.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.885 -1.135 . . . . 157.42 112.159 -171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.49 -36.12 2.43 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 114.991 1.478 . . . . 250.91 114.991 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.52 -25.43 78.69 Favored 'Trans proline' 0 CA--C 1.489 -1.753 0 N-CA-C 118.021 2.277 . . . . 207.34 118.021 -174.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.18 -34.2 74.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.95 -1.5 . . . . 192.46 106.95 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.54 -41.05 98.06 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.934 -2.066 . . . . 261.0 107.934 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.77 159.15 25.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 101.53 -3.507 . . . . 491.4 101.53 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -60.02 106.82 0.55 Allowed 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.784 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.1 m -154.04 -166.65 2.43 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 103.576 -2.75 . . . . 289.8 103.576 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.135 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.96 175.39 0.87 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 117.741 -1.123 . . . . 402.06 109.58 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.2 p -165.24 177.46 7.6 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.348 2.259 . . . . 690.53 114.906 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.37 160.6 0.0 OUTLIER 'General case' 1 C--N 1.43 4.08 1 N-CA-C 123.164 4.505 . . . . 633.62 123.164 162.662 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.325 0 C-N-CA 127.331 2.252 . . . . 617.99 110.906 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.71 174.41 5.98 Favored Pre-proline 0 C--N 1.363 1.189 0 C-N-CA 130.236 3.414 . . . . 434.98 113.423 -175.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.1 Cg_endo -44.26 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 N-CA-C 122.393 3.959 . . . . 365.88 122.393 -168.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.88 20.91 1.7 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.773 -2.306 . . . . 635.81 104.773 178.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.38 152.25 18.78 Favored 'General case' 1 CA--C 1.419 -4.058 3 N-CA-C 132.007 7.78 . . . . 999.99 132.007 -135.748 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.792 1 CA-C-N 103.293 -6.321 . . . . 594.32 113.621 149.216 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.14 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.59 1 N-CA-C 98.246 -4.724 . . . . 811.91 98.246 162.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.45 144.54 45.9 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.052 -1.859 . . . . 999.99 109.434 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.974 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.66 4.92 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.022 0.915 . . . . 431.86 110.028 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.1 148.68 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.351 1.06 . . . . 457.18 108.775 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.28 85.4 3.72 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.126 0.97 . . . . 458.77 113.519 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.34 -31.54 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.088 0 C-N-CA 124.987 1.315 . . . . 999.99 112.455 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -65.98 -45.77 5.6 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.644 ' OE1' ' N ' ' B' ' 365' ' ' ARG . 54.9 mt-10 -119.55 171.7 8.18 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.19 -1.804 . . . . 81.18 107.281 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.833 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.1 45.08 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 C-N-CA 115.535 -2.466 . . . . 999.99 108.77 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.4 Cg_endo -41.6 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.138 1 C-N-CA 126.023 4.482 . . . . 999.99 105.673 -170.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.98 97.58 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.712 2.005 . . . . 967.72 112.051 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.32 -36.51 78.1 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.755 -1.572 . . . . 934.3 106.755 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.24 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 129.187 2.995 . . . . 565.15 113.933 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.38 2.81 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.442 0.565 . . . . 755.61 109.865 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.135 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.32 67.05 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 124.54 1.136 . . . . 325.89 113.268 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -44.96 78.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 123.528 0.731 . . . . 250.21 111.655 -169.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.67 -43.35 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.624 0.726 . . . . 142.46 110.433 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.13 -41.53 96.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 123.979 0.912 . . . . 247.69 108.792 -173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.48 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.376 1.471 . . . . 199.61 113.144 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.4 -44.46 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.684 -1.228 . . . . 106.73 107.684 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.19 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.906 -0.588 . . . . 115.01 110.227 -173.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.058 HG13 HD13 ' A' ' 161' ' ' LEU . 86.8 t -65.22 -49.09 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 C-N-CA 119.394 -0.922 . . . . 129.42 111.893 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.7 m -61.95 -53.13 59.9 Favored 'General case' 0 CA--C 1.482 -1.652 0 C-N-CA 118.205 -1.398 . . . . 172.48 109.936 -172.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.7 t -63.86 -54.25 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.559 -0.456 . . . . 55.86 110.955 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.55 -51.57 58.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.535 -1.266 . . . . 184.68 111.533 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.56 -52.41 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.704 -1.998 . . . . 291.81 114.765 -174.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 115.182 1.549 . . . . 130.66 115.182 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.89 -48.53 68.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.447 1.277 . . . . 80.16 114.447 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.44 83.0 Favored Pre-proline 0 N--CA 1.435 -1.209 0 C-N-CA 119.995 -0.682 . . . . 136.02 109.477 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.1 Cg_exo -64.87 -27.12 59.14 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.581 -0.584 . . . . 92.17 110.581 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.35 76.75 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.491 -1.299 . . . . 135.6 107.491 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.66 91.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.589 -0.523 . . . . 52.1 109.589 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.76 -43.5 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 109.06 -0.718 . . . . 95.89 109.06 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.22 -42.38 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 106.703 -1.592 . . . . 43.41 106.703 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.32 99.12 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 109.354 -1.498 . . . . 27.69 109.354 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.7 -47.38 75.61 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 122.19 -0.594 . . . . 54.41 110.412 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.79 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.991 -1.485 . . . . 53.88 106.991 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.84 -40.78 94.12 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.46 -0.941 . . . . 68.29 108.46 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.75 -39.07 93.02 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 119.659 -0.816 . . . . 107.59 110.644 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.33 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 119.599 -0.841 . . . . 111.61 109.546 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.31 -22.54 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.96 99.4 Favored Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.048 -0.821 . . . . 40.71 111.048 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.71 -44.07 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.407 -0.96 . . . . 95.86 108.407 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.94 -137.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.393 -0.965 . . . . 144.37 108.393 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.35 132.17 47.42 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.459 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.36 -168.03 1.51 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.043 -1.836 . . . . 158.38 106.043 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.97 98.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.667 -0.494 . . . . 36.78 109.667 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.07 125.86 25.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.16 -1.016 . . . . 85.46 109.811 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.528 -2.027 . . . . 127.78 105.528 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.02 139.91 34.83 Favored Pre-proline 0 CA--C 1.493 -1.243 0 N-CA-C 105.978 -1.86 . . . . 164.84 105.978 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.4 Cg_exo -56.8 -39.94 87.77 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 N-CA-C 113.91 0.696 . . . . 222.35 113.91 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 166.97 44.83 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.382 -2.687 . . . . 45.22 106.382 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.77 93.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.044 -1.836 . . . . 107.57 106.044 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.73 141.81 58.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 118.922 -1.111 . . . . 167.96 109.117 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.5 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 126.717 2.007 . . . . 280.68 109.702 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.713 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 55.99 11.26 0.7 Allowed 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 124.49 1.116 . . . . 218.25 110.703 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.34 137.63 54.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.231 -2.137 . . . . 343.57 105.231 177.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.98 81.88 1.53 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.861 -1.533 . . . . 263.29 106.861 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 126.554 1.942 . . . . 261.92 108.503 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.22 -38.14 89.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.845 -1.169 . . . . 106.81 107.845 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.736 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.41 -39.94 94.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.369 -1.332 . . . . 112.2 107.54 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.3 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.235 -0.654 . . . . 45.41 109.235 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.809 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.8 p -70.88 -32.17 69.06 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 110.249 -0.278 . . . . 97.62 110.249 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.63 81.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.701 0.8 . . . . 59.29 110.972 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.53 83.96 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 124.638 1.175 . . . . 106.49 110.678 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.7 69.27 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.243 -1.021 . . . . 106.62 108.243 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -41.02 91.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.823 -0.548 . . . . 75.97 110.016 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.445 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.87 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 122.976 0.51 . . . . 65.27 109.78 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -64.06 -41.6 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.114 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.53 -40.78 97.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 O-C-N 121.705 -0.622 . . . . 87.98 110.305 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.35 96.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 118.791 -1.164 . . . . 65.5 108.366 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.6 mtt -61.77 -36.35 80.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.112 -1.07 . . . . 85.05 108.112 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.46 -45.74 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.098 -0.705 . . . . 42.25 109.098 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.31 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.409 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.84 -41.49 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.02 -1.104 . . . . 66.09 108.02 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.14 -43.2 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 120.76 -0.376 . . . . 52.39 110.295 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.7 -46.77 88.26 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.841 -0.537 . . . . 46.42 109.917 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.34 -38.14 88.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.295 -1.002 . . . . 116.51 108.295 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.3 -48.24 82.58 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.345 -0.613 . . . . 65.18 109.345 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 122.085 -0.384 . . . . 51.33 110.404 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.37 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 118.937 -1.105 . . . . 126.3 109.0 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.522 -0.871 . . . . 133.94 112.493 -176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.819 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.65 -33.46 35.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 116.84 2.163 . . . . 134.84 116.84 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.46 -41.62 90.19 Favored Pre-proline 0 CA--C 1.493 -1.228 0 O-C-N 121.652 -0.655 . . . . 72.23 111.599 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.6 Cg_exo -60.63 -36.0 87.24 Favored 'Trans proline' 0 N--CA 1.429 -2.313 0 CA-C-N 119.917 1.006 . . . . 106.13 111.358 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.63 82.27 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.706 -0.797 . . . . 128.35 110.028 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 110.245 -0.28 . . . . 100.73 110.245 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.26 -44.54 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.301 -0.96 . . . . 172.72 109.146 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.209 -1.034 . . . . 249.23 108.209 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.688 -1.597 . . . . 259.78 106.688 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.22 -44.18 72.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.585 0.957 . . . . 233.11 113.585 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.35 -48.33 91.45 Favored Pre-proline 0 N--CA 1.439 -0.998 0 C-N-CA 119.2 -1.0 . . . . 169.54 110.606 -171.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.1 Cg_exo -61.06 -24.59 79.76 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 116.712 -1.725 . . . . 255.47 114.661 174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.56 -44.2 94.8 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 119.229 0.922 . . . . 279.03 108.939 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.3 -44.8 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 110.112 -0.329 . . . . 162.21 110.112 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.782 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.85 59.31 Favored Pre-proline 0 N--CA 1.431 -1.401 0 C-N-CA 118.733 -1.187 . . . . 128.13 108.087 -178.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.04 11.19 Favored 'Trans proline' 0 C--N 1.294 -2.295 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 123.797 0.686 . . . . 312.91 109.302 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.72 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.67 142.21 47.05 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.93 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.091 -3.3 . . . . 175.26 102.091 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.54 -45.01 95.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.828 -3.767 . . . . 99.07 100.828 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.4 124.19 9.21 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.478 -2.786 . . . . 243.21 103.478 171.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.96 112.95 25.09 Favored 'General case' 0 CA--C 1.474 -1.973 0 C-N-CA 116.055 -2.258 . . . . 201.04 105.29 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 C-N-CA 115.951 -2.3 . . . . 201.36 108.723 -175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.46 -41.46 89.76 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.213 -1.812 . . . . 203.82 107.862 174.458 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.28 -45.74 86.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.182 -1.407 . . . . 215.06 112.531 -171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.61 -46.49 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.594 -1.242 . . . . 125.28 112.902 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -36.98 86.07 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.178 -1.415 . . . . 268.9 107.178 -171.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.39 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.704 1.601 . . . . 280.88 108.77 -172.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.42 86.37 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.971 -1.092 . . . . 184.47 108.992 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.13 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 119.292 -0.963 . . . . 167.92 112.712 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 117.779 -1.568 . . . . 367.18 110.815 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.19 -32.78 74.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.87 -0.519 . . . . 173.97 110.45 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.37 -36.77 85.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 123.536 0.735 . . . . 119.66 109.86 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.819 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.98 74.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.718 -1.216 . . . . 112.3 107.718 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.06 -32.04 73.32 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.218 -0.446 . . . . 174.17 110.24 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.1 m -64.8 -22.75 67.05 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 124.643 1.177 . . . . 145.27 110.613 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.763 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.59 -35.41 70.36 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.066 -1.087 . . . . 170.15 108.066 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.24 -34.16 63.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 122.691 0.396 . . . . 214.57 110.696 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.2 ttt -77.29 -33.12 55.84 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.044 1.738 . . . . 168.29 115.523 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.763 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.89 79.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.06 1.133 . . . . 167.15 114.06 -168.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.7 p-10 -64.18 -38.29 33.42 Favored Pre-proline 0 N--CA 1.433 -1.301 0 C-N-CA 115.553 -2.459 . . . . 165.13 113.956 -171.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.56 -31.86 79.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.791 2.033 . . . . 123.92 111.208 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.924 -1.11 . . . . 110.55 109.754 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.13 -40.02 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 N-CA-C 108.87 -0.789 . . . . 145.31 108.87 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.4 m-85 -58.13 -48.86 78.95 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.419 -0.912 . . . . 246.68 109.793 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.9 m -62.18 -47.5 84.21 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.563 -0.855 . . . . 64.43 109.569 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.75 -45.09 79.68 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.249 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.76 75.85 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 115.954 1.835 . . . . 140.44 115.954 -173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.8 132.24 34.43 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.062 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.01 -37.09 86.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.391 -1.277 . . . . 110.22 110.105 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.63 72.56 Favored 'General case' 0 CA--C 1.492 -1.26 0 O-C-N 121.77 -0.581 . . . . 174.78 109.74 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.84 -41.74 95.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.232 -1.025 . . . . 161.84 108.232 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.16 73.81 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 120.056 -0.657 . . . . 117.2 109.239 -173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.56 -44.06 75.29 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.34 -0.544 . . . . 112.6 111.064 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.874 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.02 -37.5 94.7 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.631 -0.988 . . . . 101.46 110.631 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.021 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.08 -46.06 90.75 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-N 118.477 1.138 . . . . 151.49 109.501 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.896 -1.52 . . . . 142.32 106.896 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.82 -41.8 92.11 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.39 85.79 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 122.321 -0.237 . . . . 76.11 111.073 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.45 -55.45 31.15 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 119.816 -0.753 . . . . 120.24 109.354 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.576 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.35 131.49 41.17 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 102.95 -2.982 . . . . 192.73 102.95 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.13 -44.21 92.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 119.019 -1.072 . . . . 176.29 109.201 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.4 m -79.37 -177.09 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 106.3 -1.741 . . . . 69.68 106.3 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.98 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.397 0 C-N-CA 118.34 -0.64 . . . . 191.05 112.607 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.48 43.97 16.29 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.562 0.539 . . . . 287.03 109.742 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.59 78.54 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.938 0 C-N-CA 112.958 -3.497 . . . . 292.29 109.841 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.44 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 104.242 -2.503 . . . . 184.57 104.242 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.66 4.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 113.062 0.764 . . . . 274.56 113.062 176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.89 57.27 Favored Glycine 0 C--N 1.348 1.235 0 C-N-CA 117.693 -2.194 . . . . 268.24 113.473 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.59 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 118.658 1.229 . . . . 200.06 110.768 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.96 74.67 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.873 -1.158 . . . . 114.44 107.873 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.2 46.08 22.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.642 -1.244 . . . . 263.81 107.642 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.33 -137.34 3.59 Favored Glycine 0 CA--C 1.478 -2.237 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 114.901 -2.72 . . . . 117.3 106.077 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.98 -39.79 90.66 Favored 'General case' 0 CA--C 1.468 -2.182 1 N-CA-C 97.946 -4.835 . . . . 231.58 97.946 167.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.044 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -133.0 163.45 29.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.085 -3.302 . . . . 303.24 102.085 169.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.57 78.85 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 116.02 -2.272 . . . . 112.72 108.407 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.69 1.21 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 109.097 -0.705 . . . . 83.22 109.097 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.24 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.827 -2.657 . . . . 174.36 103.827 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.89 160.94 8.83 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 105.775 -1.935 . . . . 202.73 105.775 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.06 52.55 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.048 -1.464 . . . . 180.62 107.048 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.55 -171.88 0.26 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 105.374 -2.084 . . . . 145.25 105.374 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.17 88.1 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.106 -1.813 . . . . 66.05 106.106 174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.71 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.519 -2.771 . . . . 266.49 103.519 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.3 -124.95 0.28 Allowed 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 117.06 -1.856 . . . . 219.2 107.751 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.42 94.19 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.554 -1.203 . . . . 94.78 112.817 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.19 100.4 9.08 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.352 -3.739 . . . . 121.41 109.474 -171.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.04 145.51 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-N 115.548 -0.751 . . . . 85.34 108.985 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.43 41.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 49.9 mtmt 50.04 69.63 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.513 -0.551 . . . . 226.1 109.513 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.05 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.985 -1.487 . . . . 154.84 106.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.35 161.99 8.44 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.625 0.726 . . . . 180.01 110.677 -173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.95 23.6 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.967 -1.494 . . . . 333.78 106.967 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.07 142.51 48.8 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.319 -1.363 . . . . 335.2 107.319 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.87 158.83 0.13 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.713 -0.847 . . . . 266.47 108.713 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.6 -46.85 88.72 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 105.691 -1.966 . . . . 59.34 105.691 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.9 11.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.419 -2.438 . . . . 201.26 104.419 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.4 mt -95.98 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 C-N-CA 116.314 -2.154 . . . . 56.23 105.507 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.18 -59.49 5.25 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 109.282 -0.636 . . . . 87.58 109.282 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.77 22.26 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.862 -1.162 . . . . 219.95 107.862 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.05 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 C-N-CA 116.305 -2.158 . . . . 121.79 105.449 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.11 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 105.855 -1.906 . . . . 53.85 105.855 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.55 77.09 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.038 -2.825 . . . . 196.55 106.038 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.697 0 N-CA-C 107.878 -1.156 . . . . 35.88 107.878 -178.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.644 ' N ' ' OE1' ' A' ' 186' ' ' GLU . 6.4 mtt180 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 365' ' ' ARG . 48.3 Cg_endo -66.65 -20.2 53.27 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.148 2.565 . . . . 1.0 113.816 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 5.2 ttpt -82.83 -55.26 0.53 Allowed Pre-proline 0 N--CA 1.471 0.581 0 N-CA-C 111.706 0.261 . . . . 1.0 111.706 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.565 ' HB2' HD21 ' A' ' 5' ' ' LEU . 26.6 Cg_endo -60.3 -27.66 85.32 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.885 1.724 . . . . 1.0 111.826 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.1 OUTLIER -94.73 51.22 1.38 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.043 0.449 . . . . 1.0 110.395 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' B' ' 372' ' ' PHE . 5.1 mt-30 -83.26 16.83 2.29 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' B' ' 369' ' ' GLN . 20.6 m-85 -75.67 20.85 0.16 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.691 -1.14 . . . . 1.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' B' ' 370' ' ' GLN . 31.7 m-85 -74.91 10.99 1.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 1.0 110.288 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' B' ' 371' ' ' PHE . . . -58.14 -10.52 7.28 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -42.19 73.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.718 0.294 . . . . 1.0 110.731 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.417 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.473 0 N-CA-C 108.372 -0.974 . . . . 97.08 108.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.57 155.39 22.4 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 122.119 0.962 . . . . 123.41 110.731 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.884 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.57 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.492 1 N-CA-C 100.114 -4.032 . . . . 151.3 100.114 173.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.62 -38.6 58.54 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 115.964 -2.294 . . . . 169.25 106.121 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.28 168.57 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 110.499 -0.616 . . . . 185.76 110.499 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.9 t -64.52 -25.91 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 C-N-CA 127.046 2.138 . . . . 145.47 110.334 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.39 21.47 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 121.033 -1.042 . . . . 102.76 109.427 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.55 154.15 25.17 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.048 -1.093 . . . . 106.25 108.048 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.95 51.9 0.74 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 117.759 -1.577 . . . . 157.81 107.603 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.14 -45.91 91.43 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.605 -2.739 . . . . 150.2 103.605 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.02 164.66 35.44 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 103.662 -2.718 . . . . 183.52 103.662 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -76.72 6.8 3.87 Favored 'Trans proline' 0 C--N 1.281 -2.98 0 N-CA-C 110.004 -0.806 . . . . 235.61 110.004 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.83 -41.31 82.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.822 1.249 . . . . 113.77 113.392 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.23 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 119.52 1.055 . . . . 150.85 110.982 -176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.48 156.29 46.39 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 107.591 -1.262 . . . . 100.42 107.591 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.085 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.05 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.949 0.88 . . . . 129.36 110.46 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.09 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 126.276 1.83 . . . . 112.34 106.67 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.16 -40.12 62.8 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.553 -0.748 . . . . 131.73 111.728 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.085 ' H ' HG23 ' A' ' 17' ' ' THR . 71.1 m -84.46 -42.95 15.09 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 116.934 2.198 . . . . 80.49 116.934 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.92 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.786 0 C-N-CA 118.187 -1.405 . . . . 98.98 111.183 -169.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.8 -10.65 17.82 Favored 'Trans proline' 0 C--N 1.322 -0.85 1 N-CA-C 128.973 6.49 . . . . 246.95 128.973 -170.124 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.6 17.48 8.63 Favored 'General case' 0 C--N 1.324 -0.517 1 CA-C-N 126.127 4.058 . . . . 269.62 114.269 175.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.07 -27.27 67.23 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.844 -1.169 . . . . 86.8 107.844 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.87 -29.28 69.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.101 -1.0 . . . . 85.91 110.523 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.55 -40.2 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 C-N-CA 123.692 0.797 . . . . 82.0 111.357 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.72 12.51 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.553 -0.906 . . . . 120.73 108.553 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.906 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.72 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 120.644 0.896 . . . . 87.86 109.906 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.26 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.887 -0.783 . . . . 36.46 108.887 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.799 -1.186 . . . . 150.6 107.799 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.906 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.13 -32.74 73.37 Favored 'General case' 0 CA--C 1.489 -1.366 0 O-C-N 121.299 -0.875 . . . . 123.26 108.703 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.48 -47.2 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.107 -0.701 . . . . 120.14 109.107 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.843 -1.169 . . . . 112.19 107.843 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.99 -47.08 84.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 119.9 -0.72 . . . . 60.87 109.658 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.64 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.978 -0.689 . . . . 157.57 110.342 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.64 -40.89 98.45 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.635 -0.876 . . . . 47.06 108.635 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.8 -0.563 . . . . 43.94 109.541 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.76 -43.33 99.06 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.734 -0.839 . . . . 42.61 108.734 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.36 -41.26 94.0 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 116.601 -0.272 . . . . 140.66 111.035 -178.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.8 -43.94 97.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 118.597 -1.241 . . . . 116.04 110.223 -175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.42 -38.81 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 108.693 -0.854 . . . . 97.16 108.693 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.26 -40.0 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.983 -0.747 . . . . 54.85 108.983 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.952 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.76 -42.3 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.855 -0.794 . . . . 45.39 108.855 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.53 -50.98 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 118.812 -1.155 . . . . 48.64 110.119 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.28 -47.07 77.95 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.15 -0.62 . . . . 116.65 111.699 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.88 -43.99 97.71 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.711 -0.477 . . . . 51.16 109.711 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.2 t -65.57 -48.89 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 119.809 -0.757 . . . . 44.3 110.841 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.72 -46.99 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.304 -0.559 . . . . 48.82 111.023 -174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.72 -44.2 95.21 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.571 -0.824 . . . . 58.7 112.01 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.62 -34.21 67.18 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 122.11 -0.641 . . . . 101.4 111.009 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.88 -38.77 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.2 t -61.44 -43.03 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.978 -0.749 . . . . 61.89 108.978 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.3 t -63.38 -51.02 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.498 -0.556 . . . . 70.01 109.498 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.801 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.44 98.8 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.134 -0.691 . . . . 132.1 109.134 -176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.56 83.31 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 116.703 -0.226 . . . . 104.5 110.488 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.85 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 C-N-CA 120.202 -0.599 . . . . 142.96 111.294 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.955 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.81 -41.69 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 116.937 -1.905 . . . . 158.32 110.873 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 117.764 -1.575 . . . . 137.11 109.505 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.52 91.06 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 122.135 -0.353 . . . . 54.66 111.029 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.621 0.724 . . . . 127.18 109.559 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.88 -36.83 80.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 124.091 0.956 . . . . 87.93 110.801 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.032 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.41 -34.59 78.54 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.625 -0.672 . . . . 131.12 111.526 -175.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.68 69.45 7.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 115.309 -2.557 . . . . 246.56 109.636 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.22 91.41 3.48 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 105.455 -2.054 . . . . 339.35 105.455 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.11 165.28 17.8 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 103.021 -2.955 . . . . 114.66 103.021 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.16 -39.41 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 106.796 -1.557 . . . . 143.28 106.796 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 96.0 m -59.72 -37.99 80.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.688 -0.856 . . . . 160.22 108.688 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.38 -31.78 72.49 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 108.861 -0.792 . . . . 120.54 108.861 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.61 -43.73 96.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.51 -0.552 . . . . 67.22 109.51 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.6 -39.73 88.51 Favored 'General case' 0 CA--C 1.497 -1.059 0 O-C-N 121.478 -0.764 . . . . 138.6 109.658 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.924 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.97 82.26 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.523 0.329 . . . . 151.46 110.634 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HD11 ' A' ' 57' ' ' ILE . 24.1 m -62.53 -37.94 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.346 -1.741 . . . . 117.93 106.751 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.05 90.83 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.828 -1.175 . . . . 56.82 107.828 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.0 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.39 -43.9 98.08 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.907 -0.775 . . . . 145.3 108.907 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.32 95.33 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.558 -0.905 . . . . 45.71 108.558 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.42 -41.99 99.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.38 -0.6 . . . . 105.61 109.38 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.39 92.53 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.647 -0.871 . . . . 47.89 108.647 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.4 84.82 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 109.928 -0.397 . . . . 124.53 109.928 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.26 99.29 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.929 -0.482 . . . . 35.89 109.827 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.25 -37.26 84.76 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.023 -1.473 . . . . 88.97 107.023 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.21 -49.14 76.97 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 119.769 -0.772 . . . . 239.91 109.043 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.44 90.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.595 -0.69 . . . . 146.1 110.63 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 117.412 -1.715 . . . . 91.74 113.847 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.58 -61.39 1.98 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.942 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.21 -42.27 55.91 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 117.949 -1.501 . . . . 242.6 114.06 -170.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.952 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.4 -36.63 84.54 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 118.945 -1.102 . . . . 215.61 109.811 -172.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.24 -46.98 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 O-C-N 121.822 -0.549 . . . . 87.19 110.498 -175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.85 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.75 -0.463 . . . . 231.82 109.75 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.18 -44.69 75.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.515 -0.741 . . . . 181.63 111.305 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.89 -45.78 93.25 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.401 -1.333 . . . . 269.02 107.401 -175.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.051 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.06 93.26 Favored 'General case' 0 N--CA 1.416 -2.158 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.03 -179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.07 -45.28 95.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.695 -1.202 . . . . 446.75 108.1 -167.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.29 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.796 -2.362 . . . . 370.05 112.229 -178.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.5 -26.46 60.01 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.546 -0.721 . . . . 354.91 112.495 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.76 4.56 1.0 Allowed 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 125.075 1.35 . . . . 462.44 111.921 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 12.0 mm-40 -172.4 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-O 121.983 0.896 . . . . 652.37 111.153 171.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.77 86.33 2.19 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 128.507 2.723 . . . . 905.99 107.914 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.9 -36.37 80.1 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.263 -1.014 . . . . 570.43 108.263 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.54 -36.37 82.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.314 1.446 . . . . 453.22 111.139 -174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.89 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.936 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.44 -41.23 76.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.28 1.432 . . . . 457.72 112.324 -170.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' B' ' 375' ' ' MET . 22.5 m-85 -58.69 -46.88 86.29 Favored 'General case' 0 CA--C 1.485 -1.552 0 C-N-CA 118.636 -1.226 . . . . 340.58 109.29 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.75 -32.09 71.6 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 118.742 -1.183 . . . . 453.6 111.597 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.06 -40.33 73.41 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.004 -1.851 . . . . 541.48 106.004 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.79 -47.15 76.07 Favored 'General case' 0 CA--C 1.486 -1.508 0 O-C-N 123.988 0.805 . . . . 466.68 110.902 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -61.74 -47.05 86.97 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 117.445 -1.702 . . . . 427.34 107.32 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 m80 -67.13 -36.75 82.55 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 112.383 0.512 . . . . 537.87 112.383 -174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.41 -42.7 74.72 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 116.894 -1.923 . . . . 422.12 111.559 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.12 -50.02 75.65 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 121.348 -0.845 . . . . 340.17 111.835 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.3 -46.56 71.32 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 119.081 -1.048 . . . . 258.06 111.711 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.48 -31.6 87.9 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.88 -40.38 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.684 -0.858 . . . . 252.7 108.684 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.67 93.95 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.799 -1.185 . . . . 149.27 107.799 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.8 95.95 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.594 -0.442 . . . . 138.08 111.491 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.8 t -66.92 -42.41 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 O-C-N 121.648 -0.657 . . . . 132.89 110.949 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.921 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.66 92.88 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.888 -0.782 . . . . 193.61 108.888 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.7 84.52 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 122.783 0.433 . . . . 63.83 110.133 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -63.99 -52.42 59.7 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.08 -0.388 . . . . 76.4 111.207 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.98 -41.64 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.177 -1.045 . . . . 171.13 108.177 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.104 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.58 91.64 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 121.799 -0.563 . . . . 78.3 110.623 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.8 t -67.09 -35.78 80.55 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.946 -1.101 . . . . 92.36 109.204 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 1.0 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.33 76.59 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.185 -1.042 . . . . 93.73 108.185 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.65 84.64 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.236 -0.986 . . . . 132.74 109.345 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.14 94.71 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.169 -1.419 . . . . 43.39 107.169 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.45 -42.0 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 108.598 -0.89 . . . . 59.34 108.598 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.05 95.54 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.807 -0.558 . . . . 69.68 110.538 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.466 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.72 91.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.355 -0.98 . . . . 106.98 108.355 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.36 -35.64 81.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.641 -0.824 . . . . 147.63 108.958 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.58 99.38 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.543 -0.91 . . . . 190.06 108.543 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.7 t80 -61.29 -44.09 97.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.311 -0.996 . . . . 118.85 108.311 -177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.4 -42.65 98.79 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.983 -0.377 . . . . 102.5 109.983 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.6 95.2 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 121.816 -0.552 . . . . 89.98 109.815 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.922 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.53 -50.73 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 C-N-CA 118.165 -1.414 . . . . 106.09 110.994 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.04 -48.33 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 C-N-CA 117.088 -1.845 . . . . 227.74 111.828 -174.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.755 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.1 50.97 Favored Pre-proline 0 CA--C 1.485 -1.52 0 C-N-CA 116.198 -2.201 . . . . 262.55 110.055 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.42 28.68 Favored 'Trans proline' 0 C--N 1.289 -2.562 0 C-N-CA 121.629 1.553 . . . . 210.25 111.379 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.31 111.97 0.99 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.513 -1.662 . . . . 270.58 106.513 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.53 24.56 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.338 -0.846 . . . . 129.84 112.344 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.0 Cg_exo -61.36 -26.61 81.78 Favored 'Trans proline' 0 N--CA 1.432 -2.118 0 N-CA-C 116.287 1.61 . . . . 330.71 116.287 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.755 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.24 7.95 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 114.461 -2.896 . . . . 204.51 107.252 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.69 147.45 0.09 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.457 -1.312 . . . . 387.41 107.457 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.72 146.99 33.59 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 118.811 -1.156 . . . . 166.22 109.46 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.15 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.854 -1.165 . . . . 44.23 107.854 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.33 -39.1 85.88 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 108.168 -1.049 . . . . 28.8 108.168 -175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.8 -38.83 92.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 109.074 -0.713 . . . . 30.29 109.074 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.848 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.57 -43.03 93.74 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.998 -0.741 . . . . 46.11 108.998 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.22 99.29 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.666 -1.235 . . . . 87.33 107.666 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.63 -42.07 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 107.993 -1.114 . . . . 23.69 107.993 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 93.0 t -63.13 -44.34 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 109.713 -0.477 . . . . 43.86 109.713 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.55 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 108.345 -0.983 . . . . 91.13 108.345 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.66 -37.91 88.23 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.76 -0.83 . . . . 65.88 108.76 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.08 -41.91 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.104 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.37 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.265 . . . . 146.52 107.586 -176.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.698 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.87 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.473 -0.891 . . . . 75.44 108.887 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 99.1 t -60.47 -48.45 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.073 -1.017 . . . . 43.64 109.748 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -37.99 89.44 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.009 -0.738 . . . . 102.57 109.009 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.09 86.93 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.397 -1.334 . . . . 58.16 107.397 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.02 -32.5 73.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.038 -0.727 . . . . 121.11 109.038 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.05 -42.33 85.18 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 118.571 -1.252 . . . . 153.15 109.873 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.529 173.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.84 95.97 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 120.887 -1.133 . . . . 157.42 112.186 -171.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.5 -36.1 2.42 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 115.004 1.483 . . . . 250.91 115.004 -173.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.2 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.489 -1.762 0 N-CA-C 117.991 2.266 . . . . 207.34 117.991 -174.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.12 -34.3 74.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.9 -1.518 . . . . 192.46 106.9 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.06 98.17 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 107.976 -2.05 . . . . 261.0 107.976 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -65.82 159.1 26.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.489 -3.523 . . . . 491.4 101.489 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 116.211 -2.196 . . . . 386.1 109.882 -176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.6 2.41 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 103.532 -2.766 . . . . 289.8 103.532 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.143 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.94 175.46 0.86 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 117.765 -1.112 . . . . 402.06 109.558 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.6 p -165.31 177.53 7.5 Favored 'General case' 0 CA--C 1.587 2.382 0 C-N-CA 127.318 2.247 . . . . 690.53 114.915 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.54 0.0 OUTLIER 'General case' 1 C--N 1.429 4.032 1 N-CA-C 123.21 4.522 . . . . 633.62 123.21 162.721 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.65 153.85 22.08 Favored 'General case' 0 C--N 1.389 2.323 0 C-N-CA 127.35 2.26 . . . . 617.99 110.937 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.048 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.72 174.37 6.04 Favored Pre-proline 0 C--N 1.364 1.21 0 C-N-CA 130.258 3.423 . . . . 434.98 113.37 -175.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.7 Cg_endo -44.2 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.543 0 N-CA-C 122.447 3.979 . . . . 365.88 122.447 -168.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.779 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.87 20.94 1.69 Allowed 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.785 -2.302 . . . . 635.81 104.785 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.455 5.0 mmp_? -94.42 152.29 18.72 Favored 'General case' 1 CA--C 1.419 -4.063 3 N-CA-C 131.99 7.774 . . . . 999.99 131.99 -135.791 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.051 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.87 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.276 -6.329 . . . . 594.32 113.564 149.231 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.23 144.14 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 1 N-CA-C 98.3 -4.704 . . . . 811.91 98.3 162.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.55 45.94 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 117.032 -1.867 . . . . 999.99 109.412 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.22 -175.58 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.035 0.921 . . . . 431.86 110.039 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.036 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.17 148.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 124.326 1.05 . . . . 457.18 108.802 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.33 85.42 3.75 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 124.125 0.97 . . . . 458.77 113.493 -174.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.31 -31.61 0.99 Allowed Pre-proline 0 N--CA 1.438 -1.042 0 C-N-CA 124.956 1.303 . . . . 999.99 112.454 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.958 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.99 -45.75 5.6 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 N-CA-C 120.843 3.363 . . . . 999.99 120.843 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.73 8.16 Favored 'General case' 0 CA--C 1.471 -2.064 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.263 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.864 0 C-N-CA 115.479 -2.488 . . . . 999.99 108.77 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.48 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.02 4.48 . . . . 999.99 105.684 -170.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.33 -44.03 97.44 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 126.773 2.029 . . . . 967.72 112.049 -165.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.19 -36.6 78.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.28 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 129.248 3.019 . . . . 565.15 113.923 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.52 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.422 0.555 . . . . 755.61 109.86 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.143 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.25 67.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.557 1.143 . . . . 325.89 113.25 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.77 -45.01 78.22 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 123.571 0.748 . . . . 250.21 111.656 -169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.71 -43.36 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.575 0.702 . . . . 142.46 110.384 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.036 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.11 -41.5 96.81 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 124.003 0.921 . . . . 247.69 108.827 -173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.823 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.57 -51.3 70.01 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 125.46 1.504 . . . . 199.61 113.087 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.36 -44.49 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.717 -1.216 . . . . 106.73 107.717 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.6 81.03 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.898 -0.592 . . . . 115.01 110.196 -173.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.24 -49.15 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 119.446 -0.902 . . . . 129.42 111.831 -174.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.6 m -61.84 -53.13 60.03 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 118.212 -1.395 . . . . 172.48 109.979 -172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.86 -54.31 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 120.477 -0.489 . . . . 55.86 110.975 -174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.45 -51.56 59.3 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.539 -1.265 . . . . 184.68 111.553 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.053 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.46 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 C-N-CA 116.681 -2.008 . . . . 291.81 114.741 -174.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.9 t80 -81.99 -55.09 4.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.15 1.537 . . . . 130.66 115.15 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.8 -48.55 68.63 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 114.511 1.3 . . . . 80.16 114.511 -170.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.904 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.58 -45.42 82.97 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 119.969 -0.693 . . . . 136.02 109.516 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.82 -27.13 59.52 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 N-CA-C 110.611 -0.573 . . . . 92.17 110.611 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.29 76.67 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.509 -1.293 . . . . 135.6 107.509 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.23 -44.66 91.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.575 -0.528 . . . . 52.1 109.575 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.7 -43.48 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.084 -0.71 . . . . 95.89 109.084 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.64 -1.615 . . . . 43.41 106.64 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.23 99.1 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.75 -47.34 75.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-N 117.392 0.596 . . . . 54.41 110.416 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.08 74.79 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.953 -1.499 . . . . 53.88 106.953 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.78 -40.86 94.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.47 -0.937 . . . . 68.29 108.47 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.02 92.93 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.636 -0.825 . . . . 107.59 110.634 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.513 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.27 -22.56 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.399 -0.963 . . . . 85.26 108.399 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.98 99.39 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.047 -0.821 . . . . 40.71 111.047 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.68 -44.08 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 108.42 -0.956 . . . . 95.86 108.42 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.82 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.92 -137.56 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.443 -0.947 . . . . 144.37 108.443 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.33 132.14 47.33 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 107.668 -1.234 . . . . 326.72 107.668 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.464 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.99 -1.856 . . . . 158.38 105.99 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.464 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.36 -41.9 98.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.671 -0.492 . . . . 36.78 109.671 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.11 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.14 -1.024 . . . . 85.46 109.822 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.56 8.86 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.549 -2.019 . . . . 127.78 105.549 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.92 34.82 Favored Pre-proline 0 CA--C 1.492 -1.258 0 N-CA-C 105.987 -1.857 . . . . 164.84 105.987 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.85 -39.86 88.37 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.956 0.714 . . . . 222.35 113.956 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.0 44.99 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 106.44 -2.664 . . . . 45.22 106.44 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.97 -45.75 93.5 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.04 -1.837 . . . . 107.57 106.04 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.8 m -65.82 141.81 58.16 Favored 'General case' 0 N--CA 1.428 -1.535 0 C-N-CA 118.923 -1.111 . . . . 167.96 109.148 -175.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.52 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.686 1.994 . . . . 280.68 109.723 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.28 0.7 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.467 1.107 . . . . 218.25 110.692 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.39 137.65 54.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.204 -2.147 . . . . 343.57 105.204 177.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.87 1.53 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.06 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 126.589 1.956 . . . . 261.92 108.509 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.11 89.86 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 107.902 -1.148 . . . . 106.81 107.902 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.38 -40.01 95.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.567 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.19 -39.78 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.312 -0.625 . . . . 45.41 109.312 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.97 -32.06 68.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 110.238 -0.282 . . . . 97.62 110.238 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.6 81.58 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.693 0.797 . . . . 59.29 111.011 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.22 -36.56 84.06 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 124.692 1.197 . . . . 106.49 110.659 -174.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.71 69.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.272 -1.01 . . . . 106.62 108.272 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.96 -41.04 91.76 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 121.861 -0.525 . . . . 75.97 110.085 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.439 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.4 t -65.53 -40.87 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 122.88 0.472 . . . . 65.27 109.785 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -63.99 -41.58 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.37 -0.532 . . . . 107.94 110.186 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.57 -40.77 97.83 Favored 'General case' 0 N--CA 1.434 -1.263 0 O-C-N 121.716 -0.615 . . . . 87.98 110.278 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.6 -40.43 96.93 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 118.802 -1.159 . . . . 65.5 108.372 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.73 -36.29 80.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.144 -1.058 . . . . 85.05 108.144 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.55 -45.74 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 109.037 -0.727 . . . . 42.25 109.037 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.25 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.544 -0.863 . . . . 91.01 109.414 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.56 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 107.993 -1.114 . . . . 66.09 107.993 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.17 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.757 -0.377 . . . . 52.39 110.359 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.77 -46.8 88.01 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.857 -0.527 . . . . 46.42 109.836 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.08 88.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.49 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.26 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.407 -0.59 . . . . 65.18 109.407 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.73 97.3 Favored 'General case' 0 CA--C 1.49 -1.349 0 O-C-N 122.07 -0.394 . . . . 51.33 110.448 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.59 -43.37 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 118.93 -1.108 . . . . 126.3 109.007 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.507 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.62 -49.31 69.17 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 119.561 -0.856 . . . . 133.94 112.487 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.818 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.69 -33.35 35.48 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 116.911 2.189 . . . . 134.84 116.911 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.46 -41.59 90.02 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.665 -0.647 . . . . 72.23 111.676 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.8 Cg_exo -60.63 -35.99 87.26 Favored 'Trans proline' 0 C--N 1.295 -2.286 0 CA-C-N 119.843 0.98 . . . . 106.13 111.36 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.85 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.43 -44.67 82.24 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.757 -0.777 . . . . 128.35 110.05 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.44 -37.87 89.03 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 110.198 -0.297 . . . . 100.73 110.198 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.24 -44.56 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 C-N-CA 119.328 -0.949 . . . . 172.72 109.185 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.57 -28.12 68.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.22 -1.03 . . . . 249.23 108.22 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.09 35.96 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.705 -1.591 . . . . 259.78 106.705 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.0 mt -69.16 -44.2 72.74 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 113.575 0.954 . . . . 233.11 113.575 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.37 -48.3 91.42 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 119.204 -0.998 . . . . 169.54 110.583 -171.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.7 Cg_exo -61.12 -24.56 79.54 Favored 'Trans proline' 0 N--CA 1.43 -2.24 0 C-N-CA 116.723 -1.718 . . . . 255.47 114.676 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.823 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.62 -44.17 94.71 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 119.227 0.921 . . . . 279.03 108.877 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.35 -44.79 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.785 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.9 59.33 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.736 -1.186 . . . . 128.13 108.103 -178.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.27 164.07 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 107.42 -1.8 . . . . 278.35 107.42 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.865 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.0 9.92 Favored 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 123.819 0.7 . . . . 312.91 109.321 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.865 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.7 -170.69 2.49 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.57 -1.641 . . . . 353.54 106.57 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.63 142.27 46.96 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 107.459 -1.312 . . . . 251.26 107.459 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 102.056 -3.313 . . . . 175.26 102.056 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.791 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.43 -45.02 96.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.791 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.37 124.18 9.23 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 103.512 -2.773 . . . . 243.21 103.512 171.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 112.96 25.1 Favored 'General case' 0 CA--C 1.473 -1.985 0 C-N-CA 116.071 -2.252 . . . . 201.04 105.284 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 C-N-CA 116.016 -2.274 . . . . 201.36 108.828 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.55 -41.4 90.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.258 -1.792 . . . . 203.82 107.884 174.504 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.63 87.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.185 -1.406 . . . . 215.06 112.586 -171.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.75 -46.37 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 C-N-CA 118.576 -1.249 . . . . 125.28 112.906 -171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.948 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.81 -37.02 86.22 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.182 -1.414 . . . . 268.9 107.182 -171.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.2 -44.96 74.65 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 125.632 1.573 . . . . 280.88 108.822 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.48 86.09 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 118.98 -1.088 . . . . 184.47 109.003 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.85 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.06 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.29 -0.964 . . . . 167.92 112.771 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.75 -38.87 90.29 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.797 -1.561 . . . . 367.18 110.766 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.13 -32.73 74.04 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.866 -0.521 . . . . 173.97 110.42 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.44 -36.79 85.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.572 0.749 . . . . 119.66 109.795 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.818 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.24 -33.95 74.34 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.737 -1.208 . . . . 112.3 107.737 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.06 73.35 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.229 -0.442 . . . . 174.17 110.221 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.81 -22.73 67.05 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.703 1.201 . . . . 145.27 110.616 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.63 -35.35 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.1 -1.074 . . . . 170.15 108.1 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.32 -34.15 63.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 116.294 -0.412 . . . . 214.57 110.626 -171.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.18 56.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.096 1.758 . . . . 168.29 115.537 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.41 -34.91 79.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 114.033 1.123 . . . . 167.15 114.033 -168.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.284 18.8 p-10 -64.13 -38.33 34.09 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.531 -2.468 . . . . 165.13 113.959 -171.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.5 -31.88 80.29 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 122.713 2.005 . . . . 123.92 111.265 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.55 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.766 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.1 -40.06 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 108.873 -0.788 . . . . 145.31 108.873 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.924 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.05 -48.88 78.77 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.837 -177.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.0 m -62.17 -47.48 84.32 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 119.489 -0.884 . . . . 64.43 109.628 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.79 -45.08 79.58 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.961 -1.096 . . . . 80.72 110.237 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.65 75.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 116.0 1.852 . . . . 140.44 116.0 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.86 132.24 34.31 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.717 -3.593 . . . . 178.87 113.005 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.611 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.14 86.63 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.102 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.69 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.733 -0.604 . . . . 174.78 109.771 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.83 -41.76 95.48 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.32 -50.21 73.65 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.177 -0.675 . . . . 117.2 109.177 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.803 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.08 75.41 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 120.393 -0.523 . . . . 112.6 111.072 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.05 -37.43 94.58 Favored Glycine 0 N--CA 1.43 -1.7 0 N-CA-C 110.65 -0.98 . . . . 101.46 110.65 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.009 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -62.15 -46.01 90.88 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 118.503 1.152 . . . . 151.49 109.542 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.05 -36.3 77.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.941 -1.503 . . . . 142.32 106.941 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.87 -41.81 92.34 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.862 -1.533 . . . . 109.09 106.862 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.8 -42.45 85.91 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.336 -0.227 . . . . 76.11 111.037 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.44 -55.44 31.27 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.858 -0.737 . . . . 120.24 109.306 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.53 41.22 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 102.907 -2.997 . . . . 192.73 102.907 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.24 92.11 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 118.997 -1.081 . . . . 176.29 109.167 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.1 m -79.36 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 106.295 -1.743 . . . . 69.68 106.295 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.92 -75.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 118.358 -0.628 . . . . 191.05 112.589 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.46 43.91 16.16 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 123.572 0.545 . . . . 287.03 109.753 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 C-N-CA 112.989 -3.485 . . . . 292.29 109.834 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.48 -152.87 0.05 Allowed 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 104.197 -2.52 . . . . 184.57 104.197 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.77 8.59 4.91 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 113.081 0.771 . . . . 274.56 113.081 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.03 0.84 57.21 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 117.704 -2.188 . . . . 268.24 113.465 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.59 -172.06 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 118.635 1.217 . . . . 200.06 110.746 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.83 -33.03 74.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.23 46.1 21.91 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.651 -1.24 . . . . 263.81 107.651 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.632 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.28 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.515 -4.234 . . . . 103.79 102.515 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.038 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.65 10.26 Favored 'General case' 0 N--CA 1.42 -1.965 0 C-N-CA 114.926 -2.71 . . . . 117.3 105.997 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.019 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.69 Favored 'General case' 0 CA--C 1.468 -2.209 1 N-CA-C 98.002 -4.814 . . . . 231.58 98.002 167.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.032 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.038 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.55 -48.64 78.6 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 116.048 -2.261 . . . . 112.72 108.438 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.6 1.24 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.104 -0.702 . . . . 83.22 109.104 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.8 m -156.3 -126.24 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.806 -2.665 . . . . 174.36 103.806 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.019 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.83 160.91 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.013 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.378 -2.082 . . . . 145.25 105.378 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.1 -43.12 88.19 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 106.139 -1.8 . . . . 66.05 106.139 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.19 0.48 Allowed 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.497 -2.779 . . . . 266.49 103.497 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.32 -124.91 0.28 Allowed 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 117.039 -1.864 . . . . 219.2 107.806 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.899 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.04 -37.47 94.26 Favored Glycine 0 N--CA 1.425 -2.051 0 CA-C-N 114.58 -1.191 . . . . 94.78 112.849 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.16 100.41 9.06 Favored 'General case' 0 CA--C 1.484 -1.585 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.461 -171.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.51 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 108.936 -0.765 . . . . 85.34 108.936 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.44 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.42 41.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.875 -1.157 . . . . 267.57 107.875 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.98 69.68 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.506 -0.553 . . . . 226.1 109.506 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.02 156.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.003 -1.48 . . . . 154.84 107.003 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.32 161.95 8.41 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.581 0.705 . . . . 180.01 110.76 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.896 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.91 23.67 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 106.958 -1.497 . . . . 333.78 106.958 -178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.52 48.74 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.339 . . . . 335.2 107.386 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.86 158.81 0.13 Allowed 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 108.742 -0.836 . . . . 266.47 108.742 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.59 -46.87 88.63 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.671 -1.974 . . . . 59.34 105.671 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.59 173.87 11.95 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 104.446 -2.428 . . . . 201.26 104.446 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.92 106.69 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.367 -2.133 . . . . 56.23 105.54 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.21 -59.48 5.26 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.261 -0.644 . . . . 87.58 109.261 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.44 153.74 22.29 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 107.895 -1.15 . . . . 219.95 107.895 -177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.79 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 C-N-CA 116.345 -2.142 . . . . 121.79 105.442 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.07 159.76 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 105.852 -1.907 . . . . 53.85 105.852 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.21 16.54 77.02 Favored Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 106.084 -2.806 . . . . 196.55 106.084 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.896 -1.15 . . . . 35.88 107.896 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.553 ' NH2' HD11 ' A' ' 15' ' ' ILE . 13.3 mtt85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.877 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 48.4 Cg_endo -66.59 -20.36 53.54 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.213 2.609 . . . . 1.0 113.76 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 368' ' ' PRO . 0.0 OUTLIER -82.77 -55.34 0.54 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 111.663 0.245 . . . . 1.0 111.663 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' B' ' 367' ' ' LYS . 26.9 Cg_endo -60.33 -27.52 85.02 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.854 1.702 . . . . 1.0 111.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' B' ' 371' ' ' PHE . 0.7 OUTLIER -94.77 51.08 1.36 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.026 0.441 . . . . 1.0 110.37 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.451 ' C ' ' H ' ' B' ' 372' ' ' PHE . 0.0 OUTLIER -83.17 16.84 2.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' B' ' 369' ' ' GLN . 5.7 m-85 -75.72 20.9 0.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.646 -1.161 . . . . 1.0 110.75 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.501 ' CZ ' HG21 ' A' ' 19' ' ' THR . 11.7 m-85 -74.92 11.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.0 110.274 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -58.21 -10.52 7.43 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.995 -0.842 . . . . 1.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 374' ' ' LEU . 0.0 OUTLIER -69.65 -42.26 74.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 1.0 110.829 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.534 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.388 -179.939 . . . . . . . . 2 2 . 1 stop_ save_